id	sid	tid	token	lemma	pos
dpc-4500	1	1	dermatology	dermatology	NOUN
dpc-4500	1	2	:	:	PUNCT
dpc-4500	1	3	practical	practical	ADJ
dpc-4500	1	4	and	and	CCONJ
dpc-4500	1	5	conceptual	conceptual	ADJ
dpc-4500	1	6	original	original	ADJ
dpc-4500	1	7	article	article	NOUN
dpc-4500	1	8	|	|	ADV
dpc-4500	1	9	dermatol	dermatol	ADJ
dpc-4500	1	10	pract	pract	NOUN
dpc-4500	1	11	concept	concept	NOUN
dpc-4500	1	12	.	.	PUNCT
dpc-4500	2	1	2024;14(4):e2024249	2024;14(4):e2024249	NUM
dpc-4500	2	2	1	1	NUM
dpc-4500	2	3	evaluation	evaluation	NOUN
dpc-4500	2	4	of	of	ADP
dpc-4500	2	5	thiol	thiol	ADJ
dpc-4500	2	6	disulfide	disulfide	NOUN
dpc-4500	2	7	,	,	PUNCT
dpc-4500	2	8	ischemia	ischemia	NOUN
dpc-4500	2	9	modified	modify	VERB
dpc-4500	2	10	albumin	albumin	NOUN
dpc-4500	2	11	,	,	PUNCT
dpc-4500	2	12	and	and	CCONJ
dpc-4500	2	13	prolidase	prolidase	NOUN
dpc-4500	2	14	parameters	parameter	NOUN
dpc-4500	2	15	in	in	ADP
dpc-4500	2	16	patients	patient	NOUN
dpc-4500	2	17	with	with	ADP
dpc-4500	2	18	localized	localized	ADJ
dpc-4500	2	19	scleroderma	scleroderma	NOUN
dpc-4500	2	20	ayşe	ayşe	PROPN
dpc-4500	2	21	akbaş1	akbaş1	PROPN
dpc-4500	2	22	,	,	PUNCT
dpc-4500	2	23	orhan	orhan	PROPN
dpc-4500	2	24	şen	şen	NOUN
dpc-4500	2	25	2	2	NUM
dpc-4500	2	26	,	,	PUNCT
dpc-4500	2	27	fadime	fadime	NOUN
dpc-4500	2	28	kılınç	kılınç	PROPN
dpc-4500	2	29	1	1	NUM
dpc-4500	2	30	,	,	PUNCT
dpc-4500	2	31	salim	salim	PROPN
dpc-4500	2	32	neşelioğlu3	neşelioğlu3	PROPN
dpc-4500	2	33	,	,	PUNCT
dpc-4500	2	34	gülhan	gülhan	VERB
dpc-4500	2	35	aksoy	aksoy	ADJ
dpc-4500	2	36	saraç1	saraç1	NOUN
dpc-4500	2	37	,	,	PUNCT
dpc-4500	2	38	akın	akın	NOUN
dpc-4500	2	39	aktaş4	aktaş4	PROPN
dpc-4500	2	40	1	1	NUM
dpc-4500	2	41	ankara	ankara	PROPN
dpc-4500	2	42	city	city	NOUN
dpc-4500	2	43	hospital	hospital	NOUN
dpc-4500	2	44	,	,	PUNCT
dpc-4500	2	45	dermatology	dermatology	NOUN
dpc-4500	2	46	,	,	PUNCT
dpc-4500	2	47	ankara	ankara	PROPN
dpc-4500	2	48	,	,	PUNCT
dpc-4500	2	49	turkey	turkey	PROPN
dpc-4500	2	50	2	2	NUM
dpc-4500	2	51	yozgat	yozgat	ADJ
dpc-4500	2	52	city	city	NOUN
dpc-4500	2	53	hospital	hospital	NOUN
dpc-4500	2	54	,	,	PUNCT
dpc-4500	2	55	dermatology	dermatology	NOUN
dpc-4500	2	56	,	,	PUNCT
dpc-4500	2	57	yozgat	yozgat	ADJ
dpc-4500	2	58	,	,	PUNCT
dpc-4500	2	59	turkey	turkey	NOUN
dpc-4500	2	60	3	3	NUM
dpc-4500	2	61	ankara	ankara	PROPN
dpc-4500	2	62	city	city	NOUN
dpc-4500	2	63	hospital	hospital	NOUN
dpc-4500	2	64	,	,	PUNCT
dpc-4500	2	65	biochemistry	biochemistry	NOUN
dpc-4500	2	66	,	,	PUNCT
dpc-4500	2	67	ankara	ankara	PROPN
dpc-4500	2	68	,	,	PUNCT
dpc-4500	2	69	turkey	turkey	PROPN
dpc-4500	2	70	4	4	NUM
dpc-4500	2	71	yildirim	yildirim	PROPN
dpc-4500	2	72	beyazit	beyazit	PROPN
dpc-4500	2	73	university	university	PROPN
dpc-4500	2	74	,	,	PUNCT
dpc-4500	2	75	medical	medical	ADJ
dpc-4500	2	76	faculty	faculty	NOUN
dpc-4500	2	77	,	,	PUNCT
dpc-4500	2	78	ankara	ankara	PROPN
dpc-4500	2	79	citation	citation	NOUN
dpc-4500	2	80	:	:	PUNCT
dpc-4500	2	81	akbaş	akbaş	PROPN
dpc-4500	2	82	a	a	PRON
dpc-4500	2	83	,	,	PUNCT
dpc-4500	2	84	şen	şen	PROPN
dpc-4500	2	85	o	o	NOUN
dpc-4500	2	86	,	,	PUNCT
dpc-4500	2	87	kılınç	kılınç	PROPN
dpc-4500	2	88	f	f	PROPN
dpc-4500	2	89	,	,	PUNCT
dpc-4500	2	90	neşelioğlu	neşelioğlu	VERB
dpc-4500	2	91	s	s	PROPN
dpc-4500	2	92	,	,	PUNCT
dpc-4500	2	93	aksoy	aksoy	ADJ
dpc-4500	2	94	saraç	saraç	NOUN
dpc-4500	2	95	g	g	NOUN
dpc-4500	2	96	,	,	PUNCT
dpc-4500	2	97	aktaş	aktaş	ADJ
dpc-4500	2	98	a.	a.	NOUN
dpc-4500	2	99	evaluation	evaluation	NOUN
dpc-4500	2	100	of	of	ADP
dpc-4500	2	101	thiol	thiol	ADJ
dpc-4500	2	102	disulfide	disulfide	NOUN
dpc-4500	2	103	,	,	PUNCT
dpc-4500	2	104	ischemia	ischemia	NOUN
dpc-4500	2	105	modified	modify	VERB
dpc-4500	2	106	albumin	albumin	NOUN
dpc-4500	2	107	,	,	PUNCT
dpc-4500	2	108	and	and	CCONJ
dpc-4500	2	109	 	 	SPACE
dpc-4500	2	110	prolidase	prolidase	NOUN
dpc-4500	2	111	parameters	parameter	NOUN
dpc-4500	2	112	in	in	ADP
dpc-4500	2	113	patients	patient	NOUN
dpc-4500	2	114	with	with	ADP
dpc-4500	2	115	localized	localized	ADJ
dpc-4500	2	116	scleroderma	scleroderma	NOUN
dpc-4500	2	117	.	.	PUNCT
dpc-4500	3	1	dermatol	dermatol	NOUN
dpc-4500	3	2	pract	pract	PROPN
dpc-4500	3	3	concept	concept	NOUN
dpc-4500	3	4	.	.	PUNCT
dpc-4500	4	1	2024;14(4):e2024249	2024;14(4):e2024249	NUM
dpc-4500	4	2	.	.	PUNCT
dpc-4500	4	3	doi	doi	PROPN
dpc-4500	4	4	:	:	PUNCT
dpc-4500	4	5	https://doi	https://doi	PROPN
dpc-4500	4	6	.org/10.5826	.org/10.5826	PROPN
dpc-4500	4	7	/	/	SYM
dpc-4500	4	8	dpc.1404a249	dpc.1404a249	PROPN
dpc-4500	4	9	accepted	accept	VERB
dpc-4500	4	10	:	:	PUNCT
dpc-4500	4	11	july	july	PROPN
dpc-4500	4	12	3	3	NUM
dpc-4500	4	13	,	,	PUNCT
dpc-4500	4	14	2024	2024	NUM
dpc-4500	4	15	;	;	PUNCT
dpc-4500	4	16	published	publish	VERB
dpc-4500	4	17	:	:	PUNCT
dpc-4500	4	18	october	october	PROPN
dpc-4500	4	19	2024	2024	NUM
dpc-4500	5	1	copyright	copyright	NOUN
dpc-4500	5	2	:	:	PUNCT
dpc-4500	5	3	©	©	PROPN
dpc-4500	5	4	2024	2024	NUM
dpc-4500	5	5	akbaş	akbaş	PROPN
dpc-4500	5	6	et	et	PROPN
dpc-4500	5	7	al	al	PROPN
dpc-4500	5	8	.	.	PUNCT
dpc-4500	6	1	this	this	PRON
dpc-4500	6	2	is	be	AUX
dpc-4500	6	3	an	an	DET
dpc-4500	6	4	open	open	ADJ
dpc-4500	6	5	-	-	PUNCT
dpc-4500	6	6	access	access	NOUN
dpc-4500	6	7	article	article	NOUN
dpc-4500	6	8	distributed	distribute	VERB
dpc-4500	6	9	under	under	ADP
dpc-4500	6	10	the	the	DET
dpc-4500	6	11	terms	term	NOUN
dpc-4500	6	12	of	of	ADP
dpc-4500	6	13	the	the	DET
dpc-4500	6	14	creative	creative	ADJ
dpc-4500	6	15	commons	common	NOUN
dpc-4500	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4500	6	17	license	license	NOUN
dpc-4500	6	18	(	(	PUNCT
dpc-4500	6	19	by	by	ADP
dpc-4500	6	20	-	-	PUNCT
dpc-4500	6	21	nc-4.0	nc-4.0	NOUN
dpc-4500	6	22	)	)	PUNCT
dpc-4500	6	23	,	,	PUNCT
dpc-4500	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4500	6	25	,	,	PUNCT
dpc-4500	6	26	which	which	PRON
dpc-4500	6	27	permits	permit	VERB
dpc-4500	6	28	unrestricted	unrestricted	ADJ
dpc-4500	6	29	noncommercial	noncommercial	ADJ
dpc-4500	6	30	use	use	NOUN
dpc-4500	6	31	,	,	PUNCT
dpc-4500	6	32	distribution	distribution	NOUN
dpc-4500	6	33	,	,	PUNCT
dpc-4500	6	34	and	and	CCONJ
dpc-4500	6	35	reproduction	reproduction	NOUN
dpc-4500	6	36	in	in	ADP
dpc-4500	6	37	any	any	DET
dpc-4500	6	38	medium	medium	NOUN
dpc-4500	6	39	,	,	PUNCT
dpc-4500	6	40	provided	provide	VERB
dpc-4500	6	41	the	the	DET
dpc-4500	6	42	original	original	ADJ
dpc-4500	6	43	authors	author	NOUN
dpc-4500	6	44	and	and	CCONJ
dpc-4500	6	45	source	source	NOUN
dpc-4500	6	46	are	be	AUX
dpc-4500	6	47	credited	credit	VERB
dpc-4500	6	48	.	.	PUNCT
dpc-4500	7	1	funding	funding	NOUN
dpc-4500	7	2	:	:	PUNCT
dpc-4500	7	3	none	none	NOUN
dpc-4500	7	4	.	.	PUNCT
dpc-4500	8	1	competing	compete	VERB
dpc-4500	8	2	interests	interest	NOUN
dpc-4500	8	3	:	:	PUNCT
dpc-4500	8	4	none	none	NOUN
dpc-4500	8	5	.	.	PUNCT
dpc-4500	9	1	authorship	authorship	NOUN
dpc-4500	9	2	:	:	PUNCT
dpc-4500	9	3	all	all	DET
dpc-4500	9	4	authors	author	NOUN
dpc-4500	9	5	have	have	AUX
dpc-4500	9	6	contributed	contribute	VERB
dpc-4500	9	7	significantly	significantly	ADV
dpc-4500	9	8	to	to	ADP
dpc-4500	9	9	this	this	DET
dpc-4500	9	10	publication	publication	NOUN
dpc-4500	9	11	.	.	PUNCT
dpc-4500	10	1	corresponding	correspond	VERB
dpc-4500	10	2	author	author	NOUN
dpc-4500	10	3	:	:	PUNCT
dpc-4500	10	4	ayşe	ayşe	PROPN
dpc-4500	10	5	akbaş	akbaş	PROPN
dpc-4500	10	6	md	md	PROPN
dpc-4500	10	7	,	,	PUNCT
dpc-4500	10	8	associate	associate	NOUN
dpc-4500	10	9	professor	professor	NOUN
dpc-4500	10	10	,	,	PUNCT
dpc-4500	10	11	ankara	ankara	PROPN
dpc-4500	10	12	city	city	PROPN
dpc-4500	10	13	hospital	hospital	PROPN
dpc-4500	10	14	,	,	PUNCT
dpc-4500	10	15	dermatology	dermatology	NOUN
dpc-4500	10	16	,	,	PUNCT
dpc-4500	10	17	ankara	ankara	PROPN
dpc-4500	10	18	,	,	PUNCT
dpc-4500	10	19	orcid.org/0000-0002-16261796	orcid.org/0000-0002-16261796	PROPN
dpc-4500	10	20	,	,	PUNCT
dpc-4500	10	21	phone	phone	NOUN
dpc-4500	10	22	:	:	PUNCT
dpc-4500	10	23	+905324064994	+905324064994	PROPN
dpc-4500	10	24	.	.	PUNCT
dpc-4500	11	1	e	e	X
dpc-4500	11	2	-	-	NOUN
dpc-4500	11	3	mail	mail	NOUN
dpc-4500	11	4	:	:	PUNCT
dpc-4500	11	5	ayseakbas62@gmail.com	ayseakbas62@gmail.com	X
dpc-4500	11	6	introduction	introduction	NOUN
dpc-4500	11	7	:	:	PUNCT
dpc-4500	11	8	localized	localized	ADJ
dpc-4500	11	9	scleroderma	scleroderma	NOUN
dpc-4500	11	10	is	be	AUX
dpc-4500	11	11	a	a	DET
dpc-4500	11	12	rare	rare	ADJ
dpc-4500	11	13	inflammatory	inflammatory	ADJ
dpc-4500	11	14	skin	skin	NOUN
dpc-4500	11	15	disease	disease	NOUN
dpc-4500	11	16	that	that	PRON
dpc-4500	11	17	causes	cause	VERB
dpc-4500	11	18	sclerosis	sclerosis	NOUN
dpc-4500	11	19	in	in	ADP
dpc-4500	11	20	the	the	DET
dpc-4500	11	21	dermis	dermis	NOUN
dpc-4500	11	22	and	and	CCONJ
dpc-4500	11	23	subcutaneous	subcutaneous	ADJ
dpc-4500	11	24	tissue	tissue	NOUN
dpc-4500	11	25	.	.	PUNCT
dpc-4500	12	1	oxidative	oxidative	ADJ
dpc-4500	12	2	stress	stress	NOUN
dpc-4500	12	3	may	may	AUX
dpc-4500	12	4	play	play	VERB
dpc-4500	12	5	a	a	DET
dpc-4500	12	6	role	role	NOUN
dpc-4500	12	7	in	in	ADP
dpc-4500	12	8	the	the	DET
dpc-4500	12	9	etiology	etiology	NOUN
dpc-4500	12	10	or	or	CCONJ
dpc-4500	12	11	be	be	AUX
dpc-4500	12	12	responsible	responsible	ADJ
dpc-4500	12	13	for	for	ADP
dpc-4500	12	14	the	the	DET
dpc-4500	12	15	chronicity	chronicity	NOUN
dpc-4500	12	16	or	or	CCONJ
dpc-4500	12	17	progression	progression	NOUN
dpc-4500	12	18	of	of	ADP
dpc-4500	12	19	the	the	DET
dpc-4500	12	20	disease	disease	NOUN
dpc-4500	12	21	.	.	PUNCT
dpc-4500	13	1	objectives	objective	NOUN
dpc-4500	13	2	:	:	PUNCT
dpc-4500	13	3	we	we	PRON
dpc-4500	13	4	aimed	aim	VERB
dpc-4500	13	5	to	to	PART
dpc-4500	13	6	investigate	investigate	VERB
dpc-4500	13	7	the	the	DET
dpc-4500	13	8	presence	presence	NOUN
dpc-4500	13	9	of	of	ADP
dpc-4500	13	10	oxidative	oxidative	ADJ
dpc-4500	13	11	stress	stress	NOUN
dpc-4500	13	12	in	in	ADP
dpc-4500	13	13	patients	patient	NOUN
dpc-4500	13	14	with	with	ADP
dpc-4500	13	15	localized	localized	ADJ
dpc-4500	13	16	scleroderma	scleroderma	NOUN
dpc-4500	13	17	by	by	ADP
dpc-4500	13	18	examining	examine	VERB
dpc-4500	13	19	thiol	thiol	ADJ
dpc-4500	13	20	-	-	PUNCT
dpc-4500	13	21	disulfide	disulfide	NOUN
dpc-4500	13	22	balance	balance	NOUN
dpc-4500	13	23	,	,	PUNCT
dpc-4500	13	24	ischemia	ischemia	NOUN
dpc-4500	13	25	-	-	PUNCT
dpc-4500	13	26	modified	modify	VERB
dpc-4500	13	27	albumin	albumin	NOUN
dpc-4500	13	28	(	(	PUNCT
dpc-4500	13	29	i	i	NOUN
dpc-4500	13	30	m	m	PROPN
dpc-4500	13	31	a	a	NOUN
dpc-4500	13	32	)	)	PUNCT
dpc-4500	13	33	,	,	PUNCT
dpc-4500	13	34	and	and	CCONJ
dpc-4500	13	35	prolidase	prolidase	NOUN
dpc-4500	13	36	parameters	parameter	NOUN
dpc-4500	13	37	.	.	PUNCT
dpc-4500	14	1	methods	method	NOUN
dpc-4500	14	2	:	:	PUNCT
dpc-4500	14	3	twenty	twenty	NUM
dpc-4500	14	4	patients	patient	NOUN
dpc-4500	14	5	over	over	ADP
dpc-4500	14	6	the	the	DET
dpc-4500	14	7	age	age	NOUN
dpc-4500	14	8	of	of	ADP
dpc-4500	14	9	18	18	NUM
dpc-4500	14	10	who	who	PRON
dpc-4500	14	11	were	be	AUX
dpc-4500	14	12	diagnosed	diagnose	VERB
dpc-4500	14	13	with	with	ADP
dpc-4500	14	14	localized	localized	ADJ
dpc-4500	14	15	scleroderma	scleroderma	NOUN
dpc-4500	14	16	both	both	CCONJ
dpc-4500	14	17	clinically	clinically	ADV
dpc-4500	14	18	and	and	CCONJ
dpc-4500	14	19	histopathologically	histopathologically	ADV
dpc-4500	14	20	and	and	CCONJ
dpc-4500	14	21	20	20	NUM
dpc-4500	14	22	control	control	NOUN
dpc-4500	14	23	subjects	subject	NOUN
dpc-4500	14	24	were	be	AUX
dpc-4500	14	25	included	include	VERB
dpc-4500	14	26	in	in	ADP
dpc-4500	14	27	the	the	DET
dpc-4500	14	28	study	study	NOUN
dpc-4500	14	29	.	.	PUNCT
dpc-4500	15	1	age	age	NOUN
dpc-4500	15	2	,	,	PUNCT
dpc-4500	15	3	sex	sex	NOUN
dpc-4500	15	4	,	,	PUNCT
dpc-4500	15	5	age	age	NOUN
dpc-4500	15	6	at	at	ADP
dpc-4500	15	7	disease	disease	NOUN
dpc-4500	15	8	onset	onset	VERB
dpc-4500	15	9	,	,	PUNCT
dpc-4500	15	10	duration	duration	NOUN
dpc-4500	15	11	of	of	ADP
dpc-4500	15	12	the	the	DET
dpc-4500	15	13	disease	disease	NOUN
dpc-4500	15	14	,	,	PUNCT
dpc-4500	15	15	and	and	CCONJ
dpc-4500	15	16	presence	presence	NOUN
dpc-4500	15	17	of	of	ADP
dpc-4500	15	18	accompanying	accompany	VERB
dpc-4500	15	19	systemic	systemic	ADJ
dpc-4500	15	20	diseases	disease	NOUN
dpc-4500	15	21	were	be	AUX
dpc-4500	15	22	questioned	question	VERB
dpc-4500	15	23	and	and	CCONJ
dpc-4500	15	24	recorded	record	VERB
dpc-4500	15	25	.	.	PUNCT
dpc-4500	16	1	lesion	lesion	NOUN
dpc-4500	16	2	type	type	NOUN
dpc-4500	16	3	and	and	CCONJ
dpc-4500	16	4	modified	modify	VERB
dpc-4500	16	5	rodnan	rodnan	NOUN
dpc-4500	16	6	and	and	CCONJ
dpc-4500	16	7	lossi	lossi	ADJ
dpc-4500	16	8	scores	score	NOUN
dpc-4500	16	9	were	be	AUX
dpc-4500	16	10	calculated	calculate	VERB
dpc-4500	16	11	through	through	ADP
dpc-4500	16	12	dermatological	dermatological	ADJ
dpc-4500	16	13	examination	examination	NOUN
dpc-4500	16	14	.	.	PUNCT
dpc-4500	17	1	crp	crp	PROPN
dpc-4500	17	2	,	,	PUNCT
dpc-4500	17	3	sedimentation	sedimentation	NOUN
dpc-4500	17	4	rate	rate	NOUN
dpc-4500	17	5	,	,	PUNCT
dpc-4500	17	6	total	total	ADJ
dpc-4500	17	7	thiol	thiol	NOUN
dpc-4500	17	8	,	,	PUNCT
dpc-4500	17	9	native	native	ADJ
dpc-4500	17	10	thiol	thiol	NOUN
dpc-4500	17	11	,	,	PUNCT
dpc-4500	17	12	and	and	CCONJ
dpc-4500	17	13	disulfide	disulfide	NOUN
dpc-4500	17	14	levels	level	NOUN
dpc-4500	17	15	indicated	indicate	VERB
dpc-4500	17	16	by	by	ADP
dpc-4500	17	17	the	the	DET
dpc-4500	17	18	erel	erel	NOUN
dpc-4500	17	19	profile	profile	NOUN
dpc-4500	17	20	,	,	PUNCT
dpc-4500	17	21	i	i	PRON
dpc-4500	17	22	m	m	VERB
dpc-4500	17	23	a	a	DET
dpc-4500	17	24	level	level	NOUN
dpc-4500	17	25	,	,	PUNCT
dpc-4500	17	26	and	and	CCONJ
dpc-4500	17	27	prolidase	prolidase	NOUN
dpc-4500	17	28	levels	level	NOUN
dpc-4500	17	29	were	be	AUX
dpc-4500	17	30	measured	measure	VERB
dpc-4500	17	31	and	and	CCONJ
dpc-4500	17	32	compared	compare	VERB
dpc-4500	17	33	in	in	ADP
dpc-4500	17	34	both	both	CCONJ
dpc-4500	17	35	the	the	DET
dpc-4500	17	36	patient	patient	ADJ
dpc-4500	17	37	and	and	CCONJ
dpc-4500	17	38	control	control	NOUN
dpc-4500	17	39	groups	group	NOUN
dpc-4500	17	40	.	.	PUNCT
dpc-4500	18	1	results	result	NOUN
dpc-4500	18	2	:	:	PUNCT
dpc-4500	18	3	levels	level	NOUN
dpc-4500	18	4	of	of	ADP
dpc-4500	18	5	native	native	ADJ
dpc-4500	18	6	thiol	thiol	PROPN
dpc-4500	18	7	(	(	PUNCT
dpc-4500	18	8	p=0.958	p=0.958	X
dpc-4500	18	9	)	)	PUNCT
dpc-4500	18	10	,	,	PUNCT
dpc-4500	18	11	total	total	ADJ
dpc-4500	18	12	thiol	thiol	NOUN
dpc-4500	18	13	(	(	PUNCT
dpc-4500	18	14	p=0.979	p=0.979	NOUN
dpc-4500	18	15	)	)	PUNCT
dpc-4500	18	16	,	,	PUNCT
dpc-4500	18	17	disulfide	disulfide	NOUN
dpc-4500	18	18	(	(	PUNCT
dpc-4500	18	19	p=0.449	p=0.449	NOUN
dpc-4500	18	20	)	)	PUNCT
dpc-4500	18	21	,	,	PUNCT
dpc-4500	18	22	(	(	PUNCT
dpc-4500	18	23	disulfide/	disulfide/	X
dpc-4500	18	24	native	native	ADJ
dpc-4500	18	25	thiol%	thiol%	PUNCT
dpc-4500	18	26	)	)	PUNCT
dpc-4500	18	27	(	(	PUNCT
dpc-4500	18	28	p=0.368	p=0.368	NOUN
dpc-4500	18	29	)	)	PUNCT
dpc-4500	18	30	,	,	PUNCT
dpc-4500	18	31	(	(	PUNCT
dpc-4500	18	32	disulfide	disulfide	NOUN
dpc-4500	18	33	/	/	SYM
dpc-4500	18	34	total	total	NOUN
dpc-4500	18	35	thiol%	thiol%	PUNCT
dpc-4500	18	36	)	)	PUNCT
dpc-4500	18	37	(	(	PUNCT
dpc-4500	18	38	p=0.361	p=0.361	NOUN
dpc-4500	18	39	)	)	PUNCT
dpc-4500	18	40	,	,	PUNCT
dpc-4500	18	41	(	(	PUNCT
dpc-4500	18	42	native	native	ADJ
dpc-4500	18	43	thiol	thiol	NOUN
dpc-4500	18	44	/	/	SYM
dpc-4500	18	45	total	total	NOUN
dpc-4500	18	46	thiol%	thiol%	PUNCT
dpc-4500	18	47	)	)	PUNCT
dpc-4500	18	48	(	(	PUNCT
dpc-4500	18	49	p=0.368	p=0.368	NOUN
dpc-4500	18	50	)	)	PUNCT
dpc-4500	18	51	,	,	PUNCT
dpc-4500	18	52	and	and	CCONJ
dpc-4500	18	53	abstract	abstract	ADJ
dpc-4500	18	54	2	2	NUM
dpc-4500	18	55	original	original	ADJ
dpc-4500	18	56	article	article	NOUN
dpc-4500	18	57	|	|	ADV
dpc-4500	18	58	dermatol	dermatol	ADJ
dpc-4500	18	59	pract	pract	NOUN
dpc-4500	18	60	concept	concept	NOUN
dpc-4500	18	61	.	.	PUNCT
dpc-4500	19	1	2024;14(4):e2024249	2024;14(4):e2024249	NUM
dpc-4500	19	2	introduction	introduction	NOUN
dpc-4500	19	3	localized	localize	VERB
dpc-4500	19	4	scleroderma	scleroderma	NOUN
dpc-4500	19	5	(	(	PUNCT
dpc-4500	19	6	ls	ls	PROPN
dpc-4500	19	7	,	,	PUNCT
dpc-4500	19	8	morphea	morphea	PROPN
dpc-4500	19	9	)	)	PUNCT
dpc-4500	19	10	is	be	AUX
dpc-4500	19	11	a	a	DET
dpc-4500	19	12	rare	rare	ADJ
dpc-4500	19	13	inflammatory	inflammatory	ADJ
dpc-4500	19	14	skin	skin	NOUN
dpc-4500	19	15	disease	disease	NOUN
dpc-4500	19	16	that	that	PRON
dpc-4500	19	17	causes	cause	VERB
dpc-4500	19	18	sclerosis	sclerosis	NOUN
dpc-4500	19	19	in	in	ADP
dpc-4500	19	20	the	the	DET
dpc-4500	19	21	dermis	dermis	NOUN
dpc-4500	19	22	and	and	CCONJ
dpc-4500	19	23	subcutaneous	subcutaneous	ADJ
dpc-4500	19	24	tissue	tissue	NOUN
dpc-4500	19	25	,	,	PUNCT
dpc-4500	19	26	with	with	ADP
dpc-4500	19	27	a	a	DET
dpc-4500	19	28	pathogenesis	pathogenesis	NOUN
dpc-4500	19	29	that	that	PRON
dpc-4500	19	30	is	be	AUX
dpc-4500	19	31	not	not	PART
dpc-4500	19	32	fully	fully	ADV
dpc-4500	19	33	understood	understand	VERB
dpc-4500	19	34	.	.	PUNCT
dpc-4500	20	1	inflammatory	inflammatory	ADJ
dpc-4500	20	2	phase	phase	NOUN
dpc-4500	20	3	manifests	manifest	NOUN
dpc-4500	20	4	as	as	ADP
dpc-4500	20	5	erythematous	erythematous	ADJ
dpc-4500	20	6	purple	purple	ADJ
dpc-4500	20	7	patches	patch	NOUN
dpc-4500	20	8	and	and	CCONJ
dpc-4500	20	9	plaques	plaque	NOUN
dpc-4500	20	10	,	,	PUNCT
dpc-4500	20	11	which	which	PRON
dpc-4500	20	12	later	later	ADV
dpc-4500	20	13	become	become	VERB
dpc-4500	20	14	white	white	ADJ
dpc-4500	20	15	sclerotic	sclerotic	ADJ
dpc-4500	20	16	lesions	lesion	NOUN
dpc-4500	20	17	surrounded	surround	VERB
dpc-4500	20	18	by	by	ADP
dpc-4500	20	19	a	a	DET
dpc-4500	20	20	violet	violet	NOUN
dpc-4500	20	21	-	-	PUNCT
dpc-4500	20	22	colored	color	VERB
dpc-4500	20	23	halo	halo	NOUN
dpc-4500	20	24	[	[	X
dpc-4500	20	25	1	1	NUM
dpc-4500	20	26	]	]	PUNCT
dpc-4500	20	27	.	.	PUNCT
dpc-4500	21	1	it	it	PRON
dpc-4500	21	2	is	be	AUX
dpc-4500	21	3	more	more	ADV
dpc-4500	21	4	common	common	ADJ
dpc-4500	21	5	in	in	ADP
dpc-4500	21	6	females	female	NOUN
dpc-4500	21	7	and	and	CCONJ
dpc-4500	21	8	occurs	occur	VERB
dpc-4500	21	9	in	in	ADP
dpc-4500	21	10	children	child	NOUN
dpc-4500	21	11	between	between	ADP
dpc-4500	21	12	the	the	DET
dpc-4500	21	13	ages	age	NOUN
dpc-4500	21	14	of	of	ADP
dpc-4500	21	15	2	2	NUM
dpc-4500	21	16	and	and	CCONJ
dpc-4500	21	17	14	14	NUM
dpc-4500	21	18	;	;	PUNCT
dpc-4500	21	19	in	in	ADP
dpc-4500	21	20	adults	adult	NOUN
dpc-4500	21	21	,	,	PUNCT
dpc-4500	21	22	it	it	PRON
dpc-4500	21	23	is	be	AUX
dpc-4500	21	24	more	more	ADV
dpc-4500	21	25	prevalent	prevalent	ADJ
dpc-4500	21	26	in	in	ADP
dpc-4500	21	27	middle	middle	ADJ
dpc-4500	21	28	age	age	NOUN
dpc-4500	22	1	[	[	X
dpc-4500	22	2	2	2	NUM
dpc-4500	22	3	]	]	PUNCT
dpc-4500	22	4	.	.	PUNCT
dpc-4500	23	1	environmental	environmental	ADJ
dpc-4500	23	2	factors	factor	NOUN
dpc-4500	23	3	such	such	ADJ
dpc-4500	23	4	as	as	ADP
dpc-4500	23	5	trauma	trauma	NOUN
dpc-4500	23	6	,	,	PUNCT
dpc-4500	23	7	radiation	radiation	NOUN
dpc-4500	23	8	,	,	PUNCT
dpc-4500	23	9	genetics	genetic	NOUN
dpc-4500	23	10	,	,	PUNCT
dpc-4500	23	11	drugs	drug	NOUN
dpc-4500	23	12	and	and	CCONJ
dpc-4500	23	13	chemicals	chemical	NOUN
dpc-4500	23	14	,	,	PUNCT
dpc-4500	23	15	infections	infection	NOUN
dpc-4500	23	16	,	,	PUNCT
dpc-4500	23	17	vascular	vascular	ADJ
dpc-4500	23	18	dysregulation	dysregulation	NOUN
dpc-4500	23	19	,	,	PUNCT
dpc-4500	23	20	autoimmunity	autoimmunity	NOUN
dpc-4500	23	21	,	,	PUNCT
dpc-4500	23	22	and	and	CCONJ
dpc-4500	23	23	oxidative	oxidative	ADJ
dpc-4500	23	24	stress	stress	NOUN
dpc-4500	23	25	can	can	AUX
dpc-4500	23	26	all	all	PRON
dpc-4500	23	27	play	play	VERB
dpc-4500	23	28	a	a	DET
dpc-4500	23	29	role	role	NOUN
dpc-4500	23	30	in	in	ADP
dpc-4500	23	31	its	its	PRON
dpc-4500	23	32	etiology	etiology	NOUN
dpc-4500	23	33	[	[	X
dpc-4500	23	34	3,4	3,4	NUM
dpc-4500	23	35	]	]	PUNCT
dpc-4500	23	36	.	.	PUNCT
dpc-4500	24	1	oxidative	oxidative	ADJ
dpc-4500	24	2	stress	stress	NOUN
dpc-4500	24	3	(	(	PUNCT
dpc-4500	24	4	os	os	NOUN
dpc-4500	24	5	)	)	PUNCT
dpc-4500	24	6	arises	arise	VERB
dpc-4500	24	7	from	from	ADP
dpc-4500	24	8	an	an	DET
dpc-4500	24	9	imbalance	imbalance	NOUN
dpc-4500	24	10	between	between	ADP
dpc-4500	24	11	the	the	DET
dpc-4500	24	12	oxidant	oxidant	ADJ
dpc-4500	24	13	system	system	NOUN
dpc-4500	24	14	and	and	CCONJ
dpc-4500	24	15	the	the	DET
dpc-4500	24	16	antioxidant	antioxidant	ADJ
dpc-4500	24	17	system	system	NOUN
dpc-4500	24	18	in	in	ADP
dpc-4500	24	19	the	the	DET
dpc-4500	24	20	organism	organism	NOUN
dpc-4500	24	21	,	,	PUNCT
dpc-4500	24	22	either	either	CCONJ
dpc-4500	24	23	due	due	ADJ
dpc-4500	24	24	to	to	ADP
dpc-4500	24	25	excessive	excessive	ADJ
dpc-4500	24	26	production	production	NOUN
dpc-4500	24	27	of	of	ADP
dpc-4500	24	28	oxidant	oxidant	ADJ
dpc-4500	24	29	radicals	radical	NOUN
dpc-4500	24	30	or	or	CCONJ
dpc-4500	24	31	to	to	ADP
dpc-4500	24	32	a	a	DET
dpc-4500	24	33	decrease	decrease	NOUN
dpc-4500	24	34	in	in	ADP
dpc-4500	24	35	antioxidants	antioxidant	NOUN
dpc-4500	24	36	or	or	CCONJ
dpc-4500	24	37	to	to	ADP
dpc-4500	24	38	both	both	PRON
dpc-4500	24	39	.	.	PUNCT
dpc-4500	25	1	this	this	PRON
dpc-4500	25	2	can	can	AUX
dpc-4500	25	3	lead	lead	VERB
dpc-4500	25	4	to	to	ADP
dpc-4500	25	5	cell	cell	NOUN
dpc-4500	25	6	membrane	membrane	NOUN
dpc-4500	25	7	damage	damage	NOUN
dpc-4500	25	8	,	,	PUNCT
dpc-4500	25	9	critical	critical	ADJ
dpc-4500	25	10	enzymes	enzyme	NOUN
dpc-4500	25	11	in	in	ADP
dpc-4500	25	12	intermediary	intermediary	ADJ
dpc-4500	25	13	metabolism	metabolism	NOUN
dpc-4500	25	14	and	and	CCONJ
dpc-4500	25	15	other	other	ADJ
dpc-4500	25	16	proteins	protein	NOUN
dpc-4500	25	17	,	,	PUNCT
dpc-4500	25	18	and	and	CCONJ
dpc-4500	25	19	dna	dna	PROPN
dpc-4500	25	20	constituents	constituent	NOUN
dpc-4500	25	21	,	,	PUNCT
dpc-4500	25	22	resulting	result	VERB
dpc-4500	25	23	in	in	ADP
dpc-4500	25	24	tissue	tissue	NOUN
dpc-4500	25	25	damage	damage	NOUN
dpc-4500	25	26	and	and	CCONJ
dpc-4500	25	27	necrosis	necrosis	NOUN
dpc-4500	25	28	in	in	ADP
dpc-4500	25	29	cells	cell	NOUN
dpc-4500	25	30	[	[	X
dpc-4500	25	31	5	5	NUM
dpc-4500	25	32	]	]	PUNCT
dpc-4500	25	33	.	.	PUNCT
dpc-4500	26	1	consequently	consequently	ADV
dpc-4500	26	2	,	,	PUNCT
dpc-4500	26	3	they	they	PRON
dpc-4500	26	4	contribute	contribute	VERB
dpc-4500	26	5	to	to	ADP
dpc-4500	26	6	the	the	DET
dpc-4500	26	7	onset	onset	NOUN
dpc-4500	26	8	or	or	CCONJ
dpc-4500	26	9	progression	progression	NOUN
dpc-4500	26	10	of	of	ADP
dpc-4500	26	11	many	many	ADJ
dpc-4500	26	12	chronic	chronic	ADJ
dpc-4500	26	13	diseases	disease	NOUN
dpc-4500	26	14	,	,	PUNCT
dpc-4500	26	15	including	include	VERB
dpc-4500	26	16	skin	skin	NOUN
dpc-4500	26	17	diseases	disease	NOUN
dpc-4500	26	18	[	[	X
dpc-4500	26	19	6	6	NUM
dpc-4500	26	20	]	]	PUNCT
dpc-4500	26	21	.	.	PUNCT
dpc-4500	27	1	various	various	ADJ
dpc-4500	27	2	parameters	parameter	NOUN
dpc-4500	27	3	have	have	AUX
dpc-4500	27	4	been	be	AUX
dpc-4500	27	5	evaluated	evaluate	VERB
dpc-4500	27	6	in	in	ADP
dpc-4500	27	7	studies	study	NOUN
dpc-4500	27	8	aimed	aim	VERB
dpc-4500	27	9	at	at	ADP
dpc-4500	27	10	understanding	understand	VERB
dpc-4500	27	11	the	the	DET
dpc-4500	27	12	impact	impact	NOUN
dpc-4500	27	13	of	of	ADP
dpc-4500	27	14	oxidative	oxidative	ADJ
dpc-4500	27	15	stress	stress	NOUN
dpc-4500	27	16	on	on	ADP
dpc-4500	27	17	skin	skin	NOUN
dpc-4500	27	18	diseases	disease	NOUN
dpc-4500	27	19	,	,	PUNCT
dpc-4500	27	20	including	include	VERB
dpc-4500	27	21	thiol	thiol	ADJ
dpc-4500	27	22	-	-	PUNCT
dpc-4500	27	23	disulfide	disulfide	NOUN
dpc-4500	27	24	balance	balance	NOUN
dpc-4500	27	25	,	,	PUNCT
dpc-4500	27	26	ischemia	ischemia	NOUN
dpc-4500	27	27	-	-	PUNCT
dpc-4500	27	28	modified	modify	VERB
dpc-4500	27	29	albumin	albumin	NOUN
dpc-4500	27	30	(	(	PUNCT
dpc-4500	27	31	i	i	NOUN
dpc-4500	27	32	m	m	PROPN
dpc-4500	27	33	a	a	NOUN
dpc-4500	27	34	)	)	PUNCT
dpc-4500	27	35	,	,	PUNCT
dpc-4500	27	36	and	and	CCONJ
dpc-4500	27	37	prolidase	prolidase	NOUN
dpc-4500	27	38	[	[	X
dpc-4500	27	39	7	7	NUM
dpc-4500	27	40	-	-	SYM
dpc-4500	27	41	10	10	NUM
dpc-4500	27	42	]	]	PUNCT
dpc-4500	27	43	.	.	PUNCT
dpc-4500	28	1	oxidant	oxidant	ADJ
dpc-4500	28	2	substances	substance	NOUN
dpc-4500	28	3	cause	cause	VERB
dpc-4500	28	4	decarboxylation	decarboxylation	NOUN
dpc-4500	28	5	in	in	ADP
dpc-4500	28	6	intracellular	intracellular	ADJ
dpc-4500	28	7	proteins	protein	NOUN
dpc-4500	28	8	,	,	PUNCT
dpc-4500	28	9	hydrolysis	hydrolysis	NOUN
dpc-4500	28	10	of	of	ADP
dpc-4500	28	11	peptide	peptide	NOUN
dpc-4500	28	12	bonds	bond	NOUN
dpc-4500	28	13	,	,	PUNCT
dpc-4500	28	14	and	and	CCONJ
dpc-4500	28	15	formation	formation	NOUN
dpc-4500	28	16	of	of	ADP
dpc-4500	28	17	disulfide	disulfide	NOUN
dpc-4500	28	18	cross	cross	NOUN
dpc-4500	28	19	-	-	NOUN
dpc-4500	28	20	links	link	NOUN
dpc-4500	28	21	[	[	X
dpc-4500	28	22	11	11	NUM
dpc-4500	28	23	]	]	PUNCT
dpc-4500	28	24	.	.	PUNCT
dpc-4500	29	1	plasma	plasma	NOUN
dpc-4500	29	2	thiols	thiol	NOUN
dpc-4500	29	3	are	be	AUX
dpc-4500	29	4	potent	potent	ADJ
dpc-4500	29	5	antioxidants	antioxidant	NOUN
dpc-4500	29	6	that	that	PRON
dpc-4500	29	7	physiologically	physiologically	ADV
dpc-4500	29	8	neutralize	neutralize	VERB
dpc-4500	29	9	free	free	ADJ
dpc-4500	29	10	radicals	radical	NOUN
dpc-4500	29	11	[	[	X
dpc-4500	29	12	12	12	NUM
dpc-4500	29	13	]	]	PUNCT
dpc-4500	29	14	.	.	PUNCT
dpc-4500	30	1	thiol	thiol	ADJ
dpc-4500	30	2	groups	group	NOUN
dpc-4500	30	3	are	be	AUX
dpc-4500	30	4	oxidized	oxidize	VERB
dpc-4500	30	5	by	by	ADP
dpc-4500	30	6	reactive	reactive	ADJ
dpc-4500	30	7	oxygen	oxygen	NOUN
dpc-4500	30	8	species	specie	NOUN
dpc-4500	30	9	(	(	PUNCT
dpc-4500	30	10	ros	ros	PROPN
dpc-4500	30	11	)	)	PUNCT
dpc-4500	30	12	,	,	PUNCT
dpc-4500	30	13	resulting	result	VERB
dpc-4500	30	14	in	in	ADP
dpc-4500	30	15	the	the	DET
dpc-4500	30	16	reversible	reversible	ADJ
dpc-4500	30	17	formation	formation	NOUN
dpc-4500	30	18	of	of	ADP
dpc-4500	30	19	disulfide	disulfide	NOUN
dpc-4500	30	20	bonds	bond	NOUN
dpc-4500	30	21	.	.	PUNCT
dpc-4500	31	1	total	total	ADJ
dpc-4500	31	2	thiol	thiol	ADJ
dpc-4500	31	3	groups	group	NOUN
dpc-4500	31	4	are	be	AUX
dpc-4500	31	5	highly	highly	ADV
dpc-4500	31	6	sensitive	sensitive	ADJ
dpc-4500	31	7	to	to	ADP
dpc-4500	31	8	oxidations	oxidation	NOUN
dpc-4500	31	9	and	and	CCONJ
dpc-4500	31	10	are	be	AUX
dpc-4500	31	11	the	the	DET
dpc-4500	31	12	first	first	ADJ
dpc-4500	31	13	to	to	PART
dpc-4500	31	14	be	be	AUX
dpc-4500	31	15	consumed	consume	VERB
dpc-4500	31	16	during	during	ADP
dpc-4500	31	17	oxidative	oxidative	ADJ
dpc-4500	31	18	stress	stress	NOUN
dpc-4500	31	19	,	,	PUNCT
dpc-4500	31	20	thus	thus	ADV
dpc-4500	31	21	neutralizing	neutralize	VERB
dpc-4500	31	22	free	free	ADJ
dpc-4500	31	23	radicals	radical	NOUN
dpc-4500	31	24	and	and	CCONJ
dpc-4500	31	25	preventing	prevent	VERB
dpc-4500	31	26	oxidative	oxidative	ADJ
dpc-4500	31	27	stress	stress	NOUN
dpc-4500	31	28	.	.	PUNCT
dpc-4500	32	1	these	these	PRON
dpc-4500	32	2	can	can	AUX
dpc-4500	32	3	be	be	AUX
dpc-4500	32	4	reduced	reduce	VERB
dpc-4500	32	5	back	back	ADV
dpc-4500	32	6	to	to	ADP
dpc-4500	32	7	thiol	thiol	ADJ
dpc-4500	32	8	groups	group	NOUN
dpc-4500	32	9	,	,	PUNCT
dpc-4500	32	10	depending	depend	VERB
dpc-4500	32	11	on	on	ADP
dpc-4500	32	12	the	the	DET
dpc-4500	32	13	situation	situation	NOUN
dpc-4500	32	14	[	[	X
dpc-4500	32	15	5,6,11	5,6,11	NUM
dpc-4500	32	16	]	]	PUNCT
dpc-4500	32	17	.	.	PUNCT
dpc-4500	33	1	this	this	DET
dpc-4500	33	2	dynamic	dynamic	ADJ
dpc-4500	33	3	balance	balance	NOUN
dpc-4500	33	4	of	of	ADP
dpc-4500	33	5	thiol	thiol	ADJ
dpc-4500	33	6	-	-	PUNCT
dpc-4500	33	7	disulfide	disulfide	NOUN
dpc-4500	33	8	is	be	AUX
dpc-4500	33	9	essential	essential	ADJ
dpc-4500	33	10	for	for	ADP
dpc-4500	33	11	critical	critical	ADJ
dpc-4500	33	12	cellular	cellular	ADJ
dpc-4500	33	13	functions	function	NOUN
dpc-4500	33	14	such	such	ADJ
dpc-4500	33	15	as	as	ADP
dpc-4500	33	16	the	the	DET
dpc-4500	33	17	antioxidant	antioxidant	ADJ
dpc-4500	33	18	defense	defense	NOUN
dpc-4500	33	19	system	system	NOUN
dpc-4500	33	20	,	,	PUNCT
dpc-4500	33	21	cellular	cellular	ADJ
dpc-4500	33	22	transcription	transcription	NOUN
dpc-4500	33	23	,	,	PUNCT
dpc-4500	33	24	cellular	cellular	ADJ
dpc-4500	33	25	signal	signal	NOUN
dpc-4500	33	26	transduction	transduction	NOUN
dpc-4500	33	27	,	,	PUNCT
dpc-4500	33	28	detoxification	detoxification	NOUN
dpc-4500	33	29	,	,	PUNCT
dpc-4500	33	30	enzymatic	enzymatic	ADJ
dpc-4500	33	31	pathways	pathway	NOUN
dpc-4500	33	32	,	,	PUNCT
dpc-4500	33	33	and	and	CCONJ
dpc-4500	33	34	apoptotic	apoptotic	ADJ
dpc-4500	33	35	pathways	pathway	NOUN
dpc-4500	34	1	[	[	X
dpc-4500	34	2	13	13	NUM
dpc-4500	34	3	]	]	PUNCT
dpc-4500	34	4	.	.	PUNCT
dpc-4500	35	1	ischemia	ischemia	NOUN
dpc-4500	35	2	modified	modify	VERB
dpc-4500	35	3	albumin	albumin	NOUN
dpc-4500	35	4	is	be	AUX
dpc-4500	35	5	a	a	DET
dpc-4500	35	6	modified	modified	ADJ
dpc-4500	35	7	type	type	NOUN
dpc-4500	35	8	of	of	ADP
dpc-4500	35	9	serum	serum	NOUN
dpc-4500	35	10	albumin	albumin	NOUN
dpc-4500	35	11	that	that	PRON
dpc-4500	35	12	forms	form	NOUN
dpc-4500	35	13	under	under	ADP
dpc-4500	35	14	oxidative	oxidative	ADJ
dpc-4500	35	15	stress	stress	NOUN
dpc-4500	35	16	conditions	condition	NOUN
dpc-4500	35	17	.	.	PUNCT
dpc-4500	36	1	this	this	DET
dpc-4500	36	2	protein	protein	NOUN
dpc-4500	36	3	arises	arise	VERB
dpc-4500	36	4	due	due	ADP
dpc-4500	36	5	to	to	ADP
dpc-4500	36	6	the	the	DET
dpc-4500	36	7	reduced	reduced	ADJ
dpc-4500	36	8	binding	bind	VERB
dpc-4500	36	9	capacity	capacity	NOUN
dpc-4500	36	10	of	of	ADP
dpc-4500	36	11	albumin	albumin	NOUN
dpc-4500	36	12	’s	’s	PART
dpc-4500	36	13	n	n	CCONJ
dpc-4500	36	14	-	-	PUNCT
dpc-4500	36	15	terminal	terminal	ADJ
dpc-4500	36	16	region	region	NOUN
dpc-4500	36	17	for	for	ADP
dpc-4500	36	18	cobalt	cobalt	NOUN
dpc-4500	36	19	,	,	PUNCT
dpc-4500	36	20	copper	copper	NOUN
dpc-4500	36	21	,	,	PUNCT
dpc-4500	36	22	and	and	CCONJ
dpc-4500	36	23	nickel	nickel	NOUN
dpc-4500	36	24	following	follow	VERB
dpc-4500	36	25	cellular	cellular	ADJ
dpc-4500	36	26	events	event	NOUN
dpc-4500	36	27	caused	cause	VERB
dpc-4500	36	28	by	by	ADP
dpc-4500	36	29	ischemia	ischemia	NOUN
dpc-4500	36	30	[	[	X
dpc-4500	36	31	9,14	9,14	X
dpc-4500	36	32	]	]	PUNCT
dpc-4500	36	33	.	.	PUNCT
dpc-4500	37	1	although	although	SCONJ
dpc-4500	37	2	primarily	primarily	ADV
dpc-4500	37	3	a	a	DET
dpc-4500	37	4	marker	marker	NOUN
dpc-4500	37	5	for	for	ADP
dpc-4500	37	6	cardiac	cardiac	ADJ
dpc-4500	37	7	ischemia	ischemia	NOUN
dpc-4500	37	8	,	,	PUNCT
dpc-4500	37	9	it	it	PRON
dpc-4500	37	10	has	have	AUX
dpc-4500	37	11	been	be	AUX
dpc-4500	37	12	reported	report	VERB
dpc-4500	37	13	in	in	ADP
dpc-4500	37	14	various	various	ADJ
dpc-4500	37	15	studies	study	NOUN
dpc-4500	37	16	that	that	PRON
dpc-4500	37	17	i	i	PRON
dpc-4500	37	18	m	m	VERB
dpc-4500	37	19	a	a	DET
dpc-4500	37	20	levels	level	NOUN
dpc-4500	37	21	can	can	AUX
dpc-4500	37	22	also	also	ADV
dpc-4500	37	23	increase	increase	VERB
dpc-4500	37	24	in	in	ADP
dpc-4500	37	25	various	various	ADJ
dpc-4500	37	26	inflammatory	inflammatory	ADJ
dpc-4500	37	27	conditions	condition	NOUN
dpc-4500	37	28	such	such	ADJ
dpc-4500	37	29	as	as	ADP
dpc-4500	37	30	psoriasis	psoriasis	NOUN
dpc-4500	37	31	and	and	CCONJ
dpc-4500	37	32	rheumatoid	rheumatoid	VERB
dpc-4500	37	33	arthritis	arthritis	NOUN
dpc-4500	37	34	and	and	CCONJ
dpc-4500	37	35	in	in	ADP
dpc-4500	37	36	disorders	disorder	NOUN
dpc-4500	37	37	related	relate	VERB
dpc-4500	37	38	to	to	PART
dpc-4500	37	39	oxidative	oxidative	ADJ
dpc-4500	37	40	stress	stress	NOUN
dpc-4500	37	41	[	[	X
dpc-4500	37	42	14	14	NUM
dpc-4500	37	43	-	-	SYM
dpc-4500	37	44	17	17	NUM
dpc-4500	37	45	]	]	PUNCT
dpc-4500	37	46	.	.	PUNCT
dpc-4500	38	1	prolidase	prolidase	PROPN
dpc-4500	38	2	is	be	AUX
dpc-4500	38	3	an	an	DET
dpc-4500	38	4	exopeptidase	exopeptidase	NOUN
dpc-4500	38	5	important	important	ADJ
dpc-4500	38	6	in	in	ADP
dpc-4500	38	7	the	the	DET
dpc-4500	38	8	collagen	collagen	NOUN
dpc-4500	38	9	cycle	cycle	NOUN
dpc-4500	38	10	abundantly	abundantly	ADV
dpc-4500	38	11	found	find	VERB
dpc-4500	38	12	in	in	ADP
dpc-4500	38	13	human	human	ADJ
dpc-4500	38	14	and	and	CCONJ
dpc-4500	38	15	animal	animal	NOUN
dpc-4500	38	16	tissues	tissue	NOUN
dpc-4500	38	17	,	,	PUNCT
dpc-4500	38	18	playing	play	VERB
dpc-4500	38	19	a	a	DET
dpc-4500	38	20	significant	significant	ADJ
dpc-4500	38	21	role	role	NOUN
dpc-4500	38	22	in	in	ADP
dpc-4500	38	23	collagen	collagen	NOUN
dpc-4500	38	24	turnover	turnover	NOUN
dpc-4500	38	25	and	and	CCONJ
dpc-4500	38	26	cell	cell	NOUN
dpc-4500	38	27	growth	growth	NOUN
dpc-4500	38	28	[	[	X
dpc-4500	38	29	10,18	10,18	NUM
dpc-4500	38	30	]	]	PUNCT
dpc-4500	38	31	.	.	PUNCT
dpc-4500	39	1	it	it	PRON
dpc-4500	39	2	is	be	AUX
dpc-4500	39	3	involved	involve	VERB
dpc-4500	39	4	in	in	ADP
dpc-4500	39	5	the	the	DET
dpc-4500	39	6	synthesis	synthesis	NOUN
dpc-4500	39	7	of	of	ADP
dpc-4500	39	8	collagen	collagen	NOUN
dpc-4500	39	9	within	within	ADP
dpc-4500	39	10	cells	cell	NOUN
dpc-4500	39	11	and	and	CCONJ
dpc-4500	39	12	the	the	DET
dpc-4500	39	13	catabolism	catabolism	NOUN
dpc-4500	39	14	of	of	ADP
dpc-4500	39	15	proteins	protein	NOUN
dpc-4500	39	16	containing	contain	VERB
dpc-4500	39	17	proline	proline	NOUN
dpc-4500	39	18	or	or	CCONJ
dpc-4500	39	19	hydroxyproline	hydroxyproline	NOUN
dpc-4500	39	20	.	.	PUNCT
dpc-4500	40	1	it	it	PRON
dpc-4500	40	2	has	have	AUX
dpc-4500	40	3	been	be	AUX
dpc-4500	40	4	suggested	suggest	VERB
dpc-4500	40	5	for	for	ADP
dpc-4500	40	6	the	the	DET
dpc-4500	40	7	detection	detection	NOUN
dpc-4500	40	8	of	of	ADP
dpc-4500	40	9	disorders	disorder	NOUN
dpc-4500	40	10	in	in	ADP
dpc-4500	40	11	collagen	collagen	NOUN
dpc-4500	40	12	metabolism	metabolism	NOUN
dpc-4500	40	13	.	.	PUNCT
dpc-4500	41	1	due	due	ADP
dpc-4500	41	2	to	to	ADP
dpc-4500	41	3	its	its	PRON
dpc-4500	41	4	widespread	widespread	ADJ
dpc-4500	41	5	tissue	tissue	NOUN
dpc-4500	41	6	distribution	distribution	NOUN
dpc-4500	41	7	,	,	PUNCT
dpc-4500	41	8	abnormalities	abnormality	NOUN
dpc-4500	41	9	in	in	ADP
dpc-4500	41	10	prolidase	prolidase	NOUN
dpc-4500	41	11	enzyme	enzyme	NOUN
dpc-4500	41	12	activity	activity	NOUN
dpc-4500	41	13	could	could	AUX
dpc-4500	41	14	be	be	AUX
dpc-4500	41	15	associated	associate	VERB
dpc-4500	41	16	with	with	ADP
dpc-4500	41	17	many	many	ADJ
dpc-4500	41	18	clinical	clinical	ADJ
dpc-4500	41	19	conditions	condition	NOUN
dpc-4500	41	20	and	and	CCONJ
dpc-4500	41	21	play	play	VERB
dpc-4500	41	22	a	a	DET
dpc-4500	41	23	role	role	NOUN
dpc-4500	41	24	in	in	ADP
dpc-4500	41	25	disease	disease	NOUN
dpc-4500	41	26	progression	progression	NOUN
dpc-4500	41	27	,	,	PUNCT
dpc-4500	41	28	particularly	particularly	ADV
dpc-4500	41	29	in	in	ADP
dpc-4500	41	30	fibrotic	fibrotic	ADJ
dpc-4500	41	31	diseases	disease	NOUN
dpc-4500	41	32	and	and	CCONJ
dpc-4500	41	33	chronic	chronic	ADJ
dpc-4500	41	34	injuries	injury	NOUN
dpc-4500	41	35	,	,	PUNCT
dpc-4500	41	36	where	where	SCONJ
dpc-4500	41	37	serum	serum	NOUN
dpc-4500	41	38	prolidase	prolidase	NOUN
dpc-4500	41	39	activity	activity	NOUN
dpc-4500	41	40	varies	vary	VERB
dpc-4500	41	41	and	and	CCONJ
dpc-4500	41	42	is	be	AUX
dpc-4500	41	43	affected	affect	VERB
dpc-4500	41	44	by	by	ADP
dpc-4500	41	45	oxidative	oxidative	ADJ
dpc-4500	41	46	stress	stress	NOUN
dpc-4500	42	1	[	[	X
dpc-4500	42	2	10,18	10,18	NUM
dpc-4500	42	3	-	-	SYM
dpc-4500	42	4	21	21	NUM
dpc-4500	42	5	]	]	PUNCT
dpc-4500	42	6	.	.	PUNCT
dpc-4500	43	1	recent	recent	ADJ
dpc-4500	43	2	studies	study	NOUN
dpc-4500	43	3	have	have	AUX
dpc-4500	43	4	continued	continue	VERB
dpc-4500	43	5	to	to	PART
dpc-4500	43	6	investigate	investigate	VERB
dpc-4500	43	7	the	the	DET
dpc-4500	43	8	role	role	NOUN
dpc-4500	43	9	of	of	ADP
dpc-4500	43	10	oxidative	oxidative	ADJ
dpc-4500	43	11	stress	stress	NOUN
dpc-4500	43	12	in	in	ADP
dpc-4500	43	13	the	the	DET
dpc-4500	43	14	pathogenesis	pathogenesis	NOUN
dpc-4500	43	15	of	of	ADP
dpc-4500	43	16	skin	skin	NOUN
dpc-4500	43	17	diseases	disease	NOUN
dpc-4500	43	18	,	,	PUNCT
dpc-4500	43	19	including	include	VERB
dpc-4500	43	20	scleroderma	scleroderma	NOUN
dpc-4500	43	21	,	,	PUNCT
dpc-4500	43	22	which	which	PRON
dpc-4500	43	23	is	be	AUX
dpc-4500	43	24	associated	associate	VERB
dpc-4500	43	25	with	with	ADP
dpc-4500	43	26	the	the	DET
dpc-4500	43	27	fibrosis	fibrosis	NOUN
dpc-4500	43	28	of	of	ADP
dpc-4500	43	29	connective	connective	ADJ
dpc-4500	43	30	tissue	tissue	NOUN
dpc-4500	43	31	[	[	X
dpc-4500	43	32	8	8	NUM
dpc-4500	43	33	-	-	SYM
dpc-4500	43	34	10	10	NUM
dpc-4500	43	35	]	]	PUNCT
dpc-4500	43	36	.	.	PUNCT
dpc-4500	44	1	various	various	ADJ
dpc-4500	44	2	oxidant	oxidant	NOUN
dpc-4500	44	3	and	and	CCONJ
dpc-4500	44	4	antioxidant	antioxidant	ADJ
dpc-4500	44	5	parameter	parameter	NOUN
dpc-4500	44	6	levels	level	NOUN
dpc-4500	44	7	have	have	AUX
dpc-4500	44	8	been	be	AUX
dpc-4500	44	9	measured	measure	VERB
dpc-4500	44	10	in	in	ADP
dpc-4500	44	11	systemic	systemic	ADJ
dpc-4500	44	12	scleroderma	scleroderma	NOUN
dpc-4500	44	13	,	,	PUNCT
dpc-4500	44	14	and	and	CCONJ
dpc-4500	44	15	numerous	numerous	ADJ
dpc-4500	44	16	hypotheses	hypothesis	NOUN
dpc-4500	44	17	have	have	AUX
dpc-4500	44	18	been	be	AUX
dpc-4500	44	19	proposed	propose	VERB
dpc-4500	44	20	[	[	PUNCT
dpc-4500	44	21	22	22	NUM
dpc-4500	44	22	-	-	SYM
dpc-4500	44	23	31	31	NUM
dpc-4500	44	24	]	]	PUNCT
dpc-4500	44	25	.	.	PUNCT
dpc-4500	45	1	however	however	ADV
dpc-4500	45	2	,	,	PUNCT
dpc-4500	45	3	these	these	DET
dpc-4500	45	4	parameters	parameter	NOUN
dpc-4500	45	5	have	have	AUX
dpc-4500	45	6	not	not	PART
dpc-4500	45	7	been	be	AUX
dpc-4500	45	8	sufficiently	sufficiently	ADV
dpc-4500	45	9	studied	study	VERB
dpc-4500	45	10	in	in	ADP
dpc-4500	45	11	localized	localized	ADJ
dpc-4500	45	12	scleroderma	scleroderma	NOUN
dpc-4500	45	13	,	,	PUNCT
dpc-4500	45	14	which	which	PRON
dpc-4500	45	15	has	have	VERB
dpc-4500	45	16	a	a	DET
dpc-4500	45	17	similar	similar	ADJ
dpc-4500	45	18	pathogenesis	pathogenesis	NOUN
dpc-4500	45	19	[	[	X
dpc-4500	45	20	32,33	32,33	NUM
dpc-4500	45	21	]	]	PUNCT
dpc-4500	45	22	.	.	PUNCT
dpc-4500	46	1	therefore	therefore	ADV
dpc-4500	46	2	,	,	PUNCT
dpc-4500	46	3	in	in	ADP
dpc-4500	46	4	this	this	DET
dpc-4500	46	5	study	study	NOUN
dpc-4500	46	6	,	,	PUNCT
dpc-4500	46	7	we	we	PRON
dpc-4500	46	8	aimed	aim	VERB
dpc-4500	46	9	to	to	PART
dpc-4500	46	10	investigate	investigate	VERB
dpc-4500	46	11	the	the	DET
dpc-4500	46	12	presence	presence	NOUN
dpc-4500	46	13	of	of	ADP
dpc-4500	46	14	oxidative	oxidative	ADJ
dpc-4500	46	15	stress	stress	NOUN
dpc-4500	46	16	in	in	ADP
dpc-4500	46	17	ls	l	VERB
dpc-4500	46	18	by	by	ADP
dpc-4500	46	19	simultaneously	simultaneously	ADV
dpc-4500	46	20	measuring	measure	VERB
dpc-4500	46	21	the	the	DET
dpc-4500	46	22	levels	level	NOUN
dpc-4500	46	23	of	of	ADP
dpc-4500	46	24	oxidative	oxidative	ADJ
dpc-4500	46	25	markers	marker	NOUN
dpc-4500	46	26	such	such	ADJ
dpc-4500	46	27	as	as	ADP
dpc-4500	46	28	thiol	thiol	NOUN
dpc-4500	46	29	-	-	PUNCT
dpc-4500	46	30	disulfide	disulfide	NOUN
dpc-4500	46	31	,	,	PUNCT
dpc-4500	46	32	i	i	PRON
dpc-4500	46	33	m	m	VERB
dpc-4500	46	34	a	a	PROPN
dpc-4500	46	35	,	,	PUNCT
dpc-4500	46	36	and	and	CCONJ
dpc-4500	46	37	prolidase	prolidase	NOUN
dpc-4500	46	38	,	,	PUNCT
dpc-4500	46	39	and	and	CCONJ
dpc-4500	46	40	comparing	compare	VERB
dpc-4500	46	41	them	they	PRON
dpc-4500	46	42	with	with	ADP
dpc-4500	46	43	a	a	DET
dpc-4500	46	44	control	control	NOUN
dpc-4500	46	45	group	group	NOUN
dpc-4500	46	46	.	.	PUNCT
dpc-4500	47	1	methods	method	NOUN
dpc-4500	47	2	this	this	PRON
dpc-4500	47	3	a	a	DET
dpc-4500	47	4	single	single	ADJ
dpc-4500	47	5	-	-	PUNCT
dpc-4500	47	6	center	center	NOUN
dpc-4500	47	7	prospective	prospective	ADJ
dpc-4500	47	8	case	case	NOUN
dpc-4500	47	9	-	-	PUNCT
dpc-4500	47	10	control	control	NOUN
dpc-4500	47	11	study	study	NOUN
dpc-4500	47	12	was	be	AUX
dpc-4500	47	13	approved	approve	VERB
dpc-4500	47	14	by	by	ADP
dpc-4500	47	15	the	the	DET
dpc-4500	47	16	local	local	ADJ
dpc-4500	47	17	ethics	ethic	NOUN
dpc-4500	47	18	committee	committee	NOUN
dpc-4500	47	19	,	,	PUNCT
dpc-4500	47	20	conducted	conduct	VERB
dpc-4500	47	21	in	in	ADP
dpc-4500	47	22	accordance	accordance	NOUN
dpc-4500	47	23	with	with	ADP
dpc-4500	47	24	the	the	DET
dpc-4500	47	25	principles	principle	NOUN
dpc-4500	47	26	of	of	ADP
dpc-4500	47	27	the	the	DET
dpc-4500	47	28	declaration	declaration	NOUN
dpc-4500	47	29	of	of	ADP
dpc-4500	47	30	helsinki	helsinki	PROPN
dpc-4500	47	31	(	(	PUNCT
dpc-4500	47	32	approval	approval	NOUN
dpc-4500	47	33	number	number	NOUN
dpc-4500	47	34	:	:	PUNCT
dpc-4500	47	35	e2	e2	PROPN
dpc-4500	47	36	-	-	PUNCT
dpc-4500	47	37	21	21	NUM
dpc-4500	47	38	-	-	SYM
dpc-4500	47	39	476	476	NUM
dpc-4500	47	40	/02.06.2021	/02.06.2021	PRON
dpc-4500	47	41	)	)	PUNCT
dpc-4500	47	42	and	and	CCONJ
dpc-4500	47	43	was	be	AUX
dpc-4500	47	44	carried	carry	VERB
dpc-4500	47	45	out	out	ADP
dpc-4500	47	46	ethically	ethically	ADV
dpc-4500	47	47	.	.	PUNCT
dpc-4500	47	48	 	 	SPACE
dpc-4500	48	1	written	write	VERB
dpc-4500	48	2	informed	informed	ADJ
dpc-4500	48	3	consent	consent	NOUN
dpc-4500	48	4	forms	form	NOUN
dpc-4500	48	5	were	be	AUX
dpc-4500	48	6	obtained	obtain	VERB
dpc-4500	48	7	from	from	ADP
dpc-4500	48	8	patients	patient	NOUN
dpc-4500	48	9	and	and	CCONJ
dpc-4500	48	10	volunteers	volunteer	NOUN
dpc-4500	48	11	.	.	PUNCT
dpc-4500	49	1	prolidase	prolidase	NOUN
dpc-4500	49	2	(	(	PUNCT
dpc-4500	49	3	p=0.121	p=0.121	ADV
dpc-4500	49	4	)	)	PUNCT
dpc-4500	49	5	were	be	AUX
dpc-4500	49	6	similar	similar	ADJ
dpc-4500	49	7	in	in	ADP
dpc-4500	49	8	both	both	CCONJ
dpc-4500	49	9	patient	patient	ADJ
dpc-4500	49	10	and	and	CCONJ
dpc-4500	49	11	control	control	NOUN
dpc-4500	49	12	groups	group	NOUN
dpc-4500	49	13	.	.	PUNCT
dpc-4500	50	1	only	only	ADV
dpc-4500	50	2	i	i	PRON
dpc-4500	50	3	m	m	VERB
dpc-4500	50	4	a	a	PROPN
dpc-4500	50	5	was	be	AUX
dpc-4500	50	6	significantly	significantly	ADV
dpc-4500	50	7	different	different	ADJ
dpc-4500	50	8	.	.	PUNCT
dpc-4500	51	1	no	no	DET
dpc-4500	51	2	significant	significant	ADJ
dpc-4500	51	3	relationship	relationship	NOUN
dpc-4500	51	4	was	be	AUX
dpc-4500	51	5	found	find	VERB
dpc-4500	51	6	between	between	ADP
dpc-4500	51	7	the	the	DET
dpc-4500	51	8	levels	level	NOUN
dpc-4500	51	9	of	of	ADP
dpc-4500	51	10	native	native	ADJ
dpc-4500	51	11	thiol	thiol	PROPN
dpc-4500	51	12	,	,	PUNCT
dpc-4500	51	13	total	total	ADJ
dpc-4500	51	14	thiol	thiol	NOUN
dpc-4500	51	15	,	,	PUNCT
dpc-4500	51	16	disulfide	disulfide	NOUN
dpc-4500	51	17	,	,	PUNCT
dpc-4500	51	18	(	(	PUNCT
dpc-4500	51	19	disulfide	disulfide	NOUN
dpc-4500	51	20	/	/	SYM
dpc-4500	51	21	native	native	ADJ
dpc-4500	51	22	thiol	thiol	NOUN
dpc-4500	51	23	)	)	PUNCT
dpc-4500	51	24	,	,	PUNCT
dpc-4500	51	25	(	(	PUNCT
dpc-4500	51	26	disulfide	disulfide	NOUN
dpc-4500	51	27	/	/	SYM
dpc-4500	51	28	total	total	ADJ
dpc-4500	51	29	thiol	thiol	NOUN
dpc-4500	51	30	)	)	PUNCT
dpc-4500	51	31	,	,	PUNCT
dpc-4500	51	32	i	i	PRON
dpc-4500	51	33	m	m	VERB
dpc-4500	51	34	a	a	PROPN
dpc-4500	51	35	,	,	PUNCT
dpc-4500	51	36	prolidase	prolidase	NOUN
dpc-4500	51	37	,	,	PUNCT
dpc-4500	51	38	and	and	CCONJ
dpc-4500	51	39	rodnan	rodnan	NOUN
dpc-4500	51	40	and	and	CCONJ
dpc-4500	51	41	lossi	lossi	ADJ
dpc-4500	51	42	scores	score	NOUN
dpc-4500	51	43	.	.	PUNCT
dpc-4500	52	1	conclusion	conclusion	NOUN
dpc-4500	52	2	:	:	PUNCT
dpc-4500	52	3	according	accord	VERB
dpc-4500	52	4	to	to	ADP
dpc-4500	52	5	the	the	DET
dpc-4500	52	6	data	datum	NOUN
dpc-4500	52	7	obtained	obtain	VERB
dpc-4500	52	8	from	from	ADP
dpc-4500	52	9	this	this	DET
dpc-4500	52	10	study	study	NOUN
dpc-4500	52	11	,	,	PUNCT
dpc-4500	52	12	we	we	PRON
dpc-4500	52	13	can	can	AUX
dpc-4500	52	14	say	say	VERB
dpc-4500	52	15	that	that	SCONJ
dpc-4500	52	16	the	the	DET
dpc-4500	52	17	thiol	thiol	ADJ
dpc-4500	52	18	-	-	PUNCT
dpc-4500	52	19	disulfide	disulfide	NOUN
dpc-4500	52	20	balance	balance	NOUN
dpc-4500	52	21	is	be	AUX
dpc-4500	52	22	not	not	PART
dpc-4500	52	23	disrupted	disrupt	VERB
dpc-4500	52	24	and	and	CCONJ
dpc-4500	52	25	that	that	SCONJ
dpc-4500	52	26	prolidase	prolidase	NOUN
dpc-4500	52	27	levels	level	NOUN
dpc-4500	52	28	are	be	AUX
dpc-4500	52	29	not	not	PART
dpc-4500	52	30	affected	affect	VERB
dpc-4500	52	31	in	in	ADP
dpc-4500	52	32	localized	localized	ADJ
dpc-4500	52	33	scleroderma	scleroderma	NOUN
dpc-4500	52	34	;	;	PUNCT
dpc-4500	52	35	however	however	ADV
dpc-4500	52	36	,	,	PUNCT
dpc-4500	52	37	i	i	PRON
dpc-4500	52	38	m	m	VERB
dpc-4500	52	39	a	a	PRON
dpc-4500	52	40	is	be	AUX
dpc-4500	52	41	negatively	negatively	ADV
dpc-4500	52	42	affected	affect	VERB
dpc-4500	52	43	.	.	PUNCT
dpc-4500	53	1	original	original	ADJ
dpc-4500	53	2	article	article	NOUN
dpc-4500	53	3	|	|	ADV
dpc-4500	53	4	dermatol	dermatol	ADJ
dpc-4500	53	5	pract	pract	NOUN
dpc-4500	53	6	concept	concept	NOUN
dpc-4500	53	7	.	.	PUNCT
dpc-4500	54	1	2024;14(4):e2024249	2024;14(4):e2024249	NUM
dpc-4500	54	2	3	3	NUM
dpc-4500	54	3	twenty	twenty	NUM
dpc-4500	54	4	patients	patient	NOUN
dpc-4500	54	5	over	over	ADP
dpc-4500	54	6	the	the	DET
dpc-4500	54	7	age	age	NOUN
dpc-4500	54	8	of	of	ADP
dpc-4500	54	9	18	18	NUM
dpc-4500	54	10	,	,	PUNCT
dpc-4500	54	11	diagnosed	diagnose	VERB
dpc-4500	54	12	with	with	ADP
dpc-4500	54	13	ls	ls	PROPN
dpc-4500	54	14	clinically	clinically	ADV
dpc-4500	54	15	and	and	CCONJ
dpc-4500	54	16	histopathologically	histopathologically	ADV
dpc-4500	54	17	and	and	CCONJ
dpc-4500	54	18	followed	follow	VERB
dpc-4500	54	19	up	up	ADP
dpc-4500	54	20	at	at	ADP
dpc-4500	54	21	our	our	PRON
dpc-4500	54	22	clinic	clinic	NOUN
dpc-4500	54	23	,	,	PUNCT
dpc-4500	54	24	and	and	CCONJ
dpc-4500	54	25	20	20	NUM
dpc-4500	54	26	control	control	NOUN
dpc-4500	54	27	subjects	subject	NOUN
dpc-4500	54	28	were	be	AUX
dpc-4500	54	29	included	include	VERB
dpc-4500	54	30	in	in	ADP
dpc-4500	54	31	the	the	DET
dpc-4500	54	32	study	study	NOUN
dpc-4500	54	33	.	.	PUNCT
dpc-4500	55	1	age	age	NOUN
dpc-4500	55	2	,	,	PUNCT
dpc-4500	55	3	sex	sex	NOUN
dpc-4500	55	4	,	,	PUNCT
dpc-4500	55	5	age	age	NOUN
dpc-4500	55	6	at	at	ADP
dpc-4500	55	7	disease	disease	NOUN
dpc-4500	55	8	onset	onset	VERB
dpc-4500	55	9	,	,	PUNCT
dpc-4500	55	10	duration	duration	NOUN
dpc-4500	55	11	of	of	ADP
dpc-4500	55	12	the	the	DET
dpc-4500	55	13	disease	disease	NOUN
dpc-4500	55	14	,	,	PUNCT
dpc-4500	55	15	and	and	CCONJ
dpc-4500	55	16	presence	presence	NOUN
dpc-4500	55	17	of	of	ADP
dpc-4500	55	18	accompanying	accompany	VERB
dpc-4500	55	19	systemic	systemic	ADJ
dpc-4500	55	20	diseases	disease	NOUN
dpc-4500	55	21	were	be	AUX
dpc-4500	55	22	questioned	question	VERB
dpc-4500	55	23	and	and	CCONJ
dpc-4500	55	24	recorded	record	VERB
dpc-4500	55	25	.	.	PUNCT
dpc-4500	56	1	lesion	lesion	NOUN
dpc-4500	56	2	type	type	NOUN
dpc-4500	56	3	,	,	PUNCT
dpc-4500	56	4	modified	modify	VERB
dpc-4500	56	5	rodnan	rodnan	NOUN
dpc-4500	56	6	and	and	CCONJ
dpc-4500	56	7	lossi	lossi	ADJ
dpc-4500	56	8	scores	score	NOUN
dpc-4500	56	9	were	be	AUX
dpc-4500	56	10	calculated	calculate	VERB
dpc-4500	56	11	through	through	ADP
dpc-4500	56	12	dermatological	dermatological	ADJ
dpc-4500	56	13	examination	examination	NOUN
dpc-4500	57	1	[	[	X
dpc-4500	57	2	34,35	34,35	NOUN
dpc-4500	57	3	]	]	PUNCT
dpc-4500	57	4	.	.	PUNCT
dpc-4500	58	1	(	(	PUNCT
dpc-4500	58	2	in	in	ADP
dpc-4500	58	3	the	the	DET
dpc-4500	58	4	modified	modify	VERB
dpc-4500	58	5	rodnan	rodnan	NOUN
dpc-4500	58	6	score	score	NOUN
dpc-4500	58	7	,	,	PUNCT
dpc-4500	58	8	the	the	DET
dpc-4500	58	9	skin	skin	NOUN
dpc-4500	58	10	area	area	NOUN
dpc-4500	58	11	is	be	AUX
dpc-4500	58	12	divided	divide	VERB
dpc-4500	58	13	into	into	ADP
dpc-4500	58	14	a	a	DET
dpc-4500	58	15	total	total	NOUN
dpc-4500	58	16	of	of	ADP
dpc-4500	58	17	17	17	NUM
dpc-4500	58	18	different	different	ADJ
dpc-4500	58	19	regions	region	NOUN
dpc-4500	58	20	,	,	PUNCT
dpc-4500	58	21	and	and	CCONJ
dpc-4500	58	22	the	the	DET
dpc-4500	58	23	score	score	NOUN
dpc-4500	58	24	is	be	AUX
dpc-4500	58	25	calculated	calculate	VERB
dpc-4500	58	26	by	by	ADP
dpc-4500	58	27	manual	manual	ADJ
dpc-4500	58	28	palpation	palpation	NOUN
dpc-4500	58	29	.	.	PUNCT
dpc-4500	59	1	scoring	scoring	NOUN
dpc-4500	59	2	is	be	AUX
dpc-4500	59	3	done	do	VERB
dpc-4500	59	4	according	accord	VERB
dpc-4500	59	5	to	to	ADP
dpc-4500	59	6	the	the	DET
dpc-4500	59	7	degree	degree	NOUN
dpc-4500	59	8	of	of	ADP
dpc-4500	59	9	thickness	thickness	NOUN
dpc-4500	59	10	of	of	ADP
dpc-4500	59	11	the	the	DET
dpc-4500	59	12	skin	skin	NOUN
dpc-4500	59	13	between	between	ADP
dpc-4500	59	14	0	0	NUM
dpc-4500	59	15	and	and	CCONJ
dpc-4500	59	16	3	3	NUM
dpc-4500	59	17	;	;	PUNCT
dpc-4500	59	18	0	0	SYM
dpc-4500	59	19	=	=	NOUN
dpc-4500	59	20	normal	normal	ADJ
dpc-4500	59	21	,	,	PUNCT
dpc-4500	59	22	1	1	NUM
dpc-4500	59	23	=	=	NUM
dpc-4500	59	24	mild	mild	ADJ
dpc-4500	59	25	thickening	thickening	NOUN
dpc-4500	59	26	,	,	PUNCT
dpc-4500	59	27	2	2	NUM
dpc-4500	59	28	=	=	NUM
dpc-4500	59	29	moderate	moderate	ADJ
dpc-4500	59	30	thickening	thickening	NOUN
dpc-4500	59	31	,	,	PUNCT
dpc-4500	59	32	and	and	CCONJ
dpc-4500	59	33	3	3	NUM
dpc-4500	59	34	=	=	NOUN
dpc-4500	59	35	severe	severe	ADJ
dpc-4500	59	36	thickening	thickening	NOUN
dpc-4500	59	37	,	,	PUNCT
dpc-4500	59	38	and	and	CCONJ
dpc-4500	59	39	the	the	DET
dpc-4500	59	40	maximum	maximum	ADJ
dpc-4500	59	41	score	score	NOUN
dpc-4500	59	42	is	be	AUX
dpc-4500	59	43	51	51	NUM
dpc-4500	59	44	.	.	PUNCT
dpc-4500	60	1	the	the	DET
dpc-4500	60	2	modified	modify	VERB
dpc-4500	60	3	lossi	lossi	ADJ
dpc-4500	60	4	score	score	NOUN
dpc-4500	60	5	evaluates	evaluate	VERB
dpc-4500	60	6	the	the	DET
dpc-4500	60	7	skin	skin	NOUN
dpc-4500	60	8	erythema	erythema	ADJ
dpc-4500	60	9	,	,	PUNCT
dpc-4500	60	10	thickness	thickness	NOUN
dpc-4500	60	11	,	,	PUNCT
dpc-4500	60	12	and	and	CCONJ
dpc-4500	60	13	development	development	NOUN
dpc-4500	60	14	of	of	ADP
dpc-4500	60	15	lesions	lesion	NOUN
dpc-4500	60	16	or	or	CCONJ
dpc-4500	60	17	lesion	lesion	NOUN
dpc-4500	60	18	enlargement	enlargement	NOUN
dpc-4500	60	19	in	in	ADP
dpc-4500	60	20	18	18	NUM
dpc-4500	60	21	anatomical	anatomical	ADJ
dpc-4500	60	22	skin	skin	NOUN
dpc-4500	60	23	areas	area	NOUN
dpc-4500	60	24	of	of	ADP
dpc-4500	60	25	the	the	DET
dpc-4500	60	26	body	body	NOUN
dpc-4500	60	27	.	.	PUNCT
dpc-4500	61	1	it	it	PRON
dpc-4500	61	2	is	be	AUX
dpc-4500	61	3	calculated	calculate	VERB
dpc-4500	61	4	by	by	ADP
dpc-4500	61	5	adding	add	VERB
dpc-4500	61	6	scores	score	NOUN
dpc-4500	61	7	between	between	ADP
dpc-4500	61	8	0	0	NUM
dpc-4500	61	9	and	and	CCONJ
dpc-4500	61	10	3	3	NUM
dpc-4500	61	11	.	.	PUNCT
dpc-4500	62	1	the	the	DET
dpc-4500	62	2	total	total	ADJ
dpc-4500	62	3	score	score	NOUN
dpc-4500	62	4	is	be	AUX
dpc-4500	62	5	between	between	ADP
dpc-4500	62	6	0	0	NUM
dpc-4500	62	7	and	and	CCONJ
dpc-4500	62	8	162	162	NUM
dpc-4500	62	9	.	.	PUNCT
dpc-4500	62	10	)	)	PUNCT
dpc-4500	62	11	individuals	individual	NOUN
dpc-4500	62	12	with	with	ADP
dpc-4500	62	13	chronic	chronic	ADJ
dpc-4500	62	14	systemic	systemic	ADJ
dpc-4500	62	15	diseases	disease	NOUN
dpc-4500	62	16	,	,	PUNCT
dpc-4500	62	17	neoplastic	neoplastic	ADJ
dpc-4500	62	18	diseases	disease	NOUN
dpc-4500	62	19	,	,	PUNCT
dpc-4500	62	20	pregnant	pregnant	ADJ
dpc-4500	62	21	women	woman	NOUN
dpc-4500	62	22	,	,	PUNCT
dpc-4500	62	23	and	and	CCONJ
dpc-4500	62	24	those	those	PRON
dpc-4500	62	25	who	who	PRON
dpc-4500	62	26	had	have	AUX
dpc-4500	62	27	received	receive	VERB
dpc-4500	62	28	systemic	systemic	ADJ
dpc-4500	62	29	or	or	CCONJ
dpc-4500	62	30	topical	topical	ADJ
dpc-4500	62	31	drug	drug	NOUN
dpc-4500	62	32	treatment	treatment	NOUN
dpc-4500	62	33	in	in	ADP
dpc-4500	62	34	the	the	DET
dpc-4500	62	35	preceding	precede	VERB
dpc-4500	62	36	three	three	NUM
dpc-4500	62	37	months	month	NOUN
dpc-4500	62	38	were	be	AUX
dpc-4500	62	39	excluded	exclude	VERB
dpc-4500	62	40	from	from	ADP
dpc-4500	62	41	the	the	DET
dpc-4500	62	42	study	study	NOUN
dpc-4500	62	43	.	.	PUNCT
dpc-4500	63	1	the	the	DET
dpc-4500	63	2	control	control	NOUN
dpc-4500	63	3	group	group	NOUN
dpc-4500	63	4	was	be	AUX
dpc-4500	63	5	selected	select	VERB
dpc-4500	63	6	from	from	ADP
dpc-4500	63	7	healthy	healthy	ADJ
dpc-4500	63	8	individuals	individual	NOUN
dpc-4500	63	9	coming	come	VERB
dpc-4500	63	10	in	in	ADP
dpc-4500	63	11	for	for	ADP
dpc-4500	63	12	general	general	ADJ
dpc-4500	63	13	check	check	NOUN
dpc-4500	63	14	-	-	PUNCT
dpc-4500	63	15	ups	up	NOUN
dpc-4500	63	16	.	.	PUNCT
dpc-4500	64	1	laboratory	laboratory	NOUN
dpc-4500	64	2	tests	test	NOUN
dpc-4500	64	3	included	include	VERB
dpc-4500	64	4	crp	crp	PROPN
dpc-4500	64	5	sedimentation	sedimentation	NOUN
dpc-4500	64	6	rate	rate	NOUN
dpc-4500	64	7	,	,	PUNCT
dpc-4500	64	8	total	total	ADJ
dpc-4500	64	9	thiol	thiol	NOUN
dpc-4500	64	10	,	,	PUNCT
dpc-4500	64	11	native	native	ADJ
dpc-4500	64	12	thiol	thiol	NOUN
dpc-4500	64	13	,	,	PUNCT
dpc-4500	64	14	and	and	CCONJ
dpc-4500	64	15	disulfide	disulfide	NOUN
dpc-4500	64	16	levels	level	NOUN
dpc-4500	64	17	indicated	indicate	VERB
dpc-4500	64	18	by	by	ADP
dpc-4500	64	19	the	the	DET
dpc-4500	64	20	erel	erel	NOUN
dpc-4500	64	21	profile	profile	NOUN
dpc-4500	64	22	,	,	PUNCT
dpc-4500	64	23	i	i	PRON
dpc-4500	64	24	m	m	VERB
dpc-4500	64	25	a	a	DET
dpc-4500	64	26	level	level	NOUN
dpc-4500	64	27	,	,	PUNCT
dpc-4500	64	28	and	and	CCONJ
dpc-4500	64	29	prolidase	prolidase	NOUN
dpc-4500	64	30	levels	level	NOUN
dpc-4500	64	31	.	.	PUNCT
dpc-4500	65	1	participants	participant	NOUN
dpc-4500	65	2	provided	provide	VERB
dpc-4500	65	3	venous	venous	ADJ
dpc-4500	65	4	blood	blood	NOUN
dpc-4500	65	5	samples	sample	NOUN
dpc-4500	65	6	after	after	ADP
dpc-4500	65	7	12	12	NUM
dpc-4500	65	8	hours	hour	NOUN
dpc-4500	65	9	of	of	ADP
dpc-4500	65	10	fasting	fasting	NOUN
dpc-4500	65	11	,	,	PUNCT
dpc-4500	65	12	which	which	PRON
dpc-4500	65	13	were	be	AUX
dpc-4500	65	14	then	then	ADV
dpc-4500	65	15	centrifuged	centrifuge	VERB
dpc-4500	65	16	at	at	ADP
dpc-4500	65	17	1500	1500	NUM
dpc-4500	65	18	rpm	rpm	NOUN
dpc-4500	65	19	for	for	ADP
dpc-4500	65	20	10	10	NUM
dpc-4500	65	21	minutes	minute	NOUN
dpc-4500	65	22	.	.	PUNCT
dpc-4500	65	23	 	 	SPACE
dpc-4500	66	1	the	the	DET
dpc-4500	66	2	separated	separate	VERB
dpc-4500	66	3	serum	serum	NOUN
dpc-4500	66	4	samples	sample	NOUN
dpc-4500	66	5	were	be	AUX
dpc-4500	66	6	frozen	freeze	VERB
dpc-4500	66	7	and	and	CCONJ
dpc-4500	66	8	stored	store	VERB
dpc-4500	66	9	at	at	ADP
dpc-4500	66	10	-80	-80	NOUN
dpc-4500	66	11	°	°	ADP
dpc-4500	66	12	c	c	NOUN
dpc-4500	66	13	until	until	ADP
dpc-4500	66	14	analysis	analysis	NOUN
dpc-4500	66	15	.	.	PUNCT
dpc-4500	66	16	 	 	SPACE
dpc-4500	67	1	all	all	DET
dpc-4500	67	2	oxidative	oxidative	ADJ
dpc-4500	67	3	parameters	parameter	NOUN
dpc-4500	67	4	were	be	AUX
dpc-4500	67	5	studied	study	VERB
dpc-4500	67	6	in	in	ADP
dpc-4500	67	7	the	the	DET
dpc-4500	67	8	same	same	ADJ
dpc-4500	67	9	samples	sample	NOUN
dpc-4500	67	10	.	.	PUNCT
dpc-4500	68	1	serum	serum	PROPN
dpc-4500	68	2	native	native	ADJ
dpc-4500	68	3	and	and	CCONJ
dpc-4500	68	4	total	total	ADJ
dpc-4500	68	5	thiol	thiol	ADJ
dpc-4500	68	6	concentrations	concentration	NOUN
dpc-4500	68	7	and	and	CCONJ
dpc-4500	68	8	disulfide	disulfide	VERB
dpc-4500	68	9	to	to	ADP
dpc-4500	68	10	native	native	ADJ
dpc-4500	68	11	and	and	CCONJ
dpc-4500	68	12	total	total	ADJ
dpc-4500	68	13	thiol	thiol	ADJ
dpc-4500	68	14	ratios	ratio	NOUN
dpc-4500	68	15	were	be	AUX
dpc-4500	68	16	determined	determine	VERB
dpc-4500	68	17	by	by	ADP
dpc-4500	68	18	the	the	DET
dpc-4500	68	19	spectrophotometric	spectrophotometric	ADJ
dpc-4500	68	20	erel	erel	NOUN
dpc-4500	68	21	method	method	NOUN
dpc-4500	68	22	using	use	VERB
dpc-4500	68	23	automatic	automatic	ADJ
dpc-4500	68	24	clinical	clinical	ADJ
dpc-4500	68	25	chemical	chemical	NOUN
dpc-4500	68	26	analyzer	analyzer	NOUN
dpc-4500	68	27	(	(	PUNCT
dpc-4500	68	28	roche	roche	PROPN
dpc-4500	68	29	,	,	PUNCT
dpc-4500	68	30	cobas	cobas	PROPN
dpc-4500	68	31	501	501	NUM
dpc-4500	68	32	,	,	PUNCT
dpc-4500	68	33	mannheim	mannheim	PROPN
dpc-4500	68	34	,	,	PUNCT
dpc-4500	68	35	germany	germany	PROPN
dpc-4500	68	36	)	)	PUNCT
dpc-4500	69	1	[	[	X
dpc-4500	69	2	13	13	NUM
dpc-4500	69	3	]	]	PUNCT
dpc-4500	69	4	.	.	PUNCT
dpc-4500	70	1	functional	functional	ADJ
dpc-4500	70	2	thiol	thiol	ADJ
dpc-4500	70	3	groups	group	NOUN
dpc-4500	70	4	were	be	AUX
dpc-4500	70	5	exposed	expose	VERB
dpc-4500	70	6	using	use	VERB
dpc-4500	70	7	sodium	sodium	NOUN
dpc-4500	70	8	borohydride	borohydride	NOUN
dpc-4500	70	9	.	.	PUNCT
dpc-4500	71	1	unused	unused	ADJ
dpc-4500	71	2	reduced	reduce	VERB
dpc-4500	71	3	sodium	sodium	NOUN
dpc-4500	71	4	borohydride	borohydride	NOUN
dpc-4500	71	5	was	be	AUX
dpc-4500	71	6	inhibited	inhibit	VERB
dpc-4500	71	7	by	by	ADP
dpc-4500	71	8	the	the	DET
dpc-4500	71	9	reduction	reduction	NOUN
dpc-4500	71	10	of	of	ADP
dpc-4500	71	11	5,5’-dithiobis-(2	5,5’-dithiobis-(2	ADJ
dpc-4500	71	12	-	-	PUNCT
dpc-4500	71	13	nitrobenzoic	nitrobenzoic	ADJ
dpc-4500	71	14	)	)	PUNCT
dpc-4500	71	15	acid	acid	NOUN
dpc-4500	71	16	(	(	PUNCT
dpc-4500	71	17	dtnb	dtnb	NOUN
dpc-4500	71	18	)	)	PUNCT
dpc-4500	71	19	with	with	ADP
dpc-4500	71	20	formaldehyde	formaldehyde	NOUN
dpc-4500	71	21	.	.	PUNCT
dpc-4500	72	1	the	the	DET
dpc-4500	72	2	total	total	ADJ
dpc-4500	72	3	thiol	thiol	ADJ
dpc-4500	72	4	groups	group	NOUN
dpc-4500	72	5	formed	form	VERB
dpc-4500	72	6	by	by	ADP
dpc-4500	72	7	reduced	reduced	ADJ
dpc-4500	72	8	and	and	CCONJ
dpc-4500	72	9	native	native	ADJ
dpc-4500	72	10	thiol	thiol	ADJ
dpc-4500	72	11	groups	group	NOUN
dpc-4500	72	12	were	be	AUX
dpc-4500	72	13	determined	determine	VERB
dpc-4500	72	14	after	after	ADP
dpc-4500	72	15	reaction	reaction	NOUN
dpc-4500	72	16	with	with	ADP
dpc-4500	72	17	dtnb	dtnb	NOUN
dpc-4500	72	18	.	.	PUNCT
dpc-4500	73	1	the	the	DET
dpc-4500	73	2	dynamic	dynamic	ADJ
dpc-4500	73	3	disulfide	disulfide	NOUN
dpc-4500	73	4	amount	amount	NOUN
dpc-4500	73	5	was	be	AUX
dpc-4500	73	6	found	find	VERB
dpc-4500	73	7	by	by	ADP
dpc-4500	73	8	dividing	divide	VERB
dpc-4500	73	9	the	the	DET
dpc-4500	73	10	difference	difference	NOUN
dpc-4500	73	11	between	between	ADP
dpc-4500	73	12	total	total	ADJ
dpc-4500	73	13	thiol	thiol	NOUN
dpc-4500	73	14	and	and	CCONJ
dpc-4500	73	15	native	native	ADJ
dpc-4500	73	16	thiol	thiol	NOUN
dpc-4500	73	17	by	by	ADP
dpc-4500	73	18	two	two	NUM
dpc-4500	73	19	.	.	PUNCT
dpc-4500	74	1	ratios	ratio	NOUN
dpc-4500	74	2	of	of	ADP
dpc-4500	74	3	disulfide	disulfide	NOUN
dpc-4500	74	4	/	/	SYM
dpc-4500	74	5	total	total	NOUN
dpc-4500	74	6	thiol	thiol	NOUN
dpc-4500	74	7	,	,	PUNCT
dpc-4500	74	8	disulfide/	disulfide/	NUM
dpc-4500	74	9	native	native	ADJ
dpc-4500	74	10	thiol	thiol	NOUN
dpc-4500	74	11	,	,	PUNCT
dpc-4500	74	12	and	and	CCONJ
dpc-4500	74	13	native	native	ADJ
dpc-4500	74	14	thiol	thiol	PROPN
dpc-4500	74	15	/	/	SYM
dpc-4500	74	16	total	total	ADJ
dpc-4500	74	17	thiol	thiol	NOUN
dpc-4500	74	18	were	be	AUX
dpc-4500	74	19	calculated	calculate	VERB
dpc-4500	74	20	,	,	PUNCT
dpc-4500	74	21	and	and	CCONJ
dpc-4500	74	22	the	the	DET
dpc-4500	74	23	results	result	NOUN
dpc-4500	74	24	were	be	AUX
dpc-4500	74	25	reported	report	VERB
dpc-4500	74	26	in	in	ADP
dpc-4500	74	27	absorbance	absorbance	NOUN
dpc-4500	74	28	units	unit	NOUN
dpc-4500	74	29	(	(	PUNCT
dpc-4500	74	30	absu	absu	PROPN
dpc-4500	74	31	)	)	PUNCT
dpc-4500	75	1	[	[	X
dpc-4500	75	2	36	36	NUM
dpc-4500	75	3	]	]	PUNCT
dpc-4500	75	4	.	.	PUNCT
dpc-4500	76	1	the	the	DET
dpc-4500	76	2	bar	bar	NOUN
dpc-4500	76	3	-	-	PUNCT
dpc-4500	76	4	or	or	CCONJ
dpc-4500	76	5	method	method	NOUN
dpc-4500	76	6	measures	measure	NOUN
dpc-4500	76	7	the	the	DET
dpc-4500	76	8	i	i	NOUN
dpc-4500	76	9	m	m	VERB
dpc-4500	76	10	a	a	DET
dpc-4500	76	11	content	content	NOUN
dpc-4500	76	12	with	with	ADP
dpc-4500	76	13	a	a	DET
dpc-4500	76	14	0.1	0.1	NUM
dpc-4500	76	15	%	%	NOUN
dpc-4500	76	16	cobalt	cobalt	NOUN
dpc-4500	76	17	binding	binding	NOUN
dpc-4500	76	18	.	.	PUNCT
dpc-4500	77	1	after	after	ADP
dpc-4500	77	2	10	10	NUM
dpc-4500	77	3	minutes	minute	NOUN
dpc-4500	77	4	of	of	ADP
dpc-4500	77	5	incubation	incubation	NOUN
dpc-4500	77	6	with	with	ADP
dpc-4500	77	7	cobalt	cobalt	NOUN
dpc-4500	77	8	,	,	PUNCT
dpc-4500	77	9	dithiothreitol	dithiothreitol	PROPN
dpc-4500	77	10	was	be	AUX
dpc-4500	77	11	added	add	VERB
dpc-4500	77	12	.	.	PUNCT
dpc-4500	78	1	finally	finally	ADV
dpc-4500	78	2	,	,	PUNCT
dpc-4500	78	3	a	a	DET
dpc-4500	78	4	0.9	0.9	NUM
dpc-4500	78	5	%	%	NOUN
dpc-4500	78	6	sodium	sodium	NOUN
dpc-4500	78	7	chloride	chloride	NOUN
dpc-4500	78	8	solution	solution	NOUN
dpc-4500	78	9	was	be	AUX
dpc-4500	78	10	added	add	VERB
dpc-4500	78	11	,	,	PUNCT
dpc-4500	78	12	and	and	CCONJ
dpc-4500	78	13	the	the	DET
dpc-4500	78	14	absorbance	absorbance	NOUN
dpc-4500	78	15	was	be	AUX
dpc-4500	78	16	measured	measure	VERB
dpc-4500	78	17	using	use	VERB
dpc-4500	78	18	a	a	DET
dpc-4500	78	19	spectrophotometer	spectrophotometer	NOUN
dpc-4500	78	20	.	.	PUNCT
dpc-4500	79	1	prolidase	prolidase	NOUN
dpc-4500	79	2	activities	activity	NOUN
dpc-4500	79	3	were	be	AUX
dpc-4500	79	4	measured	measure	VERB
dpc-4500	79	5	by	by	ADP
dpc-4500	79	6	myara	myara	ADJ
dpc-4500	79	7	method	method	NOUN
dpc-4500	79	8	[	[	X
dpc-4500	79	9	37	37	NUM
dpc-4500	79	10	]	]	PUNCT
dpc-4500	79	11	.	.	PUNCT
dpc-4500	80	1	a	a	DET
dpc-4500	80	2	commercial	commercial	ADJ
dpc-4500	80	3	kit	kit	NOUN
dpc-4500	80	4	(	(	PUNCT
dpc-4500	80	5	human	human	PROPN
dpc-4500	80	6	xaa	xaa	PROPN
dpc-4500	80	7	-	-	PUNCT
dpc-4500	80	8	pro	pro	X
dpc-4500	80	9	dipeptidase	dipeptidase	ADJ
dpc-4500	80	10	/	/	SYM
dpc-4500	80	11	prolidase	prolidase	NOUN
dpc-4500	80	12	enzyme	enzyme	NOUN
dpc-4500	80	13	-	-	PUNCT
dpc-4500	80	14	linked	link	VERB
dpc-4500	80	15	immunosorbent	immunosorbent	NOUN
dpc-4500	80	16	assay	assay	NOUN
dpc-4500	80	17	kit	kit	NOUN
dpc-4500	80	18	(	(	PUNCT
dpc-4500	80	19	cusabio	cusabio	PROPN
dpc-4500	80	20	biotech	biotech	PROPN
dpc-4500	80	21	co	co	X
dpc-4500	80	22	ltd	ltd	PROPN
dpc-4500	80	23	)	)	PUNCT
dpc-4500	80	24	was	be	AUX
dpc-4500	80	25	used	use	VERB
dpc-4500	80	26	with	with	ADP
dpc-4500	80	27	elisa	elisa	NOUN
dpc-4500	80	28	method	method	NOUN
dpc-4500	80	29	.	.	PUNCT
dpc-4500	81	1	(	(	PUNCT
dpc-4500	81	2	myara	myara	NOUN
dpc-4500	81	3	method	method	PROPN
dpc-4500	81	4	:	:	PUNCT
dpc-4500	81	5	the	the	DET
dpc-4500	81	6	enzyme	enzyme	NOUN
dpc-4500	81	7	was	be	AUX
dpc-4500	81	8	activated	activate	VERB
dpc-4500	81	9	by	by	ADP
dpc-4500	81	10	preincubation	preincubation	NOUN
dpc-4500	81	11	with	with	ADP
dpc-4500	81	12	mncl2	mncl2	NOUN
dpc-4500	81	13	for	for	ADP
dpc-4500	81	14	2	2	NUM
dpc-4500	81	15	hours	hour	NOUN
dpc-4500	81	16	(	(	PUNCT
dpc-4500	81	17	step	step	NOUN
dpc-4500	81	18	1	1	NUM
dpc-4500	81	19	)	)	PUNCT
dpc-4500	81	20	,	,	PUNCT
dpc-4500	81	21	incubated	incubate	VERB
dpc-4500	81	22	with	with	ADP
dpc-4500	81	23	gly	gly	ADJ
dpc-4500	81	24	-	-	PUNCT
dpc-4500	81	25	pro	pro	ADJ
dpc-4500	81	26	substrate	substrate	NOUN
dpc-4500	81	27	(	(	PUNCT
dpc-4500	81	28	km	km	NOUN
dpc-4500	81	29	=	=	SYM
dpc-4500	81	30	2.9	2.9	NUM
dpc-4500	81	31	mm	mm	NOUN
dpc-4500	81	32	)	)	PUNCT
dpc-4500	81	33	for	for	ADP
dpc-4500	81	34	30	30	NUM
dpc-4500	81	35	minutes	minute	NOUN
dpc-4500	81	36	(	(	PUNCT
dpc-4500	81	37	step	step	NOUN
dpc-4500	81	38	2	2	NUM
dpc-4500	81	39	)	)	PUNCT
dpc-4500	81	40	,	,	PUNCT
dpc-4500	81	41	enzyme	enzyme	NOUN
dpc-4500	81	42	activity	activity	NOUN
dpc-4500	81	43	was	be	AUX
dpc-4500	81	44	calculated	calculate	VERB
dpc-4500	81	45	by	by	ADP
dpc-4500	81	46	measuring	measure	VERB
dpc-4500	81	47	the	the	DET
dpc-4500	81	48	amount	amount	NOUN
dpc-4500	81	49	of	of	ADP
dpc-4500	81	50	proline	proline	NOUN
dpc-4500	81	51	released	release	VERB
dpc-4500	81	52	(	(	PUNCT
dpc-4500	81	53	ninhidrin	ninhidrin	ADJ
dpc-4500	81	54	rxn	rxn	NOUN
dpc-4500	81	55	)	)	PUNCT
dpc-4500	81	56	(	(	PUNCT
dpc-4500	81	57	step	step	NOUN
dpc-4500	81	58	3	3	NUM
dpc-4500	81	59	)	)	PUNCT
dpc-4500	81	60	.	.	PUNCT
dpc-4500	81	61	)	)	PUNCT
dpc-4500	82	1	statistics	statistic	NOUN
dpc-4500	82	2	statistical	statistical	ADJ
dpc-4500	82	3	analysis	analysis	NOUN
dpc-4500	82	4	presented	present	VERB
dpc-4500	82	5	data	datum	NOUN
dpc-4500	82	6	as	as	ADP
dpc-4500	82	7	counts	count	NOUN
dpc-4500	82	8	,	,	PUNCT
dpc-4500	82	9	arithmetic	arithmetic	ADJ
dpc-4500	82	10	means	mean	NOUN
dpc-4500	82	11	,	,	PUNCT
dpc-4500	82	12	and	and	CCONJ
dpc-4500	82	13	standard	standard	ADJ
dpc-4500	82	14	deviations	deviation	NOUN
dpc-4500	82	15	.	.	PUNCT
dpc-4500	83	1	the	the	DET
dpc-4500	83	2	differences	difference	NOUN
dpc-4500	83	3	in	in	ADP
dpc-4500	83	4	average	average	ADJ
dpc-4500	83	5	values	value	NOUN
dpc-4500	83	6	between	between	ADP
dpc-4500	83	7	two	two	NUM
dpc-4500	83	8	groups	group	NOUN
dpc-4500	83	9	were	be	AUX
dpc-4500	83	10	investigated	investigate	VERB
dpc-4500	83	11	using	use	VERB
dpc-4500	83	12	the	the	DET
dpc-4500	83	13	student	student	NOUN
dpc-4500	83	14	’s	’s	PART
dpc-4500	83	15	t	t	PROPN
dpc-4500	83	16	-	-	PUNCT
dpc-4500	83	17	test	test	NOUN
dpc-4500	83	18	for	for	ADP
dpc-4500	83	19	parametric	parametric	ADJ
dpc-4500	83	20	values	value	NOUN
dpc-4500	83	21	and	and	CCONJ
dpc-4500	83	22	the	the	DET
dpc-4500	83	23	mann	mann	PROPN
dpc-4500	83	24	-	-	PUNCT
dpc-4500	83	25	whitney	whitney	PROPN
dpc-4500	83	26	u	u	PROPN
dpc-4500	83	27	test	test	NOUN
dpc-4500	83	28	for	for	ADP
dpc-4500	83	29	non	non	ADJ
dpc-4500	83	30	-	-	ADJ
dpc-4500	83	31	parametric	parametric	ADJ
dpc-4500	83	32	values	value	NOUN
dpc-4500	83	33	.	.	PUNCT
dpc-4500	84	1	the	the	DET
dpc-4500	84	2	relationship	relationship	NOUN
dpc-4500	84	3	between	between	ADP
dpc-4500	84	4	patients	patient	NOUN
dpc-4500	84	5	’	’	PART
dpc-4500	84	6	parameters	parameter	NOUN
dpc-4500	84	7	and	and	CCONJ
dpc-4500	84	8	their	their	PRON
dpc-4500	84	9	demographic	demographic	ADJ
dpc-4500	84	10	and	and	CCONJ
dpc-4500	84	11	clinical	clinical	ADJ
dpc-4500	84	12	features	feature	NOUN
dpc-4500	84	13	was	be	AUX
dpc-4500	84	14	evaluated	evaluate	VERB
dpc-4500	84	15	using	use	VERB
dpc-4500	84	16	pearson	pearson	PROPN
dpc-4500	84	17	correlation	correlation	NOUN
dpc-4500	84	18	analysis	analysis	NOUN
dpc-4500	84	19	.	.	PUNCT
dpc-4500	85	1	a	a	DET
dpc-4500	85	2	  	  	SPACE
dpc-4500	85	3	p	p	NOUN
dpc-4500	85	4	-	-	PUNCT
dpc-4500	85	5	value	value	NOUN
dpc-4500	85	6	of	of	ADP
dpc-4500	85	7	<	<	NOUN
dpc-4500	85	8	0.05	0.05	NUM
dpc-4500	85	9	was	be	AUX
dpc-4500	85	10	considered	consider	VERB
dpc-4500	85	11	statistically	statistically	ADV
dpc-4500	85	12	significant	significant	ADJ
dpc-4500	85	13	in	in	ADP
dpc-4500	85	14	all	all	DET
dpc-4500	85	15	tests	test	NOUN
dpc-4500	85	16	.	.	PUNCT
dpc-4500	86	1	data	datum	NOUN
dpc-4500	86	2	were	be	AUX
dpc-4500	86	3	analyzed	analyze	VERB
dpc-4500	86	4	using	use	VERB
dpc-4500	86	5	the	the	DET
dpc-4500	86	6	spss	spss	PROPN
dpc-4500	86	7	20.0	20.0	NUM
dpc-4500	86	8	software	software	NOUN
dpc-4500	86	9	package	package	NOUN
dpc-4500	86	10	.	.	PUNCT
dpc-4500	87	1	results	result	VERB
dpc-4500	87	2	the	the	DET
dpc-4500	87	3	average	average	ADJ
dpc-4500	87	4	age	age	NOUN
dpc-4500	87	5	was	be	AUX
dpc-4500	87	6	40.24	40.24	NUM
dpc-4500	87	7	±	±	NUM
dpc-4500	87	8	14.77	14.77	NUM
dpc-4500	87	9	in	in	ADP
dpc-4500	87	10	patients	patient	NOUN
dpc-4500	87	11	and	and	CCONJ
dpc-4500	87	12	37.86	37.86	NUM
dpc-4500	87	13	±	±	NUM
dpc-4500	87	14	10.98	10.98	NUM
dpc-4500	87	15	in	in	ADP
dpc-4500	87	16	controls	control	NOUN
dpc-4500	87	17	,	,	PUNCT
dpc-4500	87	18	and	and	CCONJ
dpc-4500	87	19	85	85	NUM
dpc-4500	87	20	%	%	NOUN
dpc-4500	87	21	of	of	ADP
dpc-4500	87	22	both	both	CCONJ
dpc-4500	87	23	the	the	DET
dpc-4500	87	24	patient	patient	NOUN
dpc-4500	87	25	and	and	CCONJ
dpc-4500	87	26	the	the	DET
dpc-4500	87	27	control	control	NOUN
dpc-4500	87	28	groups	group	NOUN
dpc-4500	87	29	were	be	AUX
dpc-4500	87	30	female	female	ADJ
dpc-4500	87	31	(	(	PUNCT
dpc-4500	87	32	n=17	n=17	NOUN
dpc-4500	87	33	)	)	PUNCT
dpc-4500	87	34	.	.	PUNCT
dpc-4500	88	1	the	the	DET
dpc-4500	88	2	patient	patient	ADJ
dpc-4500	88	3	and	and	CCONJ
dpc-4500	88	4	control	control	NOUN
dpc-4500	88	5	groups	group	NOUN
dpc-4500	88	6	were	be	AUX
dpc-4500	88	7	similar	similar	ADJ
dpc-4500	88	8	in	in	ADP
dpc-4500	88	9	terms	term	NOUN
dpc-4500	88	10	of	of	ADP
dpc-4500	88	11	age	age	NOUN
dpc-4500	88	12	and	and	CCONJ
dpc-4500	88	13	sex	sex	NOUN
dpc-4500	88	14	(	(	PUNCT
dpc-4500	88	15	p=0.706	p=0.706	NOUN
dpc-4500	88	16	)	)	PUNCT
dpc-4500	88	17	.	.	PUNCT
dpc-4500	89	1	comparison	comparison	NOUN
dpc-4500	89	2	of	of	ADP
dpc-4500	89	3	serum	serum	NOUN
dpc-4500	89	4	parameter	parameter	NOUN
dpc-4500	89	5	levels	level	NOUN
dpc-4500	89	6	between	between	ADP
dpc-4500	89	7	patient	patient	NOUN
dpc-4500	89	8	and	and	CCONJ
dpc-4500	89	9	control	control	NOUN
dpc-4500	89	10	group	group	NOUN
dpc-4500	89	11	.	.	PUNCT
dpc-4500	90	1	levels	level	NOUN
dpc-4500	90	2	of	of	ADP
dpc-4500	90	3	native	native	ADJ
dpc-4500	90	4	thiol	thiol	PROPN
dpc-4500	90	5	(	(	PUNCT
dpc-4500	90	6	p=0.958	p=0.958	X
dpc-4500	90	7	)	)	PUNCT
dpc-4500	90	8	,	,	PUNCT
dpc-4500	90	9	total	total	ADJ
dpc-4500	90	10	thiol	thiol	NOUN
dpc-4500	90	11	(	(	PUNCT
dpc-4500	90	12	p=0.979	p=0.979	NOUN
dpc-4500	90	13	)	)	PUNCT
dpc-4500	90	14	,	,	PUNCT
dpc-4500	90	15	disulfide	disulfide	NOUN
dpc-4500	90	16	(	(	PUNCT
dpc-4500	90	17	p=0.449	p=0.449	NOUN
dpc-4500	90	18	)	)	PUNCT
dpc-4500	90	19	,	,	PUNCT
dpc-4500	90	20	disulfide	disulfide	NOUN
dpc-4500	90	21	/	/	SYM
dpc-4500	90	22	native	native	NOUN
dpc-4500	90	23	thiol%	thiol%	NUM
dpc-4500	90	24	(	(	PUNCT
dpc-4500	90	25	p=0.368	p=0.368	NOUN
dpc-4500	90	26	)	)	PUNCT
dpc-4500	90	27	,	,	PUNCT
dpc-4500	90	28	disulfide	disulfide	NOUN
dpc-4500	90	29	/	/	SYM
dpc-4500	90	30	total	total	ADJ
dpc-4500	90	31	thiol	thiol	ADJ
dpc-4500	90	32	%	%	NOUN
dpc-4500	90	33	(	(	PUNCT
dpc-4500	90	34	p=0.361	p=0.361	NOUN
dpc-4500	90	35	)	)	PUNCT
dpc-4500	90	36	,	,	PUNCT
dpc-4500	90	37	native	native	ADJ
dpc-4500	90	38	thiol/	thiol/	NUM
dpc-4500	90	39	total	total	ADJ
dpc-4500	90	40	thiol	thiol	ADJ
dpc-4500	90	41	%	%	NOUN
dpc-4500	90	42	(	(	PUNCT
dpc-4500	90	43	p=0.368	p=0.368	NOUN
dpc-4500	90	44	)	)	PUNCT
dpc-4500	90	45	,	,	PUNCT
dpc-4500	90	46	and	and	CCONJ
dpc-4500	90	47	prolidase	prolidase	NOUN
dpc-4500	90	48	(	(	PUNCT
dpc-4500	90	49	p=0.121	p=0.121	ADV
dpc-4500	90	50	)	)	PUNCT
dpc-4500	90	51	were	be	AUX
dpc-4500	90	52	similar	similar	ADJ
dpc-4500	90	53	in	in	ADP
dpc-4500	90	54	both	both	CCONJ
dpc-4500	90	55	patient	patient	ADJ
dpc-4500	90	56	and	and	CCONJ
dpc-4500	90	57	control	control	NOUN
dpc-4500	90	58	groups	group	NOUN
dpc-4500	90	59	.	.	PUNCT
dpc-4500	91	1	only	only	ADV
dpc-4500	91	2	i	i	PRON
dpc-4500	91	3	m	m	VERB
dpc-4500	91	4	a	a	PROPN
dpc-4500	91	5	was	be	AUX
dpc-4500	91	6	significantly	significantly	ADV
dpc-4500	91	7	different	different	ADJ
dpc-4500	91	8	(	(	PUNCT
dpc-4500	91	9	table	table	NOUN
dpc-4500	91	10	1	1	NUM
dpc-4500	91	11	)	)	PUNCT
dpc-4500	91	12	.	.	PUNCT
dpc-4500	92	1	while	while	SCONJ
dpc-4500	92	2	a	a	DET
dpc-4500	92	3	negative	negative	ADJ
dpc-4500	92	4	correlation	correlation	NOUN
dpc-4500	92	5	was	be	AUX
dpc-4500	92	6	observed	observe	VERB
dpc-4500	92	7	between	between	ADP
dpc-4500	92	8	native	native	ADJ
dpc-4500	92	9	thiol	thiol	PROPN
dpc-4500	92	10	,	,	PUNCT
dpc-4500	92	11	total	total	ADJ
dpc-4500	92	12	thiol	thiol	NOUN
dpc-4500	92	13	,	,	PUNCT
dpc-4500	92	14	and	and	CCONJ
dpc-4500	92	15	age	age	NOUN
dpc-4500	92	16	,	,	PUNCT
dpc-4500	92	17	no	no	DET
dpc-4500	92	18	significant	significant	ADJ
dpc-4500	92	19	correlation	correlation	NOUN
dpc-4500	92	20	was	be	AUX
dpc-4500	92	21	observed	observe	VERB
dpc-4500	92	22	between	between	ADP
dpc-4500	92	23	disulfide	disulfide	NOUN
dpc-4500	92	24	,	,	PUNCT
dpc-4500	92	25	disulfide	disulfide	NOUN
dpc-4500	92	26	/	/	SYM
dpc-4500	92	27	native	native	ADJ
dpc-4500	92	28	thiol	thiol	NOUN
dpc-4500	92	29	rates	rate	NOUN
dpc-4500	92	30	,	,	PUNCT
dpc-4500	92	31	disulfide	disulfide	NOUN
dpc-4500	92	32	/	/	SYM
dpc-4500	92	33	total	total	ADJ
dpc-4500	92	34	thiol	thiol	ADJ
dpc-4500	92	35	rates	rate	NOUN
dpc-4500	92	36	,	,	PUNCT
dpc-4500	92	37	i	i	PRON
dpc-4500	92	38	m	m	VERB
dpc-4500	92	39	a	a	PROPN
dpc-4500	92	40	,	,	PUNCT
dpc-4500	92	41	and	and	CCONJ
dpc-4500	92	42	prolidase	prolidase	NOUN
dpc-4500	92	43	levels	level	NOUN
dpc-4500	92	44	and	and	CCONJ
dpc-4500	92	45	age	age	NOUN
dpc-4500	92	46	.	.	PUNCT
dpc-4500	93	1	while	while	SCONJ
dpc-4500	93	2	a	a	DET
dpc-4500	93	3	negative	negative	ADJ
dpc-4500	93	4	correlation	correlation	NOUN
dpc-4500	93	5	was	be	AUX
dpc-4500	93	6	observed	observe	VERB
dpc-4500	93	7	between	between	ADP
dpc-4500	93	8	native	native	ADJ
dpc-4500	93	9	thiol	thiol	PROPN
dpc-4500	93	10	,	,	PUNCT
dpc-4500	93	11	total	total	ADJ
dpc-4500	93	12	thiol	thiol	NOUN
dpc-4500	93	13	,	,	PUNCT
dpc-4500	93	14	and	and	CCONJ
dpc-4500	93	15	disease	disease	NOUN
dpc-4500	93	16	duration	duration	NOUN
dpc-4500	93	17	,	,	PUNCT
dpc-4500	93	18	no	no	DET
dpc-4500	93	19	significant	significant	ADJ
dpc-4500	93	20	correlation	correlation	NOUN
dpc-4500	93	21	was	be	AUX
dpc-4500	93	22	observed	observe	VERB
dpc-4500	93	23	with	with	ADP
dpc-4500	93	24	disulfide	disulfide	NOUN
dpc-4500	93	25	,	,	PUNCT
dpc-4500	93	26	disulfide	disulfide	NOUN
dpc-4500	93	27	/	/	SYM
dpc-4500	93	28	native	native	ADJ
dpc-4500	93	29	thiol	thiol	NOUN
dpc-4500	93	30	rates	rate	NOUN
dpc-4500	93	31	,	,	PUNCT
dpc-4500	93	32	disulfide	disulfide	NOUN
dpc-4500	93	33	/	/	SYM
dpc-4500	93	34	total	total	ADJ
dpc-4500	93	35	thiol	thiol	ADJ
dpc-4500	93	36	rates	rate	NOUN
dpc-4500	93	37	,	,	PUNCT
dpc-4500	93	38	i	i	PRON
dpc-4500	93	39	m	m	VERB
dpc-4500	93	40	a	a	PROPN
dpc-4500	93	41	,	,	PUNCT
dpc-4500	93	42	and	and	CCONJ
dpc-4500	93	43	prolidase	prolidase	NOUN
dpc-4500	93	44	levels	level	NOUN
dpc-4500	93	45	.	.	PUNCT
dpc-4500	94	1	no	no	DET
dpc-4500	94	2	significant	significant	ADJ
dpc-4500	94	3	relationship	relationship	NOUN
dpc-4500	94	4	was	be	AUX
dpc-4500	94	5	found	find	VERB
dpc-4500	94	6	between	between	ADP
dpc-4500	94	7	the	the	DET
dpc-4500	94	8	levels	level	NOUN
dpc-4500	94	9	of	of	ADP
dpc-4500	94	10	native	native	ADJ
dpc-4500	94	11	thiol	thiol	PROPN
dpc-4500	94	12	,	,	PUNCT
dpc-4500	94	13	total	total	ADJ
dpc-4500	94	14	thiol	thiol	NOUN
dpc-4500	94	15	,	,	PUNCT
dpc-4500	94	16	disulfide	disulfide	ADJ
dpc-4500	94	17	,	,	PUNCT
dpc-4500	94	18	disulfide	disulfide	NOUN
dpc-4500	94	19	/	/	SYM
dpc-4500	94	20	native	native	ADJ
dpc-4500	94	21	thiol	thiol	NOUN
dpc-4500	94	22	rates	rate	NOUN
dpc-4500	94	23	,	,	PUNCT
dpc-4500	94	24	disulfide	disulfide	NOUN
dpc-4500	94	25	/	/	SYM
dpc-4500	94	26	total	total	ADJ
dpc-4500	94	27	thiol	thiol	ADJ
dpc-4500	94	28	rates	rate	NOUN
dpc-4500	94	29	,	,	PUNCT
dpc-4500	94	30	i	i	PRON
dpc-4500	94	31	m	m	VERB
dpc-4500	94	32	a	a	PROPN
dpc-4500	94	33	,	,	PUNCT
dpc-4500	94	34	prolidase	prolidase	NOUN
dpc-4500	94	35	,	,	PUNCT
dpc-4500	94	36	and	and	CCONJ
dpc-4500	94	37	rodnan	rodnan	NOUN
dpc-4500	94	38	and	and	CCONJ
dpc-4500	94	39	lossi	lossi	ADJ
dpc-4500	94	40	scores	score	NOUN
dpc-4500	94	41	.	.	PUNCT
dpc-4500	95	1	native	native	ADJ
dpc-4500	95	2	thiol	thiol	PROPN
dpc-4500	95	3	(	(	PUNCT
dpc-4500	95	4	p<0.001	p<0.001	PROPN
dpc-4500	95	5	,	,	PUNCT
dpc-4500	95	6	r=	r=	ADJ
dpc-4500	95	7	-0.538	-0.538	NUM
dpc-4500	95	8	)	)	PUNCT
dpc-4500	95	9	and	and	CCONJ
dpc-4500	95	10	total	total	ADJ
dpc-4500	95	11	thiol	thiol	NOUN
dpc-4500	95	12	(	(	PUNCT
dpc-4500	95	13	p<0.001	p<0.001	PROPN
dpc-4500	95	14	,	,	PUNCT
dpc-4500	95	15	r=	r=	ADJ
dpc-4500	95	16	-0.553	-0.553	NUM
dpc-4500	95	17	)	)	PUNCT
dpc-4500	95	18	were	be	AUX
dpc-4500	95	19	negatively	negatively	ADV
dpc-4500	95	20	correlated	correlate	VERB
dpc-4500	95	21	with	with	ADP
dpc-4500	95	22	age	age	NOUN
dpc-4500	95	23	.	.	PUNCT
dpc-4500	96	1	native	native	ADJ
dpc-4500	96	2	thiol	thiol	PROPN
dpc-4500	96	3	and	and	CCONJ
dpc-4500	96	4	total	total	ADJ
dpc-4500	96	5	thiol	thiol	ADJ
dpc-4500	96	6	levels	level	NOUN
dpc-4500	96	7	decreased	decrease	VERB
dpc-4500	96	8	with	with	ADP
dpc-4500	96	9	increasing	increase	VERB
dpc-4500	96	10	age	age	NOUN
dpc-4500	96	11	.	.	PUNCT
dpc-4500	97	1	native	native	ADJ
dpc-4500	97	2	thiol	thiol	PROPN
dpc-4500	97	3	(	(	PUNCT
dpc-4500	97	4	p=0.008	p=0.008	NOUN
dpc-4500	97	5	,	,	PUNCT
dpc-4500	97	6	r=	r=	ADJ
dpc-4500	97	7	-0.574	-0.574	NOUN
dpc-4500	97	8	)	)	PUNCT
dpc-4500	97	9	and	and	CCONJ
dpc-4500	97	10	total	total	ADJ
dpc-4500	97	11	thiol	thiol	NOUN
dpc-4500	97	12	(	(	PUNCT
dpc-4500	97	13	p=0.007	p=0.007	X
dpc-4500	97	14	,	,	PUNCT
dpc-4500	97	15	r=	r=	ADJ
dpc-4500	97	16	-0.583	-0.583	NOUN
dpc-4500	97	17	)	)	PUNCT
dpc-4500	97	18	were	be	AUX
dpc-4500	97	19	negatively	negatively	ADV
dpc-4500	97	20	correlated	correlate	VERB
dpc-4500	97	21	with	with	ADP
dpc-4500	97	22	disease	disease	NOUN
dpc-4500	97	23	duration	duration	NOUN
dpc-4500	97	24	.	.	PUNCT
dpc-4500	98	1	native	native	ADJ
dpc-4500	98	2	thiol	thiol	PROPN
dpc-4500	98	3	and	and	CCONJ
dpc-4500	98	4	total	total	ADJ
dpc-4500	98	5	thiol	thiol	ADJ
dpc-4500	98	6	levels	level	NOUN
dpc-4500	98	7	decreased	decrease	VERB
dpc-4500	98	8	with	with	ADP
dpc-4500	98	9	increasing	increase	VERB
dpc-4500	98	10	disease	disease	NOUN
dpc-4500	98	11	duration	duration	NOUN
dpc-4500	98	12	.	.	PUNCT
dpc-4500	99	1	native	native	ADJ
dpc-4500	99	2	thiol	thiol	PROPN
dpc-4500	99	3	and	and	CCONJ
dpc-4500	99	4	total	total	ADJ
dpc-4500	99	5	thiol	thiol	ADJ
dpc-4500	99	6	levels	level	NOUN
dpc-4500	99	7	decreased	decrease	VERB
dpc-4500	99	8	with	with	ADP
dpc-4500	99	9	increasing	increase	VERB
dpc-4500	99	10	disease	disease	NOUN
dpc-4500	99	11	duration	duration	NOUN
dpc-4500	99	12	(	(	PUNCT
dpc-4500	99	13	table	table	NOUN
dpc-4500	99	14	2	2	NUM
dpc-4500	99	15	)	)	PUNCT
dpc-4500	99	16	.	.	PUNCT
dpc-4500	100	1	4	4	NUM
dpc-4500	100	2	original	original	ADJ
dpc-4500	100	3	article	article	NOUN
dpc-4500	100	4	|	|	ADV
dpc-4500	100	5	dermatol	dermatol	ADJ
dpc-4500	100	6	pract	pract	NOUN
dpc-4500	100	7	concept	concept	NOUN
dpc-4500	100	8	.	.	PUNCT
dpc-4500	101	1	2024;14(4):e2024249	2024;14(4):e2024249	NUM
dpc-4500	101	2	hyperactivation	hyperactivation	NOUN
dpc-4500	101	3	that	that	PRON
dpc-4500	101	4	exhibits	exhibit	VERB
dpc-4500	101	5	abnormal	abnormal	ADJ
dpc-4500	101	6	profibrotic	profibrotic	ADJ
dpc-4500	101	7	activity	activity	NOUN
dpc-4500	101	8	,	,	PUNCT
dpc-4500	101	9	increases	increase	VERB
dpc-4500	101	10	collagen	collagen	NOUN
dpc-4500	101	11	synthesis	synthesis	NOUN
dpc-4500	101	12	,	,	PUNCT
dpc-4500	101	13	and	and	CCONJ
dpc-4500	101	14	decreases	decrease	VERB
dpc-4500	101	15	collagenase	collagenase	NOUN
dpc-4500	101	16	synthesis	synthesis	NOUN
dpc-4500	102	1	[	[	X
dpc-4500	102	2	1,3,23,38	1,3,23,38	X
dpc-4500	102	3	]	]	PUNCT
dpc-4500	102	4	.	.	PUNCT
dpc-4500	103	1	ros	ros	PROPN
dpc-4500	103	2	in	in	ADP
dpc-4500	103	3	the	the	DET
dpc-4500	103	4	environment	environment	NOUN
dpc-4500	103	5	directly	directly	ADV
dpc-4500	103	6	or	or	CCONJ
dpc-4500	103	7	indirectly	indirectly	ADV
dpc-4500	103	8	mediate	mediate	VERB
dpc-4500	103	9	extracellular	extracellular	ADJ
dpc-4500	103	10	and	and	CCONJ
dpc-4500	103	11	intracellular	intracellular	ADJ
dpc-4500	103	12	oxidative	oxidative	ADJ
dpc-4500	103	13	processes	process	NOUN
dpc-4500	103	14	and	and	CCONJ
dpc-4500	103	15	stimulate	stimulate	VERB
dpc-4500	103	16	the	the	DET
dpc-4500	103	17	accumulation	accumulation	NOUN
dpc-4500	103	18	of	of	ADP
dpc-4500	103	19	matrix	matrix	NOUN
dpc-4500	103	20	proteins	protein	NOUN
dpc-4500	103	21	by	by	ADP
dpc-4500	103	22	affecting	affect	VERB
dpc-4500	103	23	endothelial	endothelial	ADJ
dpc-4500	103	24	cells	cell	NOUN
dpc-4500	103	25	and	and	CCONJ
dpc-4500	103	26	fibroblasts	fibroblast	NOUN
dpc-4500	103	27	[	[	X
dpc-4500	103	28	24,28,29	24,28,29	NUM
dpc-4500	103	29	]	]	PUNCT
dpc-4500	103	30	.	.	PUNCT
dpc-4500	104	1	murrel	murrel	NOUN
dpc-4500	104	2	revealed	reveal	VERB
dpc-4500	104	3	the	the	DET
dpc-4500	104	4	effect	effect	NOUN
dpc-4500	104	5	of	of	ADP
dpc-4500	104	6	os	os	NOUN
dpc-4500	104	7	in	in	ADP
dpc-4500	104	8	the	the	DET
dpc-4500	104	9	pathogenesis	pathogenesis	NOUN
dpc-4500	104	10	of	of	ADP
dpc-4500	104	11	scleroderma	scleroderma	NOUN
dpc-4500	104	12	for	for	ADP
dpc-4500	104	13	the	the	DET
dpc-4500	104	14	first	first	ADJ
dpc-4500	104	15	time	time	NOUN
dpc-4500	104	16	[	[	X
dpc-4500	104	17	39	39	NUM
dpc-4500	104	18	]	]	PUNCT
dpc-4500	104	19	.	.	PUNCT
dpc-4500	105	1	several	several	ADJ
dpc-4500	105	2	subsequent	subsequent	ADJ
dpc-4500	105	3	studies	study	NOUN
dpc-4500	105	4	discussion	discussion	NOUN
dpc-4500	105	5	in	in	ADP
dpc-4500	105	6	morphea	morphea	PROPN
dpc-4500	105	7	,	,	PUNCT
dpc-4500	105	8	the	the	DET
dpc-4500	105	9	pathological	pathological	ADJ
dpc-4500	105	10	process	process	NOUN
dpc-4500	105	11	starts	start	VERB
dpc-4500	105	12	in	in	ADP
dpc-4500	105	13	the	the	DET
dpc-4500	105	14	vascular	vascular	ADJ
dpc-4500	105	15	endothelium	endothelium	NOUN
dpc-4500	105	16	.	.	PUNCT
dpc-4500	106	1	excessive	excessive	ADJ
dpc-4500	106	2	release	release	NOUN
dpc-4500	106	3	of	of	ADP
dpc-4500	106	4	various	various	ADJ
dpc-4500	106	5	adhesion	adhesion	NOUN
dpc-4500	106	6	molecules	molecule	NOUN
dpc-4500	106	7	on	on	ADP
dpc-4500	106	8	the	the	DET
dpc-4500	106	9	endothelial	endothelial	ADJ
dpc-4500	106	10	cell	cell	NOUN
dpc-4500	106	11	surface	surface	NOUN
dpc-4500	106	12	triggers	trigger	VERB
dpc-4500	106	13	an	an	DET
dpc-4500	106	14	inflammatory	inflammatory	ADJ
dpc-4500	106	15	cascade	cascade	NOUN
dpc-4500	106	16	involving	involve	VERB
dpc-4500	106	17	proinflammatory	proinflammatory	ADJ
dpc-4500	106	18	cytokines	cytokine	NOUN
dpc-4500	106	19	and	and	CCONJ
dpc-4500	106	20	chemokines	chemokine	NOUN
dpc-4500	106	21	as	as	ADV
dpc-4500	106	22	well	well	ADV
dpc-4500	106	23	as	as	ADP
dpc-4500	106	24	growth	growth	NOUN
dpc-4500	106	25	factors	factor	NOUN
dpc-4500	106	26	with	with	ADP
dpc-4500	106	27	fibrogenetic	fibrogenetic	ADJ
dpc-4500	106	28	potential	potential	NOUN
dpc-4500	106	29	.	.	PUNCT
dpc-4500	107	1	transforming	transform	VERB
dpc-4500	107	2	growth	growth	NOUN
dpc-4500	107	3	factor	factor	NOUN
dpc-4500	107	4	β	β	X
dpc-4500	107	5	(	(	PUNCT
dpc-4500	107	6	tgf	tgf	PROPN
dpc-4500	107	7	-	-	PUNCT
dpc-4500	107	8	β	β	NOUN
dpc-4500	107	9	)	)	PUNCT
dpc-4500	107	10	stimulates	stimulate	VERB
dpc-4500	107	11	fibroblast	fibroblast	ADJ
dpc-4500	107	12	table	table	NOUN
dpc-4500	107	13	1	1	NUM
dpc-4500	107	14	.	.	PUNCT
dpc-4500	107	15	native	native	ADJ
dpc-4500	107	16	thiol	thiol	PROPN
dpc-4500	107	17	,	,	PUNCT
dpc-4500	107	18	total	total	ADJ
dpc-4500	107	19	thiol	thiol	NOUN
dpc-4500	107	20	,	,	PUNCT
dpc-4500	107	21	disulfide	disulfide	ADJ
dpc-4500	107	22	,	,	PUNCT
dpc-4500	107	23	disulfide	disulfide	NOUN
dpc-4500	107	24	/	/	SYM
dpc-4500	107	25	native	native	ADJ
dpc-4500	107	26	thiol	thiol	NOUN
dpc-4500	107	27	(	(	PUNCT
dpc-4500	107	28	%	%	INTJ
dpc-4500	107	29	)	)	PUNCT
dpc-4500	107	30	,	,	PUNCT
dpc-4500	107	31	disulfide	disulfide	NOUN
dpc-4500	107	32	/	/	SYM
dpc-4500	107	33	total	total	NOUN
dpc-4500	107	34	thiol	thiol	NOUN
dpc-4500	107	35	(	(	PUNCT
dpc-4500	107	36	%	%	NOUN
dpc-4500	107	37	)	)	PUNCT
dpc-4500	107	38	,	,	PUNCT
dpc-4500	107	39	i	i	PRON
dpc-4500	107	40	m	m	VERB
dpc-4500	107	41	a	a	PROPN
dpc-4500	107	42	,	,	PUNCT
dpc-4500	107	43	investigation	investigation	NOUN
dpc-4500	107	44	of	of	ADP
dpc-4500	107	45	the	the	DET
dpc-4500	107	46	relationship	relationship	NOUN
dpc-4500	107	47	between	between	ADP
dpc-4500	107	48	prolidase	prolidase	NOUN
dpc-4500	107	49	levels	level	NOUN
dpc-4500	107	50	and	and	CCONJ
dpc-4500	107	51	demographic	demographic	ADJ
dpc-4500	107	52	and	and	CCONJ
dpc-4500	107	53	clinical	clinical	ADJ
dpc-4500	107	54	characteristics	characteristic	NOUN
dpc-4500	107	55	of	of	ADP
dpc-4500	107	56	patients	patient	NOUN
dpc-4500	107	57	.	.	PUNCT
dpc-4500	108	1	comparison	comparison	NOUN
dpc-4500	108	2	of	of	ADP
dpc-4500	108	3	mean	mean	ADJ
dpc-4500	108	4	parameters	parameter	NOUN
dpc-4500	108	5	between	between	ADP
dpc-4500	108	6	patient	patient	NOUN
dpc-4500	108	7	and	and	CCONJ
dpc-4500	108	8	control	control	NOUN
dpc-4500	108	9	groups	group	NOUN
dpc-4500	108	10	parameters	parameter	NOUN
dpc-4500	108	11	patient	patient	ADJ
dpc-4500	108	12	mean	mean	VERB
dpc-4500	108	13	±	±	NUM
dpc-4500	108	14	sd	sd	NOUN
dpc-4500	108	15	control	control	NOUN
dpc-4500	108	16	mean	mean	VERB
dpc-4500	108	17	±	±	NUM
dpc-4500	108	18	sd	sd	ADP
dpc-4500	108	19	p	p	NOUN
dpc-4500	108	20	-	-	PUNCT
dpc-4500	108	21	value	value	NOUN
dpc-4500	108	22	(	(	PUNCT
dpc-4500	108	23	mann	mann	PROPN
dpc-4500	108	24	-	-	PUNCT
dpc-4500	108	25	whitney	whitney	PROPN
dpc-4500	108	26	u	u	PROPN
dpc-4500	108	27	test	test	NOUN
dpc-4500	108	28	)	)	PUNCT
dpc-4500	108	29	native	native	ADJ
dpc-4500	108	30	thiol	thiol	PROPN
dpc-4500	108	31	 	 	SPACE
dpc-4500	108	32	(	(	PUNCT
dpc-4500	108	33	μmol/	μmol/	NUM
dpc-4500	108	34	)	)	PUNCT
dpc-4500	108	35	424.61	424.61	NUM
dpc-4500	108	36	±	±	NUM
dpc-4500	108	37	71.57	71.57	NUM
dpc-4500	108	38	427.88	427.88	NUM
dpc-4500	108	39	±	±	NUM
dpc-4500	108	40	62.84	62.84	NUM
dpc-4500	108	41	0.958	0.958	NUM
dpc-4500	108	42	total	total	NOUN
dpc-4500	108	43	thiol	thiol	PROPN
dpc-4500	108	44	 	 	SPACE
dpc-4500	108	45	(	(	PUNCT
dpc-4500	108	46	μmol	μmol	PROPN
dpc-4500	108	47	/	/	SYM
dpc-4500	108	48	l	l	NOUN
dpc-4500	108	49	)	)	PUNCT
dpc-4500	108	50	468.99	468.99	NUM
dpc-4500	108	51	±	±	NUM
dpc-4500	108	52	77.19	77.19	NUM
dpc-4500	108	53	473.55	473.55	NUM
dpc-4500	108	54	±	±	NOUN
dpc-4500	108	55	66.46	66.46	NUM
dpc-4500	108	56	0.979	0.979	NUM
dpc-4500	108	57	disulfide	disulfide	NOUN
dpc-4500	108	58	(	(	PUNCT
dpc-4500	108	59	μmol	μmol	NOUN
dpc-4500	108	60	/	/	SYM
dpc-4500	108	61	l/	l/	NOUN
dpc-4500	108	62	)	)	PUNCT
dpc-4500	108	63	22.19	22.19	NUM
dpc-4500	108	64	±	±	NUM
dpc-4500	108	65	8.72	8.72	NUM
dpc-4500	108	66	.	.	PUNCT
dpc-4500	109	1	0.449	0.449	NUM
dpc-4500	109	2	disulfide	disulfide	NOUN
dpc-4500	109	3	/	/	SYM
dpc-4500	109	4	native	native	ADJ
dpc-4500	109	5	thiol	thiol	NOUN
dpc-4500	109	6	(	(	PUNCT
dpc-4500	109	7	%	%	INTJ
dpc-4500	109	8	)	)	PUNCT
dpc-4500	109	9	5.28	5.28	NUM
dpc-4500	109	10	±	±	NUM
dpc-4500	109	11	2.15	2.15	NUM
dpc-4500	109	12	5.39	5.39	NUM
dpc-4500	109	13	±	±	NUM
dpc-4500	109	14	1.18	1.18	NUM
dpc-4500	109	15	0.368	0.368	NUM
dpc-4500	109	16	disulfide	disulfide	NOUN
dpc-4500	109	17	/	/	SYM
dpc-4500	109	18	total	total	NOUN
dpc-4500	109	19	thiol	thiol	NOUN
dpc-4500	109	20	(	(	PUNCT
dpc-4500	109	21	%	%	INTJ
dpc-4500	109	22	)	)	PUNCT
dpc-4500	109	23	4.71	4.71	NUM
dpc-4500	109	24	±	±	NUM
dpc-4500	109	25	1.71	1.71	NUM
dpc-4500	109	26	4.84	4.84	NUM
dpc-4500	109	27	±	±	NUM
dpc-4500	109	28	0.98	0.98	NUM
dpc-4500	109	29	0.361	0.361	NUM
dpc-4500	109	30	native	native	ADJ
dpc-4500	109	31	thiol	thiol	NOUN
dpc-4500	109	32	/	/	SYM
dpc-4500	109	33	total	total	ADJ
dpc-4500	109	34	thiol	thiol	NOUN
dpc-4500	109	35	(	(	PUNCT
dpc-4500	109	36	%	%	INTJ
dpc-4500	109	37	)	)	PUNCT
dpc-4500	109	38	90.56	90.56	NUM
dpc-4500	109	39	±	±	NUM
dpc-4500	109	40	3.43	3.43	NUM
dpc-4500	109	41	90.30	90.30	NUM
dpc-4500	109	42	±	±	NUM
dpc-4500	109	43	1.97	1.97	NUM
dpc-4500	109	44	0.368	0.368	NUM
dpc-4500	109	45	ima(absu	ima(absu	NOUN
dpc-4500	109	46	)	)	PUNCT
dpc-4500	109	47	0.63	0.63	NUM
dpc-4500	109	48	±	±	NUM
dpc-4500	109	49	0.18	0.18	NUM
dpc-4500	109	50	0.88	0.88	NUM
dpc-4500	109	51	±	±	NUM
dpc-4500	109	52	0.22	0.22	NUM
dpc-4500	109	53	0.001	0.001	NUM
dpc-4500	109	54	prolidase(u	prolidase(u	NOUN
dpc-4500	109	55	/	/	SYM
dpc-4500	109	56	l	l	NOUN
dpc-4500	109	57	)	)	PUNCT
dpc-4500	109	58	1015.87	1015.87	NUM
dpc-4500	109	59	±	±	NUM
dpc-4500	109	60	31.34	31.34	NUM
dpc-4500	109	61	994.91	994.91	NUM
dpc-4500	109	62	±	±	NUM
dpc-4500	109	63	50.78	50.78	NUM
dpc-4500	109	64	0.121	0.121	NUM
dpc-4500	109	65	table	table	NOUN
dpc-4500	109	66	2	2	NUM
dpc-4500	109	67	.	.	PUNCT
dpc-4500	110	1	the	the	DET
dpc-4500	110	2	correlation	correlation	NOUN
dpc-4500	110	3	between	between	ADP
dpc-4500	110	4	parameters	parameter	NOUN
dpc-4500	110	5	and	and	CCONJ
dpc-4500	110	6	age	age	NOUN
dpc-4500	110	7	,	,	PUNCT
dpc-4500	110	8	disease	disease	NOUN
dpc-4500	110	9	duration	duration	NOUN
dpc-4500	110	10	,	,	PUNCT
dpc-4500	110	11	and	and	CCONJ
dpc-4500	110	12	scoring	scoring	NOUN
dpc-4500	110	13	.	.	PUNCT
dpc-4500	111	1	age	age	NOUN
dpc-4500	111	2	r	r	NOUN
dpc-4500	111	3	value	value	NOUN
dpc-4500	111	4	p	p	NOUN
dpc-4500	111	5	-	-	PUNCT
dpc-4500	111	6	value	value	NOUN
dpc-4500	111	7	duration	duration	NOUN
dpc-4500	111	8	of	of	ADP
dpc-4500	111	9	disease	disease	NOUN
dpc-4500	111	10	r	r	NOUN
dpc-4500	111	11	value	value	NOUN
dpc-4500	111	12	p	p	NOUN
dpc-4500	111	13	-	-	PUNCT
dpc-4500	111	14	value	value	NOUN
dpc-4500	111	15	rodnan	rodnan	NOUN
dpc-4500	111	16	r	r	NOUN
dpc-4500	111	17	value	value	NOUN
dpc-4500	111	18	p	p	NOUN
dpc-4500	111	19	-	-	PUNCT
dpc-4500	111	20	value	value	NOUN
dpc-4500	111	21	lossi	lossi	ADJ
dpc-4500	111	22	r	r	NOUN
dpc-4500	111	23	value	value	NOUN
dpc-4500	111	24	p	p	NOUN
dpc-4500	111	25	-	-	PUNCT
dpc-4500	111	26	value	value	NOUN
dpc-4500	111	27	native	native	ADJ
dpc-4500	111	28	thiol	thiol	NOUN
dpc-4500	111	29	(	(	PUNCT
dpc-4500	111	30	μmol	μmol	NOUN
dpc-4500	111	31	/	/	SYM
dpc-4500	111	32	l	l	NOUN
dpc-4500	111	33	)	)	PUNCT
dpc-4500	111	34	-0.538	-0.538	PUNCT
dpc-4500	111	35	<	<	X
dpc-4500	111	36	0.001	0.001	NUM
dpc-4500	111	37	-0.574	-0.574	NOUN
dpc-4500	111	38	0.008	0.008	NUM
dpc-4500	111	39	-0.051	-0.051	NUM
dpc-4500	111	40	0.833	0.833	NUM
dpc-4500	111	41	0.056	0.056	NUM
dpc-4500	111	42	0.814	0.814	NUM
dpc-4500	111	43	total	total	ADJ
dpc-4500	111	44	thiol	thiol	NOUN
dpc-4500	111	45	(	(	PUNCT
dpc-4500	111	46	μmol	μmol	NOUN
dpc-4500	111	47	/	/	SYM
dpc-4500	111	48	l	l	NOUN
dpc-4500	111	49	)	)	PUNCT
dpc-4500	111	50	-0.553	-0.553	PUNCT
dpc-4500	112	1	<	<	X
dpc-4500	112	2	0.001	0.001	NUM
dpc-4500	112	3	-0.583	-0.583	NOUN
dpc-4500	112	4	0.007	0.007	NUM
dpc-4500	112	5	-0.011	-0.011	NUM
dpc-4500	112	6	0.963	0.963	NUM
dpc-4500	112	7	0.110	0.110	NUM
dpc-4500	112	8	0.645	0.645	NUM
dpc-4500	112	9	disulfide	disulfide	NOUN
dpc-4500	112	10	(	(	PUNCT
dpc-4500	112	11	μmol	μmol	NOUN
dpc-4500	112	12	/	/	SYM
dpc-4500	112	13	l	l	NOUN
dpc-4500	112	14	)	)	PUNCT
dpc-4500	112	15	-0.252	-0.252	NOUN
dpc-4500	112	16	0.112	0.112	NUM
dpc-4500	112	17	-0.222	-0.222	NOUN
dpc-4500	112	18	0.346	0.346	NUM
dpc-4500	112	19	0.158	0.158	NUM
dpc-4500	112	20	0.506	0.506	NUM
dpc-4500	112	21	0.255	0.255	NUM
dpc-4500	112	22	0.278	0.278	NUM
dpc-4500	112	23	disulfide	disulfide	NOUN
dpc-4500	112	24	/	/	SYM
dpc-4500	112	25	native	native	ADJ
dpc-4500	112	26	thiol	thiol	NOUN
dpc-4500	112	27	(	(	PUNCT
dpc-4500	112	28	%	%	INTJ
dpc-4500	112	29	)	)	PUNCT
dpc-4500	112	30	-0.007	-0.007	NOUN
dpc-4500	113	1	0.966	0.966	NUM
dpc-4500	113	2	0.011	0.011	NUM
dpc-4500	113	3	0.963	0.963	NUM
dpc-4500	113	4	0.136	0.136	NUM
dpc-4500	113	5	0.567	0.567	NUM
dpc-4500	113	6	0.193	0.193	NUM
dpc-4500	113	7	0.414	0.414	NUM
dpc-4500	113	8	disulfide	disulfide	NOUN
dpc-4500	113	9	/	/	SYM
dpc-4500	113	10	total	total	NOUN
dpc-4500	113	11	thiol	thiol	NOUN
dpc-4500	113	12	(	(	PUNCT
dpc-4500	113	13	%	%	INTJ
dpc-4500	113	14	)	)	PUNCT
dpc-4500	113	15	0.001	0.001	NUM
dpc-4500	113	16	0.993	0.993	NUM
dpc-4500	113	17	-0.014	-0.014	NUM
dpc-4500	113	18	0.954	0.954	NUM
dpc-4500	113	19	0.135	0.135	NUM
dpc-4500	113	20	0.571	0.571	NUM
dpc-4500	113	21	0.198	0.198	NUM
dpc-4500	113	22	0.403	0.403	NUM
dpc-4500	113	23	native	native	ADJ
dpc-4500	113	24	thiol	thiol	PROPN
dpc-4500	113	25	/	/	SYM
dpc-4500	113	26	total	total	ADJ
dpc-4500	113	27	thiol	thiol	NOUN
dpc-4500	113	28	(	(	PUNCT
dpc-4500	113	29	%	%	INTJ
dpc-4500	113	30	)	)	PUNCT
dpc-4500	113	31	-0.001	-0.001	PUNCT
dpc-4500	114	1	0.995	0.995	NUM
dpc-4500	114	2	0.014	0.014	NUM
dpc-4500	114	3	0.954	0.954	NUM
dpc-4500	114	4	-0.135	-0.135	NUM
dpc-4500	114	5	0.571	0.571	NUM
dpc-4500	114	6	-0.198	-0.198	NOUN
dpc-4500	114	7	0.403	0.403	NUM
dpc-4500	114	8	i	i	PRON
dpc-4500	114	9	m	m	VERB
dpc-4500	114	10	a	a	PRON
dpc-4500	114	11	(	(	PUNCT
dpc-4500	114	12	absu	absu	PROPN
dpc-4500	114	13	)	)	PUNCT
dpc-4500	114	14	-0.188	-0.188	PROPN
dpc-4500	114	15	0.240	0.240	NUM
dpc-4500	114	16	0.074	0.074	NUM
dpc-4500	114	17	0.756	0.756	NUM
dpc-4500	114	18	0.219	0.219	NUM
dpc-4500	114	19	0.354	0.354	NUM
dpc-4500	114	20	0.338	0.338	NUM
dpc-4500	114	21	0.145	0.145	NUM
dpc-4500	114	22	prolidase	prolidase	NOUN
dpc-4500	114	23	(	(	PUNCT
dpc-4500	114	24	u	u	NOUN
dpc-4500	114	25	/	/	SYM
dpc-4500	114	26	l	l	NOUN
dpc-4500	114	27	)	)	PUNCT
dpc-4500	114	28	-0.265	-0.265	PUNCT
dpc-4500	114	29	0.094	0.094	NUM
dpc-4500	114	30	-0.089	-0.089	NOUN
dpc-4500	114	31	0.709	0.709	NUM
dpc-4500	114	32	0.053	0.053	NUM
dpc-4500	114	33	0.823	0.823	NUM
dpc-4500	114	34	0.013	0.013	NUM
dpc-4500	114	35	0.958	0.958	NUM
dpc-4500	114	36	rodnan	rodnan	NOUN
dpc-4500	114	37	0.231	0.231	NUM
dpc-4500	114	38	0.313	0.313	NUM
dpc-4500	114	39	-0.065	-0.065	NUM
dpc-4500	114	40	0.778	0.778	NUM
dpc-4500	114	41	lossi	lossi	ADJ
dpc-4500	114	42	0.100	0.100	NUM
dpc-4500	114	43	0.666	0.666	NUM
dpc-4500	114	44	-0.198	-0.198	NUM
dpc-4500	114	45	0.390	0.390	NUM
dpc-4500	114	46	abbreviations	abbreviation	NOUN
dpc-4500	114	47	:	:	PUNCT
dpc-4500	114	48	r	r	NOUN
dpc-4500	114	49	:	:	PUNCT
dpc-4500	114	50	correlation	correlation	NOUN
dpc-4500	114	51	coefficient	coefficient	NOUN
dpc-4500	114	52	.	.	PUNCT
dpc-4500	115	1	original	original	ADJ
dpc-4500	115	2	article	article	NOUN
dpc-4500	115	3	|	|	ADV
dpc-4500	115	4	dermatol	dermatol	ADJ
dpc-4500	115	5	pract	pract	NOUN
dpc-4500	115	6	concept	concept	NOUN
dpc-4500	115	7	.	.	PUNCT
dpc-4500	116	1	2024;14(4):e2024249	2024;14(4):e2024249	NUM
dpc-4500	116	2	5	5	NUM
dpc-4500	116	3	riccieri	riccieri	PROPN
dpc-4500	116	4	et	et	PROPN
dpc-4500	116	5	al	al	PROPN
dpc-4500	116	6	.	.	PROPN
dpc-4500	116	7	suggested	suggest	VERB
dpc-4500	116	8	that	that	SCONJ
dpc-4500	116	9	the	the	DET
dpc-4500	116	10	levels	level	NOUN
dpc-4500	116	11	of	of	ADP
dpc-4500	116	12	carbonyl	carbonyl	NOUN
dpc-4500	116	13	groups	group	NOUN
dpc-4500	116	14	,	,	PUNCT
dpc-4500	116	15	which	which	PRON
dpc-4500	116	16	are	be	AUX
dpc-4500	116	17	biomarkers	biomarker	NOUN
dpc-4500	116	18	of	of	ADP
dpc-4500	116	19	protein	protein	NOUN
dpc-4500	116	20	oxidation	oxidation	NOUN
dpc-4500	116	21	,	,	PUNCT
dpc-4500	116	22	are	be	AUX
dpc-4500	116	23	inversely	inversely	ADV
dpc-4500	116	24	correlated	correlate	VERB
dpc-4500	116	25	with	with	ADP
dpc-4500	116	26	the	the	DET
dpc-4500	116	27	modified	modify	VERB
dpc-4500	116	28	rodnan	rodnan	NOUN
dpc-4500	116	29	skin	skin	NOUN
dpc-4500	116	30	score	score	NOUN
dpc-4500	116	31	used	use	VERB
dpc-4500	116	32	for	for	ADP
dpc-4500	116	33	skin	skin	NOUN
dpc-4500	116	34	symptoms	symptom	NOUN
dpc-4500	116	35	in	in	ADP
dpc-4500	116	36	systemic	systemic	ADJ
dpc-4500	116	37	scleroderma	scleroderma	NOUN
dpc-4500	117	1	[	[	X
dpc-4500	117	2	43	43	NUM
dpc-4500	117	3	]	]	PUNCT
dpc-4500	117	4	.	.	PUNCT
dpc-4500	118	1	in	in	ADP
dpc-4500	118	2	this	this	DET
dpc-4500	118	3	study	study	NOUN
dpc-4500	118	4	,	,	PUNCT
dpc-4500	118	5	no	no	DET
dpc-4500	118	6	significant	significant	ADJ
dpc-4500	118	7	correlation	correlation	NOUN
dpc-4500	118	8	was	be	AUX
dpc-4500	118	9	found	find	VERB
dpc-4500	118	10	between	between	ADP
dpc-4500	118	11	the	the	DET
dpc-4500	118	12	lossi	lossi	PROPN
dpc-4500	118	13	and	and	CCONJ
dpc-4500	118	14	rodnan	rodnan	NOUN
dpc-4500	118	15	scales	scale	NOUN
dpc-4500	118	16	showing	show	VERB
dpc-4500	118	17	lesion	lesion	NOUN
dpc-4500	118	18	severity	severity	NOUN
dpc-4500	118	19	in	in	ADP
dpc-4500	118	20	ls	ls	PROPN
dpc-4500	118	21	and	and	CCONJ
dpc-4500	118	22	thiol	thiol	PROPN
dpc-4500	118	23	,	,	PUNCT
dpc-4500	118	24	i	i	PRON
dpc-4500	118	25	m	m	VERB
dpc-4500	118	26	a	a	PROPN
dpc-4500	118	27	,	,	PUNCT
dpc-4500	118	28	and	and	CCONJ
dpc-4500	118	29	prolidase	prolidase	NOUN
dpc-4500	118	30	levels	level	NOUN
dpc-4500	118	31	.	.	PUNCT
dpc-4500	119	1	this	this	PRON
dpc-4500	119	2	may	may	AUX
dpc-4500	119	3	be	be	AUX
dpc-4500	119	4	influenced	influence	VERB
dpc-4500	119	5	by	by	ADP
dpc-4500	119	6	the	the	DET
dpc-4500	119	7	low	low	ADJ
dpc-4500	119	8	patient	patient	NOUN
dpc-4500	119	9	scores	score	NOUN
dpc-4500	119	10	in	in	ADP
dpc-4500	119	11	our	our	PRON
dpc-4500	119	12	study	study	NOUN
dpc-4500	119	13	.	.	PUNCT
dpc-4500	120	1	in	in	ADP
dpc-4500	120	2	addition	addition	NOUN
dpc-4500	120	3	,	,	PUNCT
dpc-4500	120	4	we	we	PRON
dpc-4500	120	5	think	think	VERB
dpc-4500	120	6	that	that	SCONJ
dpc-4500	120	7	the	the	DET
dpc-4500	120	8	low	low	ADJ
dpc-4500	120	9	i	i	PRON
dpc-4500	120	10	m	m	VERB
dpc-4500	120	11	a	a	DET
dpc-4500	120	12	levels	level	NOUN
dpc-4500	120	13	in	in	ADP
dpc-4500	120	14	the	the	DET
dpc-4500	120	15	study	study	NOUN
dpc-4500	120	16	may	may	AUX
dpc-4500	120	17	be	be	AUX
dpc-4500	120	18	due	due	ADJ
dpc-4500	120	19	to	to	ADP
dpc-4500	120	20	the	the	DET
dpc-4500	120	21	absence	absence	NOUN
dpc-4500	120	22	of	of	ADP
dpc-4500	120	23	ischemia	ischemia	NOUN
dpc-4500	120	24	in	in	ADP
dpc-4500	120	25	the	the	DET
dpc-4500	120	26	ls	ls	PROPN
dpc-4500	120	27	.	.	PUNCT
dpc-4500	121	1	in	in	ADP
dpc-4500	121	2	conclusion	conclusion	NOUN
dpc-4500	121	3	,	,	PUNCT
dpc-4500	121	4	this	this	DET
dpc-4500	121	5	evaluation	evaluation	NOUN
dpc-4500	121	6	shows	show	VERB
dpc-4500	121	7	that	that	SCONJ
dpc-4500	121	8	ls	ls	ADJ
dpc-4500	121	9	is	be	AUX
dpc-4500	121	10	not	not	PART
dpc-4500	121	11	affected	affect	VERB
dpc-4500	121	12	by	by	ADP
dpc-4500	121	13	oxidative	oxidative	ADJ
dpc-4500	121	14	stress	stress	NOUN
dpc-4500	121	15	as	as	ADV
dpc-4500	121	16	much	much	ADV
dpc-4500	121	17	as	as	ADP
dpc-4500	121	18	systemic	systemic	ADJ
dpc-4500	121	19	scleroderma	scleroderma	NOUN
dpc-4500	121	20	due	due	ADP
dpc-4500	121	21	to	to	ADP
dpc-4500	121	22	its	its	PRON
dpc-4500	121	23	limited	limited	ADJ
dpc-4500	121	24	involvement	involvement	NOUN
dpc-4500	121	25	or	or	CCONJ
dpc-4500	121	26	it	it	PRON
dpc-4500	121	27	can	can	AUX
dpc-4500	121	28	limit	limit	VERB
dpc-4500	121	29	itself	itself	PRON
dpc-4500	121	30	with	with	ADP
dpc-4500	121	31	other	other	ADJ
dpc-4500	121	32	antioxidant	antioxidant	ADJ
dpc-4500	121	33	systems	system	NOUN
dpc-4500	121	34	.	.	PUNCT
dpc-4500	122	1	it	it	PRON
dpc-4500	122	2	could	could	AUX
dpc-4500	122	3	be	be	AUX
dpc-4500	122	4	argued	argue	VERB
dpc-4500	122	5	that	that	SCONJ
dpc-4500	122	6	the	the	DET
dpc-4500	122	7	aging	age	VERB
dpc-4500	122	8	process	process	NOUN
dpc-4500	122	9	potentially	potentially	ADV
dpc-4500	122	10	affects	affect	VERB
dpc-4500	122	11	os	os	NOUN
dpc-4500	122	12	levels	level	NOUN
dpc-4500	122	13	.	.	PUNCT
dpc-4500	123	1	for	for	ADP
dpc-4500	123	2	example	example	NOUN
dpc-4500	123	3	,	,	PUNCT
dpc-4500	123	4	several	several	ADJ
dpc-4500	123	5	studies	study	NOUN
dpc-4500	123	6	have	have	AUX
dpc-4500	123	7	shown	show	VERB
dpc-4500	123	8	that	that	SCONJ
dpc-4500	123	9	aging	age	VERB
dpc-4500	123	10	cells	cell	NOUN
dpc-4500	123	11	accumulate	accumulate	VERB
dpc-4500	123	12	increasing	increase	VERB
dpc-4500	123	13	levels	level	NOUN
dpc-4500	123	14	of	of	ADP
dpc-4500	123	15	oxidant	oxidant	NOUN
dpc-4500	123	16	-	-	PUNCT
dpc-4500	123	17	damaged	damage	VERB
dpc-4500	123	18	dna	dna	NOUN
dpc-4500	123	19	,	,	PUNCT
dpc-4500	123	20	which	which	PRON
dpc-4500	123	21	can	can	AUX
dpc-4500	123	22	further	far	ADV
dpc-4500	123	23	increase	increase	VERB
dpc-4500	123	24	the	the	DET
dpc-4500	123	25	level	level	NOUN
dpc-4500	123	26	of	of	ADP
dpc-4500	123	27	os	os	NOUN
dpc-4500	123	28	.	.	PUNCT
dpc-4500	123	29	 	 	SPACE
dpc-4500	123	30	the	the	DET
dpc-4500	123	31	mean	mean	ADJ
dpc-4500	123	32	age	age	NOUN
dpc-4500	123	33	of	of	ADP
dpc-4500	123	34	the	the	DET
dpc-4500	123	35	patients	patient	NOUN
dpc-4500	123	36	in	in	ADP
dpc-4500	123	37	this	this	DET
dpc-4500	123	38	study	study	NOUN
dpc-4500	123	39	was	be	AUX
dpc-4500	123	40	40.24	40.24	NUM
dpc-4500	123	41	years	year	NOUN
dpc-4500	123	42	.	.	PUNCT
dpc-4500	124	1	it	it	PRON
dpc-4500	124	2	was	be	AUX
dpc-4500	124	3	observed	observe	VERB
dpc-4500	124	4	that	that	SCONJ
dpc-4500	124	5	native	native	ADJ
dpc-4500	124	6	and	and	CCONJ
dpc-4500	124	7	total	total	ADJ
dpc-4500	124	8	thiol	thiol	ADJ
dpc-4500	124	9	values	value	NOUN
dpc-4500	124	10	decreased	decrease	VERB
dpc-4500	124	11	with	with	ADP
dpc-4500	124	12	increasing	increase	VERB
dpc-4500	124	13	age	age	NOUN
dpc-4500	124	14	.	.	PUNCT
dpc-4500	125	1	the	the	DET
dpc-4500	125	2	decrease	decrease	NOUN
dpc-4500	125	3	in	in	ADP
dpc-4500	125	4	these	these	DET
dpc-4500	125	5	values	value	NOUN
dpc-4500	125	6	with	with	ADP
dpc-4500	125	7	age	age	NOUN
dpc-4500	125	8	supports	support	VERB
dpc-4500	125	9	that	that	SCONJ
dpc-4500	125	10	while	while	SCONJ
dpc-4500	125	11	the	the	DET
dpc-4500	125	12	production	production	NOUN
dpc-4500	125	13	of	of	ADP
dpc-4500	125	14	free	free	ADJ
dpc-4500	125	15	radicals	radical	NOUN
dpc-4500	125	16	increases	increase	VERB
dpc-4500	125	17	with	with	ADP
dpc-4500	125	18	aging	age	VERB
dpc-4500	125	19	,	,	PUNCT
dpc-4500	125	20	endogenous	endogenous	ADJ
dpc-4500	125	21	defense	defense	NOUN
dpc-4500	125	22	mechanisms	mechanism	NOUN
dpc-4500	125	23	decrease	decrease	NOUN
dpc-4500	125	24	and	and	CCONJ
dpc-4500	125	25	the	the	DET
dpc-4500	125	26	balance	balance	NOUN
dpc-4500	125	27	shifts	shift	NOUN
dpc-4500	125	28	to	to	ADP
dpc-4500	125	29	the	the	DET
dpc-4500	125	30	os	os	ADJ
dpc-4500	125	31	side	side	NOUN
dpc-4500	126	1	[	[	X
dpc-4500	126	2	44	44	NUM
dpc-4500	126	3	]	]	PUNCT
dpc-4500	126	4	.	.	PUNCT
dpc-4500	127	1	there	there	PRON
dpc-4500	127	2	was	be	VERB
dpc-4500	127	3	no	no	DET
dpc-4500	127	4	significant	significant	ADJ
dpc-4500	127	5	difference	difference	NOUN
dpc-4500	127	6	between	between	ADP
dpc-4500	127	7	i	i	PRON
dpc-4500	127	8	m	m	PROPN
dpc-4500	127	9	a	a	PRON
dpc-4500	127	10	and	and	CCONJ
dpc-4500	127	11	prolidase	prolidase	NOUN
dpc-4500	127	12	levels	level	NOUN
dpc-4500	127	13	and	and	CCONJ
dpc-4500	127	14	age	age	NOUN
dpc-4500	127	15	.	.	PUNCT
dpc-4500	128	1	we	we	PRON
dpc-4500	128	2	can	can	AUX
dpc-4500	128	3	say	say	VERB
dpc-4500	128	4	that	that	SCONJ
dpc-4500	128	5	these	these	DET
dpc-4500	128	6	enzymes	enzyme	NOUN
dpc-4500	128	7	are	be	AUX
dpc-4500	128	8	not	not	PART
dpc-4500	128	9	affected	affect	VERB
dpc-4500	128	10	by	by	ADP
dpc-4500	128	11	age	age	NOUN
dpc-4500	128	12	.	.	PUNCT
dpc-4500	129	1	in	in	ADP
dpc-4500	129	2	this	this	DET
dpc-4500	129	3	study	study	NOUN
dpc-4500	129	4	,	,	PUNCT
dpc-4500	129	5	a	a	DET
dpc-4500	129	6	negative	negative	ADJ
dpc-4500	129	7	correlation	correlation	NOUN
dpc-4500	129	8	was	be	AUX
dpc-4500	129	9	observed	observe	VERB
dpc-4500	129	10	between	between	ADP
dpc-4500	129	11	native	native	ADJ
dpc-4500	129	12	thiol	thiol	PROPN
dpc-4500	129	13	and	and	CCONJ
dpc-4500	129	14	total	total	ADJ
dpc-4500	129	15	thiol	thiol	NOUN
dpc-4500	129	16	and	and	CCONJ
dpc-4500	129	17	disease	disease	NOUN
dpc-4500	129	18	duration	duration	NOUN
dpc-4500	129	19	.	.	PUNCT
dpc-4500	130	1	native	native	ADJ
dpc-4500	130	2	thiol	thiol	PROPN
dpc-4500	130	3	and	and	CCONJ
dpc-4500	130	4	total	total	ADJ
dpc-4500	130	5	thiol	thiol	ADJ
dpc-4500	130	6	levels	level	NOUN
dpc-4500	130	7	decreased	decrease	VERB
dpc-4500	130	8	with	with	ADP
dpc-4500	130	9	increasing	increase	VERB
dpc-4500	130	10	disease	disease	NOUN
dpc-4500	130	11	.	.	PUNCT
dpc-4500	131	1	this	this	PRON
dpc-4500	131	2	may	may	AUX
dpc-4500	131	3	indicate	indicate	VERB
dpc-4500	131	4	that	that	SCONJ
dpc-4500	131	5	os	os	NOUN
dpc-4500	131	6	increases	increase	NOUN
dpc-4500	131	7	as	as	ADP
dpc-4500	131	8	the	the	DET
dpc-4500	131	9	disease	disease	NOUN
dpc-4500	131	10	duration	duration	NOUN
dpc-4500	131	11	increases	increase	NOUN
dpc-4500	131	12	,	,	PUNCT
dpc-4500	131	13	or	or	CCONJ
dpc-4500	131	14	that	that	SCONJ
dpc-4500	131	15	the	the	DET
dpc-4500	131	16	disease	disease	NOUN
dpc-4500	131	17	becomes	become	VERB
dpc-4500	131	18	chronic	chronic	ADJ
dpc-4500	131	19	as	as	ADP
dpc-4500	131	20	os	os	NOUN
dpc-4500	131	21	increases	increase	NOUN
dpc-4500	131	22	.	.	PUNCT
dpc-4500	132	1	this	this	DET
dpc-4500	132	2	negative	negative	ADJ
dpc-4500	132	3	correlation	correlation	NOUN
dpc-4500	132	4	suggests	suggest	VERB
dpc-4500	132	5	that	that	SCONJ
dpc-4500	132	6	the	the	DET
dpc-4500	132	7	decrease	decrease	NOUN
dpc-4500	132	8	in	in	ADP
dpc-4500	132	9	native	native	ADJ
dpc-4500	132	10	and	and	CCONJ
dpc-4500	132	11	total	total	ADJ
dpc-4500	132	12	thiols	thiol	NOUN
dpc-4500	132	13	may	may	AUX
dpc-4500	132	14	be	be	AUX
dpc-4500	132	15	associated	associate	VERB
dpc-4500	132	16	with	with	ADP
dpc-4500	132	17	the	the	DET
dpc-4500	132	18	chronicization	chronicization	NOUN
dpc-4500	132	19	of	of	ADP
dpc-4500	132	20	the	the	DET
dpc-4500	132	21	disease	disease	NOUN
dpc-4500	132	22	and	and	CCONJ
dpc-4500	132	23	that	that	SCONJ
dpc-4500	132	24	these	these	DET
dpc-4500	132	25	parameters	parameter	NOUN
dpc-4500	132	26	may	may	AUX
dpc-4500	132	27	be	be	AUX
dpc-4500	132	28	a	a	DET
dpc-4500	132	29	marker	marker	NOUN
dpc-4500	132	30	.	.	PUNCT
dpc-4500	133	1	however	however	ADV
dpc-4500	133	2	,	,	PUNCT
dpc-4500	133	3	there	there	PRON
dpc-4500	133	4	was	be	VERB
dpc-4500	133	5	no	no	DET
dpc-4500	133	6	significant	significant	ADJ
dpc-4500	133	7	difference	difference	NOUN
dpc-4500	133	8	between	between	ADP
dpc-4500	133	9	i	i	PRON
dpc-4500	133	10	m	m	PROPN
dpc-4500	133	11	a	a	PRON
dpc-4500	133	12	and	and	CCONJ
dpc-4500	133	13	prolidase	prolidase	NOUN
dpc-4500	133	14	levels	level	NOUN
dpc-4500	133	15	and	and	CCONJ
dpc-4500	133	16	disease	disease	NOUN
dpc-4500	133	17	duration	duration	NOUN
dpc-4500	133	18	.	.	PUNCT
dpc-4500	134	1	i	i	PRON
dpc-4500	134	2	m	m	VERB
dpc-4500	134	3	a	a	PROPN
dpc-4500	134	4	is	be	AUX
dpc-4500	134	5	related	relate	VERB
dpc-4500	134	6	to	to	PART
dpc-4500	134	7	os	os	VERB
dpc-4500	134	8	caused	cause	VERB
dpc-4500	134	9	by	by	ADP
dpc-4500	134	10	free	free	ADJ
dpc-4500	134	11	radicals	radical	NOUN
dpc-4500	134	12	during	during	ADP
dpc-4500	134	13	ischemia	ischemia	NOUN
dpc-4500	134	14	and/or	and/or	CCONJ
dpc-4500	134	15	reperfusion	reperfusion	NOUN
dpc-4500	134	16	.	.	PUNCT
dpc-4500	135	1	although	although	SCONJ
dpc-4500	135	2	most	most	ADJ
dpc-4500	135	3	biomarkers	biomarker	NOUN
dpc-4500	135	4	are	be	AUX
dpc-4500	135	5	negative	negative	ADJ
dpc-4500	135	6	in	in	ADP
dpc-4500	135	7	ischemia	ischemia	NOUN
dpc-4500	135	8	,	,	PUNCT
dpc-4500	135	9	i	i	PRON
dpc-4500	135	10	m	m	VERB
dpc-4500	135	11	a	a	PROPN
dpc-4500	135	12	is	be	AUX
dpc-4500	135	13	highly	highly	ADV
dpc-4500	135	14	sensitive	sensitive	ADJ
dpc-4500	135	15	and	and	CCONJ
dpc-4500	135	16	can	can	AUX
dpc-4500	135	17	be	be	AUX
dpc-4500	135	18	detected	detect	VERB
dpc-4500	135	19	at	at	ADP
dpc-4500	135	20	an	an	DET
dpc-4500	135	21	early	early	ADJ
dpc-4500	135	22	stage	stage	NOUN
dpc-4500	135	23	[	[	X
dpc-4500	135	24	14,45	14,45	NOUN
dpc-4500	135	25	]	]	X
dpc-4500	135	26	.	.	PUNCT
dpc-4500	136	1	therefore	therefore	ADV
dpc-4500	136	2	,	,	PUNCT
dpc-4500	136	3	it	it	PRON
dpc-4500	136	4	has	have	AUX
dpc-4500	136	5	been	be	AUX
dpc-4500	136	6	suggested	suggest	VERB
dpc-4500	136	7	that	that	SCONJ
dpc-4500	136	8	serum	serum	NOUN
dpc-4500	136	9	i	i	PRON
dpc-4500	136	10	m	m	VERB
dpc-4500	136	11	a	a	DET
dpc-4500	136	12	levels	level	NOUN
dpc-4500	136	13	may	may	AUX
dpc-4500	136	14	be	be	AUX
dpc-4500	136	15	used	use	VERB
dpc-4500	136	16	as	as	ADP
dpc-4500	136	17	a	a	DET
dpc-4500	136	18	marker	marker	NOUN
dpc-4500	136	19	of	of	ADP
dpc-4500	136	20	systemic	systemic	ADJ
dpc-4500	136	21	oxidative	oxidative	ADJ
dpc-4500	136	22	stress	stress	NOUN
dpc-4500	136	23	.	.	PUNCT
dpc-4500	137	1	elevated	elevate	VERB
dpc-4500	138	1	i	i	PRON
dpc-4500	138	2	m	m	VERB
dpc-4500	138	3	a	a	DET
dpc-4500	138	4	levels	level	NOUN
dpc-4500	138	5	have	have	AUX
dpc-4500	138	6	been	be	AUX
dpc-4500	138	7	reported	report	VERB
dpc-4500	138	8	in	in	ADP
dpc-4500	138	9	various	various	ADJ
dpc-4500	138	10	clinical	clinical	ADJ
dpc-4500	138	11	pathologic	pathologic	ADJ
dpc-4500	138	12	conditions	condition	NOUN
dpc-4500	138	13	including	include	VERB
dpc-4500	138	14	vascular	vascular	ADJ
dpc-4500	138	15	endothelial	endothelial	ADJ
dpc-4500	138	16	cell	cell	NOUN
dpc-4500	138	17	disorder	disorder	NOUN
dpc-4500	138	18	,	,	PUNCT
dpc-4500	138	19	diabetes	diabetes	NOUN
dpc-4500	138	20	mellitus	mellitus	NOUN
dpc-4500	138	21	,	,	PUNCT
dpc-4500	138	22	liver	liver	NOUN
dpc-4500	138	23	and	and	CCONJ
dpc-4500	138	24	kidney	kidney	NOUN
dpc-4500	138	25	diseases	disease	NOUN
dpc-4500	138	26	,	,	PUNCT
dpc-4500	138	27	some	some	DET
dpc-4500	138	28	cancers	cancer	NOUN
dpc-4500	138	29	,	,	PUNCT
dpc-4500	138	30	and	and	CCONJ
dpc-4500	138	31	systemic	systemic	ADJ
dpc-4500	138	32	sclerosis	sclerosis	NOUN
dpc-4500	138	33	in	in	ADP
dpc-4500	138	34	which	which	PRON
dpc-4500	138	35	oxidative	oxidative	ADJ
dpc-4500	138	36	status	status	NOUN
dpc-4500	138	37	is	be	AUX
dpc-4500	138	38	affected	affect	VERB
dpc-4500	138	39	[	[	PUNCT
dpc-4500	138	40	9,46,47	9,46,47	NUM
dpc-4500	138	41	]	]	X
dpc-4500	138	42	.	.	PUNCT
dpc-4500	139	1	some	some	DET
dpc-4500	139	2	investigators	investigator	NOUN
dpc-4500	139	3	have	have	AUX
dpc-4500	139	4	shown	show	VERB
dpc-4500	139	5	that	that	DET
dpc-4500	139	6	vasculopathy	vasculopathy	NOUN
dpc-4500	139	7	in	in	ADP
dpc-4500	139	8	scleroderma	scleroderma	NOUN
dpc-4500	139	9	causes	cause	VERB
dpc-4500	139	10	tissue	tissue	NOUN
dpc-4500	139	11	hypoxia	hypoxia	NOUN
dpc-4500	139	12	,	,	PUNCT
dpc-4500	139	13	resulting	result	VERB
dpc-4500	139	14	in	in	ADP
dpc-4500	139	15	increased	increase	VERB
dpc-4500	139	16	os	os	NOUN
dpc-4500	139	17	,	,	PUNCT
dpc-4500	139	18	fibrotic	fibrotic	ADJ
dpc-4500	139	19	changes	change	NOUN
dpc-4500	139	20	,	,	PUNCT
dpc-4500	139	21	and	and	CCONJ
dpc-4500	139	22	skin	skin	NOUN
dpc-4500	139	23	thickening	thickening	NOUN
dpc-4500	139	24	[	[	X
dpc-4500	139	25	24	24	NUM
dpc-4500	139	26	]	]	PUNCT
dpc-4500	139	27	.	.	PUNCT
dpc-4500	140	1	it	it	PRON
dpc-4500	140	2	has	have	AUX
dpc-4500	140	3	been	be	AUX
dpc-4500	140	4	suggested	suggest	VERB
dpc-4500	140	5	that	that	SCONJ
dpc-4500	140	6	it	it	PRON
dpc-4500	140	7	may	may	AUX
dpc-4500	140	8	be	be	AUX
dpc-4500	140	9	distinctive	distinctive	ADJ
dpc-4500	140	10	especially	especially	ADV
dpc-4500	140	11	during	during	ADP
dpc-4500	140	12	the	the	DET
dpc-4500	140	13	active	active	ADJ
dpc-4500	140	14	period	period	NOUN
dpc-4500	140	15	of	of	ADP
dpc-4500	140	16	the	the	DET
dpc-4500	140	17	disease	disease	NOUN
dpc-4500	140	18	.	.	PUNCT
dpc-4500	141	1	in	in	ADP
dpc-4500	141	2	our	our	PRON
dpc-4500	141	3	study	study	NOUN
dpc-4500	141	4	,	,	PUNCT
dpc-4500	141	5	i	i	PRON
dpc-4500	141	6	m	m	VERB
dpc-4500	141	7	a	a	DET
dpc-4500	141	8	levels	level	NOUN
dpc-4500	141	9	were	be	AUX
dpc-4500	141	10	significantly	significantly	ADV
dpc-4500	141	11	lower	low	ADJ
dpc-4500	141	12	compared	compare	VERB
dpc-4500	141	13	to	to	ADP
dpc-4500	141	14	controls	control	NOUN
dpc-4500	141	15	.	.	PUNCT
dpc-4500	142	1	this	this	PRON
dpc-4500	142	2	may	may	AUX
dpc-4500	142	3	suggest	suggest	VERB
dpc-4500	142	4	that	that	SCONJ
dpc-4500	142	5	ls	ls	PROPN
dpc-4500	142	6	is	be	AUX
dpc-4500	142	7	not	not	PART
dpc-4500	142	8	affected	affect	VERB
dpc-4500	142	9	by	by	ADP
dpc-4500	142	10	ischemia	ischemia	NOUN
dpc-4500	142	11	-	-	PUNCT
dpc-4500	142	12	induced	induce	VERB
dpc-4500	142	13	os	os	NOUN
dpc-4500	142	14	.	.	PUNCT
dpc-4500	142	15	have	have	AUX
dpc-4500	142	16	supported	support	VERB
dpc-4500	142	17	this	this	DET
dpc-4500	142	18	hypothesis	hypothesis	NOUN
dpc-4500	142	19	for	for	ADP
dpc-4500	142	20	both	both	CCONJ
dpc-4500	142	21	localized	localized	ADJ
dpc-4500	142	22	and	and	CCONJ
dpc-4500	142	23	systemic	systemic	ADJ
dpc-4500	142	24	scleroderma	scleroderma	NOUN
dpc-4500	142	25	,	,	PUNCT
dpc-4500	142	26	but	but	CCONJ
dpc-4500	142	27	the	the	DET
dpc-4500	142	28	specific	specific	ADJ
dpc-4500	142	29	role	role	NOUN
dpc-4500	142	30	of	of	ADP
dpc-4500	142	31	os	os	NOUN
dpc-4500	142	32	in	in	ADP
dpc-4500	142	33	the	the	DET
dpc-4500	142	34	pathogenesis	pathogenesis	NOUN
dpc-4500	142	35	of	of	ADP
dpc-4500	142	36	vascular	vascular	ADJ
dpc-4500	142	37	injury	injury	NOUN
dpc-4500	142	38	and	and	CCONJ
dpc-4500	142	39	fibrosis	fibrosis	NOUN
dpc-4500	142	40	has	have	VERB
dpc-4500	142	41	yet	yet	ADV
dpc-4500	142	42	to	to	PART
dpc-4500	142	43	be	be	AUX
dpc-4500	142	44	elucidated	elucidate	VERB
dpc-4500	142	45	[	[	PUNCT
dpc-4500	142	46	23,27,31,40	23,27,31,40	NUM
dpc-4500	142	47	-	-	SYM
dpc-4500	142	48	42	42	NUM
dpc-4500	142	49	]	]	PUNCT
dpc-4500	142	50	.	.	PUNCT
dpc-4500	143	1	ros	ros	PROPN
dpc-4500	143	2	are	be	AUX
dpc-4500	143	3	considered	consider	VERB
dpc-4500	143	4	to	to	PART
dpc-4500	143	5	play	play	VERB
dpc-4500	143	6	a	a	DET
dpc-4500	143	7	background	background	NOUN
dpc-4500	143	8	role	role	NOUN
dpc-4500	143	9	in	in	ADP
dpc-4500	143	10	the	the	DET
dpc-4500	143	11	pathology	pathology	NOUN
dpc-4500	143	12	of	of	ADP
dpc-4500	143	13	this	this	DET
dpc-4500	143	14	disease	disease	NOUN
dpc-4500	143	15	and	and	CCONJ
dpc-4500	143	16	are	be	AUX
dpc-4500	143	17	considered	consider	VERB
dpc-4500	143	18	to	to	PART
dpc-4500	143	19	be	be	AUX
dpc-4500	143	20	instrumental	instrumental	ADJ
dpc-4500	143	21	in	in	ADP
dpc-4500	143	22	the	the	DET
dpc-4500	143	23	manifestation	manifestation	NOUN
dpc-4500	143	24	of	of	ADP
dpc-4500	143	25	clinical	clinical	ADJ
dpc-4500	143	26	symptoms	symptom	NOUN
dpc-4500	143	27	.	.	PUNCT
dpc-4500	144	1	ros	ros	PROPN
dpc-4500	144	2	generated	generate	VERB
dpc-4500	144	3	by	by	ADP
dpc-4500	144	4	various	various	ADJ
dpc-4500	144	5	reactions	reaction	NOUN
dpc-4500	144	6	can	can	AUX
dpc-4500	144	7	stimulate	stimulate	VERB
dpc-4500	144	8	the	the	DET
dpc-4500	144	9	production	production	NOUN
dpc-4500	144	10	of	of	ADP
dpc-4500	144	11	proinflammatory	proinflammatory	ADJ
dpc-4500	144	12	cytokines	cytokine	NOUN
dpc-4500	144	13	.	.	PUNCT
dpc-4500	145	1	fibrotic	fibrotic	ADJ
dpc-4500	145	2	cytokines	cytokine	NOUN
dpc-4500	145	3	induce	induce	VERB
dpc-4500	145	4	proliferation	proliferation	NOUN
dpc-4500	145	5	and	and	CCONJ
dpc-4500	145	6	activation	activation	NOUN
dpc-4500	145	7	of	of	ADP
dpc-4500	145	8	fibroblasts	fibroblast	NOUN
dpc-4500	145	9	,	,	PUNCT
dpc-4500	145	10	increase	increase	VERB
dpc-4500	145	11	type	type	NOUN
dpc-4500	145	12	i	i	PRON
dpc-4500	145	13	collagen	collagen	NOUN
dpc-4500	145	14	synthesis	synthesis	NOUN
dpc-4500	145	15	,	,	PUNCT
dpc-4500	145	16	and	and	CCONJ
dpc-4500	145	17	cause	cause	VERB
dpc-4500	145	18	vascular	vascular	ADJ
dpc-4500	145	19	dysfunction	dysfunction	NOUN
dpc-4500	145	20	.	.	PUNCT
dpc-4500	146	1	skin	skin	NOUN
dpc-4500	146	2	changes	change	NOUN
dpc-4500	146	3	typical	typical	ADJ
dpc-4500	146	4	for	for	ADP
dpc-4500	146	5	scleroderma	scleroderma	NOUN
dpc-4500	146	6	have	have	AUX
dpc-4500	146	7	been	be	AUX
dpc-4500	146	8	demonstrated	demonstrate	VERB
dpc-4500	146	9	in	in	ADP
dpc-4500	146	10	vivo	vivo	NOUN
dpc-4500	146	11	by	by	ADP
dpc-4500	146	12	intradermal	intradermal	ADJ
dpc-4500	146	13	injection	injection	NOUN
dpc-4500	146	14	of	of	ADP
dpc-4500	146	15	ros	ros	PROPN
dpc-4500	146	16	-	-	PUNCT
dpc-4500	146	17	producing	produce	VERB
dpc-4500	146	18	compounds	compound	NOUN
dpc-4500	146	19	in	in	ADP
dpc-4500	146	20	several	several	ADJ
dpc-4500	146	21	animal	animal	NOUN
dpc-4500	146	22	studies	study	NOUN
dpc-4500	146	23	[	[	X
dpc-4500	146	24	23	23	NUM
dpc-4500	146	25	]	]	PUNCT
dpc-4500	146	26	.	.	PUNCT
dpc-4500	147	1	there	there	PRON
dpc-4500	147	2	are	be	VERB
dpc-4500	147	3	studies	study	NOUN
dpc-4500	147	4	  	  	SPACE
dpc-4500	147	5	showing	show	VERB
dpc-4500	147	6	that	that	SCONJ
dpc-4500	147	7	antioxidant	antioxidant	ADJ
dpc-4500	147	8	capacity	capacity	NOUN
dpc-4500	147	9	decreases	decrease	VERB
dpc-4500	147	10	in	in	ADP
dpc-4500	147	11	patients	patient	NOUN
dpc-4500	147	12	with	with	ADP
dpc-4500	147	13	systemic	systemic	ADJ
dpc-4500	147	14	scleroderma	scleroderma	NOUN
dpc-4500	147	15	[	[	X
dpc-4500	147	16	27,30,42	27,30,42	NUM
dpc-4500	147	17	]	]	PUNCT
dpc-4500	147	18	.	.	PUNCT
dpc-4500	148	1	bozkurt	bozkurt	PROPN
dpc-4500	148	2	et	et	PROPN
dpc-4500	148	3	al	al	PROPN
dpc-4500	148	4	.	.	PROPN
dpc-4500	148	5	found	find	VERB
dpc-4500	148	6	that	that	SCONJ
dpc-4500	148	7	serum	serum	NOUN
dpc-4500	148	8	total	total	ADJ
dpc-4500	148	9	oxidant	oxidant	ADJ
dpc-4500	148	10	capacity	capacity	NOUN
dpc-4500	148	11	and	and	CCONJ
dpc-4500	148	12	oxidative	oxidative	ADJ
dpc-4500	148	13	stress	stress	NOUN
dpc-4500	148	14	index	index	NOUN
dpc-4500	148	15	(	(	PUNCT
dpc-4500	148	16	osi	osi	PROPN
dpc-4500	148	17	)	)	PUNCT
dpc-4500	148	18	were	be	AUX
dpc-4500	148	19	high	high	ADJ
dpc-4500	148	20	in	in	ADP
dpc-4500	148	21	patients	patient	NOUN
dpc-4500	148	22	with	with	ADP
dpc-4500	148	23	systemic	systemic	ADJ
dpc-4500	148	24	scleroderma	scleroderma	NOUN
dpc-4500	148	25	.	.	PUNCT
dpc-4500	149	1	they	they	PRON
dpc-4500	149	2	also	also	ADV
dpc-4500	149	3	reported	report	VERB
dpc-4500	149	4	that	that	SCONJ
dpc-4500	149	5	prolidase	prolidase	NOUN
dpc-4500	149	6	activity	activity	NOUN
dpc-4500	149	7	is	be	AUX
dpc-4500	149	8	also	also	ADV
dpc-4500	149	9	high	high	ADJ
dpc-4500	149	10	in	in	ADP
dpc-4500	149	11	fibrotic	fibrotic	ADJ
dpc-4500	149	12	diseases	disease	NOUN
dpc-4500	149	13	,	,	PUNCT
dpc-4500	149	14	and	and	CCONJ
dpc-4500	149	15	this	this	PRON
dpc-4500	149	16	may	may	AUX
dpc-4500	149	17	be	be	AUX
dpc-4500	149	18	an	an	DET
dpc-4500	149	19	important	important	ADJ
dpc-4500	149	20	marker	marker	NOUN
dpc-4500	149	21	for	for	ADP
dpc-4500	149	22	os	os	NOUN
dpc-4500	149	23	[	[	X
dpc-4500	149	24	18	18	NUM
dpc-4500	149	25	]	]	PUNCT
dpc-4500	149	26	.	.	PUNCT
dpc-4500	150	1	ls	ls	PROPN
dpc-4500	150	2	,	,	PUNCT
dpc-4500	150	3	which	which	PRON
dpc-4500	150	4	is	be	AUX
dpc-4500	150	5	a	a	DET
dpc-4500	150	6	localized	localized	ADJ
dpc-4500	150	7	form	form	NOUN
dpc-4500	150	8	of	of	ADP
dpc-4500	150	9	scleroderma	scleroderma	NOUN
dpc-4500	150	10	,	,	PUNCT
dpc-4500	150	11	is	be	AUX
dpc-4500	150	12	thought	think	VERB
dpc-4500	150	13	to	to	PART
dpc-4500	150	14	have	have	VERB
dpc-4500	150	15	a	a	DET
dpc-4500	150	16	common	common	ADJ
dpc-4500	150	17	pathogenesis	pathogenesis	NOUN
dpc-4500	150	18	;	;	PUNCT
dpc-4500	150	19	therefore	therefore	ADV
dpc-4500	150	20	,	,	PUNCT
dpc-4500	150	21	similar	similar	ADJ
dpc-4500	150	22	studies	study	NOUN
dpc-4500	150	23	on	on	ADP
dpc-4500	150	24	os	os	NOUN
dpc-4500	150	25	have	have	AUX
dpc-4500	150	26	also	also	ADV
dpc-4500	150	27	been	be	AUX
dpc-4500	150	28	conducted	conduct	VERB
dpc-4500	150	29	in	in	ADP
dpc-4500	150	30	ls	ls	PROPN
dpc-4500	150	31	,	,	PUNCT
dpc-4500	150	32	albeit	albeit	SCONJ
dpc-4500	150	33	to	to	ADP
dpc-4500	150	34	a	a	DET
dpc-4500	150	35	lesser	less	ADJ
dpc-4500	150	36	extent	extent	NOUN
dpc-4500	150	37	.	.	PUNCT
dpc-4500	151	1	the	the	DET
dpc-4500	151	2	researchers	researcher	NOUN
dpc-4500	151	3	investigated	investigate	VERB
dpc-4500	151	4	os	os	NOUN
dpc-4500	151	5	parameters	parameter	NOUN
dpc-4500	151	6	in	in	ADP
dpc-4500	151	7	both	both	DET
dpc-4500	151	8	tissue	tissue	NOUN
dpc-4500	151	9	and	and	CCONJ
dpc-4500	151	10	plasma	plasma	NOUN
dpc-4500	151	11	[	[	X
dpc-4500	151	12	32,33	32,33	NUM
dpc-4500	151	13	]	]	PUNCT
dpc-4500	151	14	.	.	PUNCT
dpc-4500	152	1	in	in	ADP
dpc-4500	152	2	these	these	DET
dpc-4500	152	3	studies	study	NOUN
dpc-4500	152	4	,	,	PUNCT
dpc-4500	152	5	it	it	PRON
dpc-4500	152	6	was	be	AUX
dpc-4500	152	7	attempted	attempt	VERB
dpc-4500	152	8	to	to	PART
dpc-4500	152	9	prove	prove	VERB
dpc-4500	152	10	the	the	DET
dpc-4500	152	11	presence	presence	NOUN
dpc-4500	152	12	of	of	ADP
dpc-4500	152	13	os	os	NOUN
dpc-4500	152	14	in	in	ADP
dpc-4500	152	15	ls	ls	PROPN
dpc-4500	152	16	,	,	PUNCT
dpc-4500	152	17	with	with	ADP
dpc-4500	152	18	significant	significant	ADJ
dpc-4500	152	19	changes	change	NOUN
dpc-4500	152	20	in	in	ADP
dpc-4500	152	21	os	os	NOUN
dpc-4500	152	22	parameters	parameter	NOUN
dpc-4500	152	23	such	such	ADJ
dpc-4500	152	24	as	as	ADP
dpc-4500	152	25	serum	serum	NOUN
dpc-4500	152	26	s	s	PART
dpc-4500	152	27	glutathione	glutathione	NOUN
dpc-4500	152	28	transferase	transferase	NOUN
dpc-4500	152	29	and	and	CCONJ
dpc-4500	152	30	total	total	ADJ
dpc-4500	152	31	oxidant	oxidant	ADJ
dpc-4500	152	32	capacity	capacity	NOUN
dpc-4500	152	33	compared	compare	VERB
dpc-4500	152	34	to	to	ADP
dpc-4500	152	35	controls	control	NOUN
dpc-4500	152	36	.	.	PUNCT
dpc-4500	153	1	based	base	VERB
dpc-4500	153	2	on	on	ADP
dpc-4500	153	3	the	the	DET
dpc-4500	153	4	same	same	ADJ
dpc-4500	153	5	hypothesis	hypothesis	NOUN
dpc-4500	153	6	,	,	PUNCT
dpc-4500	153	7	we	we	PRON
dpc-4500	153	8	investigated	investigate	VERB
dpc-4500	153	9	thiol/	thiol/	NUM
dpc-4500	153	10	disulfide	disulfide	NOUN
dpc-4500	153	11	,	,	PUNCT
dpc-4500	153	12	i	i	PRON
dpc-4500	153	13	m	m	VERB
dpc-4500	153	14	a	a	PROPN
dpc-4500	153	15	,	,	PUNCT
dpc-4500	153	16	and	and	CCONJ
dpc-4500	153	17	prolidase	prolidase	NOUN
dpc-4500	153	18	enzymes	enzyme	NOUN
dpc-4500	153	19	,	,	PUNCT
dpc-4500	153	20	which	which	PRON
dpc-4500	153	21	are	be	AUX
dpc-4500	153	22	among	among	ADP
dpc-4500	153	23	the	the	DET
dpc-4500	153	24	os	os	NOUN
dpc-4500	153	25	parameters	parameter	NOUN
dpc-4500	153	26	thought	think	VERB
dpc-4500	153	27	to	to	PART
dpc-4500	153	28	play	play	VERB
dpc-4500	153	29	a	a	DET
dpc-4500	153	30	role	role	NOUN
dpc-4500	153	31	in	in	ADP
dpc-4500	153	32	the	the	DET
dpc-4500	153	33	pathogenesis	pathogenesis	NOUN
dpc-4500	153	34	of	of	ADP
dpc-4500	153	35	ls	ls	PROPN
dpc-4500	153	36	.	.	PUNCT
dpc-4500	154	1	unlike	unlike	ADP
dpc-4500	154	2	other	other	ADJ
dpc-4500	154	3	studies	study	NOUN
dpc-4500	154	4	,	,	PUNCT
dpc-4500	154	5	these	these	DET
dpc-4500	154	6	parameters	parameter	NOUN
dpc-4500	154	7	were	be	AUX
dpc-4500	154	8	measured	measure	VERB
dpc-4500	154	9	simultaneously	simultaneously	ADV
dpc-4500	154	10	in	in	ADP
dpc-4500	154	11	patient	patient	ADJ
dpc-4500	154	12	sera	sera	NOUN
dpc-4500	154	13	and	and	CCONJ
dpc-4500	154	14	compared	compare	VERB
dpc-4500	154	15	with	with	ADP
dpc-4500	154	16	the	the	DET
dpc-4500	154	17	control	control	NOUN
dpc-4500	154	18	group	group	NOUN
dpc-4500	154	19	.	.	PUNCT
dpc-4500	155	1	thiols	thiol	NOUN
dpc-4500	155	2	are	be	AUX
dpc-4500	155	3	antioxidants	antioxidant	NOUN
dpc-4500	155	4	that	that	PRON
dpc-4500	155	5	react	react	VERB
dpc-4500	155	6	quickly	quickly	ADV
dpc-4500	155	7	in	in	ADP
dpc-4500	155	8	oxidative	oxidative	ADJ
dpc-4500	155	9	environments	environment	NOUN
dpc-4500	155	10	.	.	PUNCT
dpc-4500	156	1	in	in	ADP
dpc-4500	156	2	various	various	ADJ
dpc-4500	156	3	studies	study	NOUN
dpc-4500	156	4	,	,	PUNCT
dpc-4500	156	5	it	it	PRON
dpc-4500	156	6	has	have	AUX
dpc-4500	156	7	been	be	AUX
dpc-4500	156	8	reported	report	VERB
dpc-4500	156	9	that	that	SCONJ
dpc-4500	156	10	disulfide	disulfide	NOUN
dpc-4500	156	11	levels	level	NOUN
dpc-4500	156	12	increase	increase	VERB
dpc-4500	156	13	in	in	ADP
dpc-4500	156	14	inflammatory	inflammatory	ADJ
dpc-4500	156	15	diseases	disease	NOUN
dpc-4500	156	16	and	and	CCONJ
dpc-4500	156	17	decrease	decrease	NOUN
dpc-4500	156	18	in	in	ADP
dpc-4500	156	19	malignant	malignant	ADJ
dpc-4500	156	20	diseases	disease	NOUN
dpc-4500	156	21	[	[	X
dpc-4500	156	22	6,8,26	6,8,26	NUM
dpc-4500	156	23	]	]	X
dpc-4500	156	24	.	.	PUNCT
dpc-4500	157	1	therefore	therefore	ADV
dpc-4500	157	2	,	,	PUNCT
dpc-4500	157	3	it	it	PRON
dpc-4500	157	4	has	have	AUX
dpc-4500	157	5	been	be	AUX
dpc-4500	157	6	stated	state	VERB
dpc-4500	157	7	that	that	SCONJ
dpc-4500	157	8	the	the	DET
dpc-4500	157	9	increase	increase	NOUN
dpc-4500	157	10	in	in	ADP
dpc-4500	157	11	disulfide	disulfide	NOUN
dpc-4500	157	12	concentrations	concentration	NOUN
dpc-4500	157	13	is	be	AUX
dpc-4500	157	14	associated	associate	VERB
dpc-4500	157	15	with	with	ADP
dpc-4500	157	16	os	os	NOUN
dpc-4500	157	17	,	,	PUNCT
dpc-4500	157	18	and	and	CCONJ
dpc-4500	157	19	the	the	DET
dpc-4500	157	20	increase	increase	NOUN
dpc-4500	157	21	in	in	ADP
dpc-4500	157	22	native	native	ADJ
dpc-4500	157	23	thiol	thiol	NOUN
dpc-4500	157	24	levels	level	NOUN
dpc-4500	157	25	may	may	AUX
dpc-4500	157	26	be	be	AUX
dpc-4500	157	27	an	an	DET
dpc-4500	157	28	indicator	indicator	NOUN
dpc-4500	157	29	of	of	ADP
dpc-4500	157	30	a	a	DET
dpc-4500	157	31	reaction	reaction	NOUN
dpc-4500	157	32	against	against	ADP
dpc-4500	157	33	the	the	DET
dpc-4500	157	34	oxidative	oxidative	ADJ
dpc-4500	157	35	environment	environment	NOUN
dpc-4500	157	36	[	[	X
dpc-4500	157	37	6	6	NUM
dpc-4500	157	38	]	]	PUNCT
dpc-4500	157	39	.	.	PUNCT
dpc-4500	158	1	kılınç	kılınç	VERB
dpc-4500	158	2	et	et	PROPN
dpc-4500	158	3	al	al	PROPN
dpc-4500	158	4	.	.	PROPN
dpc-4500	158	5	investigated	investigate	VERB
dpc-4500	158	6	total	total	ADJ
dpc-4500	158	7	oxidant	oxidant	NOUN
dpc-4500	158	8	capacity	capacity	NOUN
dpc-4500	158	9	(	(	PUNCT
dpc-4500	158	10	toc	toc	PROPN
dpc-4500	158	11	)	)	PUNCT
dpc-4500	158	12	,	,	PUNCT
dpc-4500	158	13	osi	osi	NOUN
dpc-4500	158	14	,	,	PUNCT
dpc-4500	158	15	and	and	CCONJ
dpc-4500	158	16	arylesterase	arylesterase	NOUN
dpc-4500	158	17	as	as	ADP
dpc-4500	158	18	os	os	NOUN
dpc-4500	158	19	markers	marker	NOUN
dpc-4500	158	20	in	in	ADP
dpc-4500	158	21	ls	ls	ADJ
dpc-4500	158	22	patients	patient	NOUN
dpc-4500	158	23	in	in	ADP
dpc-4500	158	24	a	a	DET
dpc-4500	158	25	previous	previous	ADJ
dpc-4500	158	26	study	study	NOUN
dpc-4500	158	27	using	use	VERB
dpc-4500	158	28	a	a	DET
dpc-4500	158	29	control	control	NOUN
dpc-4500	158	30	group	group	NOUN
dpc-4500	158	31	;	;	PUNCT
dpc-4500	158	32	they	they	PRON
dpc-4500	158	33	found	find	VERB
dpc-4500	158	34	a	a	DET
dpc-4500	158	35	significant	significant	ADJ
dpc-4500	158	36	increase	increase	NOUN
dpc-4500	158	37	in	in	ADP
dpc-4500	158	38	the	the	DET
dpc-4500	158	39	patient	patient	ADJ
dpc-4500	158	40	group	group	NOUN
dpc-4500	158	41	[	[	X
dpc-4500	158	42	32	32	NUM
dpc-4500	158	43	]	]	PUNCT
dpc-4500	158	44	.	.	PUNCT
dpc-4500	159	1	uzun	uzun	PROPN
dpc-4500	159	2	çakmak	çakmak	PROPN
dpc-4500	159	3	et	et	PROPN
dpc-4500	159	4	al	al	PROPN
dpc-4500	159	5	.	.	PROPN
dpc-4500	159	6	found	find	VERB
dpc-4500	159	7	that	that	SCONJ
dpc-4500	159	8	glutathione	glutathione	NOUN
dpc-4500	159	9	s	s	NOUN
dpc-4500	159	10	-	-	PUNCT
dpc-4500	159	11	transferase	transferase	NOUN
dpc-4500	159	12	isoenzymes	isoenzyme	NOUN
dpc-4500	159	13	were	be	AUX
dpc-4500	159	14	significantly	significantly	ADV
dpc-4500	159	15	higher	high	ADJ
dpc-4500	159	16	in	in	ADP
dpc-4500	159	17	tissue	tissue	NOUN
dpc-4500	159	18	biopsies	biopsy	NOUN
dpc-4500	159	19	obtained	obtain	VERB
dpc-4500	159	20	from	from	ADP
dpc-4500	159	21	patients	patient	NOUN
dpc-4500	159	22	with	with	ADP
dpc-4500	159	23	ls	ls	PROPN
dpc-4500	159	24	compared	compare	VERB
dpc-4500	159	25	to	to	ADP
dpc-4500	159	26	control	control	NOUN
dpc-4500	159	27	tissues	tissue	NOUN
dpc-4500	159	28	[	[	X
dpc-4500	159	29	33	33	NUM
dpc-4500	159	30	]	]	PUNCT
dpc-4500	159	31	.	.	PUNCT
dpc-4500	160	1	in	in	ADP
dpc-4500	160	2	this	this	DET
dpc-4500	160	3	study	study	NOUN
dpc-4500	160	4	,	,	PUNCT
dpc-4500	160	5	when	when	SCONJ
dpc-4500	160	6	we	we	PRON
dpc-4500	160	7	compared	compare	VERB
dpc-4500	160	8	ls	ls	ADJ
dpc-4500	160	9	patients	patient	NOUN
dpc-4500	160	10	with	with	ADP
dpc-4500	160	11	the	the	DET
dpc-4500	160	12	control	control	NOUN
dpc-4500	160	13	group	group	NOUN
dpc-4500	160	14	,	,	PUNCT
dpc-4500	160	15	we	we	PRON
dpc-4500	160	16	found	find	VERB
dpc-4500	160	17	that	that	SCONJ
dpc-4500	160	18	the	the	DET
dpc-4500	160	19	native	native	ADJ
dpc-4500	160	20	thiol	thiol	NOUN
dpc-4500	160	21	,	,	PUNCT
dpc-4500	160	22	total	total	ADJ
dpc-4500	160	23	thiol	thiol	NOUN
dpc-4500	160	24	,	,	PUNCT
dpc-4500	160	25	disulfide	disulfide	NOUN
dpc-4500	160	26	values	value	NOUN
dpc-4500	160	27	,	,	PUNCT
dpc-4500	160	28	and	and	CCONJ
dpc-4500	160	29	their	their	PRON
dpc-4500	160	30	ratios	ratio	NOUN
dpc-4500	160	31	to	to	ADP
dpc-4500	160	32	each	each	DET
dpc-4500	160	33	other	other	ADJ
dpc-4500	160	34	did	do	AUX
dpc-4500	160	35	not	not	PART
dpc-4500	160	36	change	change	VERB
dpc-4500	160	37	,	,	PUNCT
dpc-4500	160	38	i.e.	i.e.	X
dpc-4500	160	39	,	,	PUNCT
dpc-4500	160	40	the	the	DET
dpc-4500	160	41	thiol	thiol	ADJ
dpc-4500	160	42	-	-	PUNCT
dpc-4500	160	43	disulfide	disulfide	NOUN
dpc-4500	160	44	balance	balance	NOUN
dpc-4500	160	45	was	be	AUX
dpc-4500	160	46	not	not	PART
dpc-4500	160	47	impaired	impaired	ADJ
dpc-4500	160	48	.	.	PUNCT
dpc-4500	161	1	prolidase	prolidase	NOUN
dpc-4500	161	2	activity	activity	NOUN
dpc-4500	161	3	levels	level	NOUN
dpc-4500	161	4	were	be	AUX
dpc-4500	161	5	similar	similar	ADJ
dpc-4500	161	6	to	to	ADP
dpc-4500	161	7	controls	control	NOUN
dpc-4500	161	8	.	.	PUNCT
dpc-4500	162	1	i	i	PRON
dpc-4500	162	2	m	m	VERB
dpc-4500	162	3	a	a	DET
dpc-4500	162	4	levels	level	NOUN
dpc-4500	162	5	were	be	AUX
dpc-4500	162	6	lower	low	ADJ
dpc-4500	162	7	in	in	ADP
dpc-4500	162	8	the	the	DET
dpc-4500	162	9	patient	patient	NOUN
dpc-4500	162	10	group	group	NOUN
dpc-4500	162	11	(	(	PUNCT
dpc-4500	162	12	p<0.05	p<0.05	PROPN
dpc-4500	162	13	)	)	PUNCT
dpc-4500	162	14	.	.	PUNCT
dpc-4500	163	1	6	6	NUM
dpc-4500	163	2	original	original	ADJ
dpc-4500	163	3	article	article	NOUN
dpc-4500	163	4	|	|	ADV
dpc-4500	163	5	dermatol	dermatol	ADJ
dpc-4500	163	6	pract	pract	NOUN
dpc-4500	163	7	concept	concept	NOUN
dpc-4500	163	8	.	.	PUNCT
dpc-4500	164	1	2024;14(4):e2024249	2024;14(4):e2024249	NUM
dpc-4500	164	2	13;10:1108623	13;10:1108623	NUM
dpc-4500	164	3	.	.	PUNCT
dpc-4500	165	1	doi	doi	NOUN
dpc-4500	165	2	:	:	PUNCT
dpc-4500	165	3	10.3389	10.3389	NUM
dpc-4500	165	4	/	/	SYM
dpc-4500	165	5	fmed.2023.1108623	fmed.2023.1108623	NOUN
dpc-4500	165	6	.	.	PUNCT
dpc-4500	166	1	pmid	pmid	NOUN
dpc-4500	166	2	:	:	PUNCT
dpc-4500	166	3	3686	3686	NUM
dpc-4500	166	4	0340	0340	NUM
dpc-4500	166	5	;	;	PUNCT
dpc-4500	166	6	pmcid	pmcid	NOUN
dpc-4500	166	7	:	:	PUNCT
dpc-4500	166	8	pmc9969991	pmc9969991	ADJ
dpc-4500	166	9	.	.	PUNCT
dpc-4500	167	1	2	2	X
dpc-4500	167	2	.	.	X
dpc-4500	167	3	florez	florez	PROPN
dpc-4500	167	4	-	-	PUNCT
dpc-4500	167	5	pollack	pollack	PROPN
dpc-4500	167	6	s	s	PROPN
dpc-4500	167	7	,	,	PUNCT
dpc-4500	167	8	kunzler	kunzler	PROPN
dpc-4500	167	9	e	e	NOUN
dpc-4500	167	10	,	,	PUNCT
dpc-4500	167	11	jacobe	jacobe	PROPN
dpc-4500	167	12	ht	ht	PROPN
dpc-4500	167	13	.	.	PUNCT
dpc-4500	167	14	morphea	morphea	PROPN
dpc-4500	167	15	:	:	PUNCT
dpc-4500	167	16	current	current	ADJ
dpc-4500	167	17	concepts	concept	NOUN
dpc-4500	167	18	.	.	PUNCT
dpc-4500	168	1	clin	clin	PROPN
dpc-4500	168	2	dermatol	dermatol	NOUN
dpc-4500	168	3	.	.	PUNCT
dpc-4500	169	1	2018;36(4):475	2018;36(4):475	NUM
dpc-4500	169	2	-	-	SYM
dpc-4500	169	3	486	486	NUM
dpc-4500	169	4	.	.	PUNCT
dpc-4500	170	1	doi	doi	NOUN
dpc-4500	170	2	:	:	PUNCT
dpc-4500	170	3	10.1016	10.1016	NUM
dpc-4500	170	4	/	/	SYM
dpc-4500	170	5	j.clindermatol	j.clindermatol	NOUN
dpc-4500	170	6	.	.	PUNCT
dpc-4500	171	1	2018.04.005	2018.04.005	X
dpc-4500	171	2	.	.	PUNCT
dpc-4500	172	1	epub	epub	PROPN
dpc-4500	172	2	2018	2018	NUM
dpc-4500	172	3	apr	apr	NOUN
dpc-4500	172	4	10	10	NUM
dpc-4500	172	5	.	.	PUNCT
dpc-4500	173	1	pmid	pmid	NOUN
dpc-4500	173	2	:	:	PUNCT
dpc-4500	173	3	30047431	30047431	NUM
dpc-4500	173	4	.	.	PUNCT
dpc-4500	174	1	3	3	X
dpc-4500	174	2	.	.	NOUN
dpc-4500	174	3	torok	torok	PROPN
dpc-4500	174	4	ks	ks	PROPN
dpc-4500	174	5	,	,	PUNCT
dpc-4500	174	6	li	li	PROPN
dpc-4500	174	7	sc	sc	PROPN
dpc-4500	174	8	,	,	PUNCT
dpc-4500	174	9	jacobe	jacobe	PROPN
dpc-4500	174	10	hm	hm	INTJ
dpc-4500	174	11	,	,	PUNCT
dpc-4500	174	12	et	et	PROPN
dpc-4500	174	13	al	al	PROPN
dpc-4500	174	14	.	.	PROPN
dpc-4500	174	15	immunopathogenesis	immunopathogenesis	NOUN
dpc-4500	174	16	of	of	ADP
dpc-4500	174	17	pediatric	pediatric	ADJ
dpc-4500	174	18	localized	localize	VERB
dpc-4500	174	19	scleroderma	scleroderma	NOUN
dpc-4500	174	20	.	.	PUNCT
dpc-4500	175	1	front	front	ADJ
dpc-4500	175	2	immunol	immunol	NOUN
dpc-4500	175	3	.	.	PUNCT
dpc-4500	176	1	2019;10:908	2019;10:908	X
dpc-4500	176	2	.	.	PUNCT
dpc-4500	177	1	published	publish	VERB
dpc-4500	177	2	2019	2019	NUM
dpc-4500	177	3	apr	apr	NOUN
dpc-4500	177	4	30	30	NUM
dpc-4500	177	5	.	.	PUNCT
dpc-4500	177	6	doi:10.3389	doi:10.3389	PROPN
dpc-4500	177	7	/	/	SYM
dpc-4500	177	8	fimmu.2019.00908	fimmu.2019.00908	PROPN
dpc-4500	177	9	.	.	PUNCT
dpc-4500	178	1	4	4	NUM
dpc-4500	178	2	.	.	NOUN
dpc-4500	178	3	abbas	abbas	PROPN
dpc-4500	178	4	l	l	PROPN
dpc-4500	178	5	,	,	PUNCT
dpc-4500	178	6	joseph	joseph	PROPN
dpc-4500	178	7	a	a	PROPN
dpc-4500	178	8	,	,	PUNCT
dpc-4500	178	9	kunzler	kunzler	PROPN
dpc-4500	178	10	e	e	NOUN
dpc-4500	178	11	,	,	PUNCT
dpc-4500	178	12	et	et	PROPN
dpc-4500	178	13	al	al	PROPN
dpc-4500	178	14	.	.	PROPN
dpc-4500	178	15	morphea	morphea	PROPN
dpc-4500	178	16	:	:	PUNCT
dpc-4500	178	17	progress	progress	NOUN
dpc-4500	178	18	to	to	ADP
dpc-4500	178	19	date	date	NOUN
dpc-4500	178	20	and	and	CCONJ
dpc-4500	178	21	the	the	DET
dpc-4500	178	22	road	road	NOUN
dpc-4500	178	23	ahead	ahead	ADV
dpc-4500	178	24	.	.	PUNCT
dpc-4500	179	1	ann	ann	PROPN
dpc-4500	179	2	transl	transl	PROPN
dpc-4500	179	3	med.2021;9(5):437	med.2021;9(5):437	PROPN
dpc-4500	179	4	.	.	PUNCT
dpc-4500	180	1	doi	doi	PROPN
dpc-4500	180	2	:	:	PUNCT
dpc-4500	180	3	10.21037	10.21037	NUM
dpc-4500	180	4	/atm-20	/atm-20	SYM
dpc-4500	180	5	-	-	PUNCT
dpc-4500	180	6	6222	6222	NUM
dpc-4500	180	7	.	.	PUNCT
dpc-4500	181	1	pmid	pmid	NOUN
dpc-4500	181	2	:	:	PUNCT
dpc-4500	181	3	33842658	33842658	NUM
dpc-4500	181	4	;	;	PUNCT
dpc-4500	181	5	pmcid	pmcid	ADJ
dpc-4500	181	6	:	:	PUNCT
dpc-4500	181	7	pmc8033330	pmc8033330	NOUN
dpc-4500	181	8	.	.	PUNCT
dpc-4500	182	1	5	5	X
dpc-4500	182	2	.	.	X
dpc-4500	182	3	baba	baba	PROPN
dpc-4500	182	4	sp	sp	PROPN
dpc-4500	182	5	,	,	PUNCT
dpc-4500	182	6	bhatnagar	bhatnagar	NOUN
dpc-4500	182	7	a.	a.	NOUN
dpc-4500	182	8	role	role	NOUN
dpc-4500	182	9	of	of	ADP
dpc-4500	182	10	tiyols	tiyol	NOUN
dpc-4500	182	11	ın	ın	VERB
dpc-4500	182	12	oxidative	oxidative	ADJ
dpc-4500	182	13	stres	stre	NOUN
dpc-4500	182	14	.	.	PUNCT
dpc-4500	183	1	curr	curr	PROPN
dpc-4500	183	2	opin	opin	PROPN
dpc-4500	183	3	toxicol.2018	toxicol.2018	PROPN
dpc-4500	183	4	;	;	PUNCT
dpc-4500	183	5	7:133	7:133	NUM
dpc-4500	183	6	-	-	SYM
dpc-4500	183	7	139	139	NUM
dpc-4500	183	8	.	.	PUNCT
dpc-4500	184	1	doi	doi	NOUN
dpc-4500	184	2	:	:	PUNCT
dpc-4500	184	3	10.1016	10.1016	NUM
dpc-4500	184	4	/	/	SYM
dpc-4500	184	5	j.cotox.2018.03	j.cotox.2018.03	PROPN
dpc-4500	184	6	.005	.005	NUM
dpc-4500	184	7	.	.	PUNCT
dpc-4500	185	1	pmid	pmid	NOUN
dpc-4500	185	2	:	:	PUNCT
dpc-4500	185	3	30338308	30338308	NUM
dpc-4500	185	4	.	.	PUNCT
dpc-4500	186	1	6	6	NUM
dpc-4500	186	2	.	.	NUM
dpc-4500	186	3	erel	erel	PROPN
dpc-4500	186	4	ö	ö	NOUN
dpc-4500	186	5	,	,	PUNCT
dpc-4500	186	6	erdoğan	erdoğan	NOUN
dpc-4500	186	7	s	s	PART
dpc-4500	186	8	thiol	thiol	ADJ
dpc-4500	186	9	-	-	PUNCT
dpc-4500	186	10	disulfide	disulfide	NOUN
dpc-4500	186	11	homeostasis	homeostasis	NOUN
dpc-4500	186	12	:	:	PUNCT
dpc-4500	186	13	an	an	DET
dpc-4500	186	14	integrated	integrated	ADJ
dpc-4500	186	15	approach	approach	NOUN
dpc-4500	186	16	with	with	ADP
dpc-4500	186	17	biochemical	biochemical	ADJ
dpc-4500	186	18	and	and	CCONJ
dpc-4500	186	19	clinical	clinical	ADJ
dpc-4500	186	20	aspects	aspect	NOUN
dpc-4500	186	21	.	.	PUNCT
dpc-4500	187	1	turk	turk	PROPN
dpc-4500	187	2	j	j	PROPN
dpc-4500	187	3	med	med	PROPN
dpc-4500	187	4	sci	sci	PROPN
dpc-4500	187	5	.2020	.2020	PROPN
dpc-4500	187	6	;	;	PUNCT
dpc-4500	187	7	50	50	NUM
dpc-4500	187	8	:	:	SYM
dpc-4500	187	9	1728	1728	NUM
dpc-4500	187	10	-	-	SYM
dpc-4500	187	11	1738	1738	NUM
dpc-4500	187	12	©	©	PROPN
dpc-4500	187	13	tübitak	tübitak	NOUN
dpc-4500	187	14	.	.	PUNCT
dpc-4500	188	1	doi:10.3906	doi:10.3906	NOUN
dpc-4500	188	2	/	/	SYM
dpc-4500	188	3	sag-2003	sag-2003	NOUN
dpc-4500	188	4	-	-	PUNCT
dpc-4500	188	5	64	64	NUM
dpc-4500	188	6	.	.	PUNCT
dpc-4500	189	1	7	7	X
dpc-4500	189	2	.	.	X
dpc-4500	189	3	nakai	nakai	PROPN
dpc-4500	189	4	,	,	PUNCT
dpc-4500	189	5	k.	k.	PROPN
dpc-4500	189	6	tsuruta	tsuruta	PROPN
dpc-4500	189	7	,	,	PUNCT
dpc-4500	189	8	d.	d.	PROPN
dpc-4500	189	9	what	what	PRON
dpc-4500	189	10	are	be	AUX
dpc-4500	189	11	reactive	reactive	ADJ
dpc-4500	189	12	oxygen	oxygen	NOUN
dpc-4500	189	13	species	specie	NOUN
dpc-4500	189	14	,	,	PUNCT
dpc-4500	189	15	free	free	ADJ
dpc-4500	189	16	radicals	radical	NOUN
dpc-4500	189	17	,	,	PUNCT
dpc-4500	189	18	and	and	CCONJ
dpc-4500	189	19	oxidative	oxidative	ADJ
dpc-4500	189	20	stress	stress	NOUN
dpc-4500	189	21	in	in	ADP
dpc-4500	189	22	skin	skin	NOUN
dpc-4500	189	23	diseases	disease	NOUN
dpc-4500	189	24	?	?	PUNCT
dpc-4500	189	25	  	  	SPACE
dpc-4500	189	26	int	int	NOUN
dpc-4500	189	27	.	.	PUNCT
dpc-4500	190	1	j.	j.	PROPN
dpc-4500	190	2	mol	mol	PROPN
dpc-4500	190	3	.	.	PUNCT
dpc-4500	191	1	sci	sci	PROPN
dpc-4500	191	2	.	.	PUNCT
dpc-4500	191	3	  	  	SPACE
dpc-4500	191	4	2021	2021	NUM
dpc-4500	191	5	  	  	SPACE
dpc-4500	191	6	;	;	PUNCT
dpc-4500	191	7	22	22	NUM
dpc-4500	191	8	:	:	SYM
dpc-4500	191	9	10799	10799	NUM
dpc-4500	191	10	.	.	PUNCT
dpc-4500	192	1	doi	doi	NOUN
dpc-4500	192	2	:	:	PUNCT
dpc-4500	192	3	10.3390	10.3390	NUM
dpc-4500	192	4	/	/	SYM
dpc-4500	192	5	ijms221910799	ijms221910799	PROPN
dpc-4500	192	6	.	.	PUNCT
dpc-4500	193	1	pmid	pmid	NOUN
dpc-4500	193	2	:	:	PUNCT
dpc-4500	193	3	34639139	34639139	NUM
dpc-4500	193	4	;	;	PUNCT
dpc-4500	193	5	pmcid	pmcid	ADJ
dpc-4500	193	6	:	:	PUNCT
dpc-4500	193	7	pmc8509443	pmc8509443	NOUN
dpc-4500	193	8	.	.	PUNCT
dpc-4500	194	1	8	8	X
dpc-4500	194	2	.	.	X
dpc-4500	194	3	georgescu	georgescu	PROPN
dpc-4500	194	4	sr	sr	PROPN
dpc-4500	194	5	,	,	PUNCT
dpc-4500	194	6	mitran	mitran	PROPN
dpc-4500	194	7	ci	ci	PROPN
dpc-4500	194	8	,	,	PUNCT
dpc-4500	194	9	mitran	mitran	NOUN
dpc-4500	194	10	mi	mi	PROPN
dpc-4500	194	11	,	,	PUNCT
dpc-4500	194	12	et	et	PROPN
dpc-4500	194	13	al	al	PROPN
dpc-4500	194	14	.	.	PUNCT
dpc-4500	194	15	thiol	thiol	ADJ
dpc-4500	194	16	-	-	PUNCT
dpc-4500	194	17	disulfide	disulfide	NOUN
dpc-4500	194	18	homeostasis	homeostasis	NOUN
dpc-4500	194	19	in	in	ADP
dpc-4500	194	20	skin	skin	NOUN
dpc-4500	194	21	diseases	disease	NOUN
dpc-4500	194	22	.	.	PUNCT
dpc-4500	195	1	j	j	PROPN
dpc-4500	195	2	clin	clin	PROPN
dpc-4500	195	3	med	med	PROPN
dpc-4500	195	4	.	.	PUNCT
dpc-4500	196	1	2022	2022	NUM
dpc-4500	196	2	9;11(6):1507	9;11(6):1507	NOUN
dpc-4500	196	3	.	.	PUNCT
dpc-4500	197	1	doi	doi	NOUN
dpc-4500	197	2	:	:	PUNCT
dpc-4500	197	3	10.3390	10.3390	NUM
dpc-4500	197	4	/	/	SYM
dpc-4500	197	5	jcm11061507	jcm11061507	NOUN
dpc-4500	197	6	.	.	PUNCT
dpc-4500	198	1	pmid	pmid	NOUN
dpc-4500	198	2	:	:	PUNCT
dpc-4500	198	3	35329832	35329832	NUM
dpc-4500	198	4	;	;	PUNCT
dpc-4500	198	5	pmcid	pmcid	ADJ
dpc-4500	198	6	:	:	PUNCT
dpc-4500	198	7	pmc8954849	pmc8954849	VERB
dpc-4500	198	8	9	9	NUM
dpc-4500	198	9	.	.	PUNCT
dpc-4500	198	10	tampa	tampa	PROPN
dpc-4500	198	11	m	m	PROPN
dpc-4500	198	12	,	,	PUNCT
dpc-4500	198	13	mitran	mitran	PROPN
dpc-4500	198	14	ci	ci	PROPN
dpc-4500	198	15	,	,	PUNCT
dpc-4500	198	16	mitran	mitran	NOUN
dpc-4500	198	17	mi	mi	PROPN
dpc-4500	198	18	,	,	PUNCT
dpc-4500	198	19	amuzescu	amuzescu	NOUN
dpc-4500	198	20	a	a	X
dpc-4500	198	21	,	,	PUNCT
dpc-4500	198	22	matei	matei	NOUN
dpc-4500	198	23	c	c	PROPN
dpc-4500	198	24	,	,	PUNCT
dpc-4500	198	25	georgescu	georgescu	PROPN
dpc-4500	198	26	sr	sr	PROPN
dpc-4500	198	27	.	.	PUNCT
dpc-4500	198	28	ischemia	ischemia	NOUN
dpc-4500	198	29	-	-	PUNCT
dpc-4500	198	30	modified	modify	VERB
dpc-4500	198	31	albumin	albumin	NOUN
dpc-4500	198	32	-	-	PUNCT
dpc-4500	198	33	a	a	DET
dpc-4500	198	34	potential	potential	ADJ
dpc-4500	198	35	new	new	ADJ
dpc-4500	198	36	marker	marker	NOUN
dpc-4500	198	37	of	of	ADP
dpc-4500	198	38	oxidative	oxidative	ADJ
dpc-4500	198	39	stress	stress	NOUN
dpc-4500	198	40	in	in	ADP
dpc-4500	198	41	dermatological	dermatological	ADJ
dpc-4500	198	42	diseases	disease	NOUN
dpc-4500	198	43	.	.	PUNCT
dpc-4500	199	1	medicina	medicina	PROPN
dpc-4500	199	2	(	(	PUNCT
dpc-4500	199	3	kaunas	kaunas	PROPN
dpc-4500	199	4	)	)	PUNCT
dpc-4500	199	5	.	.	PUNCT
dpc-4500	200	1	2022	2022	NUM
dpc-4500	200	2	may	may	PROPN
dpc-4500	200	3	17;58(5):669	17;58(5):669	NUM
dpc-4500	200	4	.	.	PUNCT
dpc-4500	201	1	doi	doi	NOUN
dpc-4500	201	2	:	:	PUNCT
dpc-4500	201	3	10.3390	10.3390	NUM
dpc-4500	201	4	/	/	SYM
dpc-4500	201	5	medicina	medicina	NOUN
dpc-4500	201	6	58050669	58050669	NUM
dpc-4500	201	7	.	.	PUNCT
dpc-4500	202	1	pmid	pmid	NOUN
dpc-4500	202	2	:	:	PUNCT
dpc-4500	202	3	35630086	35630086	NUM
dpc-4500	202	4	;	;	PUNCT
dpc-4500	202	5	pmcid	pmcid	NOUN
dpc-4500	202	6	:	:	PUNCT
dpc-4500	202	7	pmc9147831	pmc9147831	ADJ
dpc-4500	202	8	.	.	PUNCT
dpc-4500	203	1	10	10	NUM
dpc-4500	203	2	.	.	X
dpc-4500	203	3	eni	eni	PROPN
dpc-4500	203	4	-	-	PUNCT
dpc-4500	203	5	aganga	aganga	PROPN
dpc-4500	203	6	i	i	PRON
dpc-4500	203	7	,	,	PUNCT
dpc-4500	203	8	lanaghan	lanaghan	PROPN
dpc-4500	203	9	zm	zm	PROPN
dpc-4500	203	10	,	,	PUNCT
dpc-4500	203	11	balasubramaniam	balasubramaniam	PROPN
dpc-4500	203	12	m	m	PROPN
dpc-4500	203	13	,	,	PUNCT
dpc-4500	203	14	dash	dash	NOUN
dpc-4500	203	15	c	c	NOUN
dpc-4500	203	16	,	,	PUNCT
dpc-4500	203	17	pandhare	pandhare	VERB
dpc-4500	203	18	j.	j.	PROPN
dpc-4500	203	19	prolidase	prolidase	PROPN
dpc-4500	203	20	:	:	PUNCT
dpc-4500	203	21	a	a	DET
dpc-4500	203	22	review	review	NOUN
dpc-4500	203	23	from	from	ADP
dpc-4500	203	24	discovery	discovery	NOUN
dpc-4500	203	25	to	to	ADP
dpc-4500	203	26	its	its	PRON
dpc-4500	203	27	role	role	NOUN
dpc-4500	203	28	in	in	ADP
dpc-4500	203	29	health	health	NOUN
dpc-4500	203	30	and	and	CCONJ
dpc-4500	203	31	disease	disease	NOUN
dpc-4500	203	32	.	.	PUNCT
dpc-4500	203	33	 	 	SPACE
dpc-4500	204	1	front	front	NOUN
dpc-4500	204	2	mol	mol	ADP
dpc-4500	204	3	biosci	biosci	PROPN
dpc-4500	204	4	.	.	PUNCT
dpc-4500	205	1	2021;8:723003	2021;8:723003	NOUN
dpc-4500	205	2	.	.	PUNCT
dpc-4500	206	1	published	publish	VERB
dpc-4500	206	2	2021	2021	NUM
dpc-4500	206	3	aug	aug	PROPN
dpc-4500	206	4	31	31	NUM
dpc-4500	206	5	.	.	PUNCT
dpc-4500	207	1	doi:10.3389	doi:10.3389	PROPN
dpc-4500	207	2	/	/	SYM
dpc-4500	207	3	fmolb.2021.723003	fmolb.2021.723003	PROPN
dpc-4500	207	4	.	.	PUNCT
dpc-4500	208	1	11	11	NUM
dpc-4500	208	2	.	.	PUNCT
dpc-4500	208	3	radi	radi	NOUN
dpc-4500	208	4	r	r	PROPN
dpc-4500	208	5	,	,	PUNCT
dpc-4500	208	6	trujillo	trujillo	PROPN
dpc-4500	208	7	m.	m.	PROPN
dpc-4500	208	8	special	special	ADJ
dpc-4500	208	9	issue	issue	NOUN
dpc-4500	208	10	on	on	ADP
dpc-4500	208	11	“	"	PUNCT
dpc-4500	208	12	free	free	ADJ
dpc-4500	208	13	radical	radical	ADJ
dpc-4500	208	14	and	and	CCONJ
dpc-4500	208	15	redox	redox	ADJ
dpc-4500	208	16	biochemistry	biochemistry	NOUN
dpc-4500	208	17	of	of	ADP
dpc-4500	208	18	thiols	thiol	NOUN
dpc-4500	208	19	”	"	PUNCT
dpc-4500	208	20	.	.	PUNCT
dpc-4500	208	21	  	  	SPACE
dpc-4500	209	1	free	free	ADJ
dpc-4500	209	2	radic	radic	ADJ
dpc-4500	209	3	res	re	NOUN
dpc-4500	209	4	.	.	PUNCT
dpc-4500	210	1	2016;50(2):123	2016;50(2):123	NOUN
dpc-4500	210	2	-	-	PUNCT
dpc-4500	210	3	125	125	NUM
dpc-4500	210	4	.	.	PUNCT
dpc-4500	211	1	doi:10.3109/10715762.2015.1121254	doi:10.3109/10715762.2015.1121254	PROPN
dpc-4500	211	2	.	.	PUNCT
dpc-4500	212	1	12	12	NUM
dpc-4500	212	2	.	.	PUNCT
dpc-4500	213	1	chianeh	chianeh	PROPN
dpc-4500	213	2	yr	yr	PROPN
dpc-4500	213	3	,	,	PUNCT
dpc-4500	213	4	prabhu	prabhu	PROPN
dpc-4500	213	5	k.	k.	PROPN
dpc-4500	213	6	protein	protein	NOUN
dpc-4500	213	7	tiyols	tiyol	NOUN
dpc-4500	213	8	as	as	ADP
dpc-4500	213	9	an	an	DET
dpc-4500	213	10	indication	indication	NOUN
dpc-4500	213	11	of	of	ADP
dpc-4500	213	12	oxidative	oxidative	ADJ
dpc-4500	213	13	stres	stre	NOUN
dpc-4500	213	14	.	.	PUNCT
dpc-4500	214	1	arch	arch	NOUN
dpc-4500	214	2	.	.	PUNCT
dpc-4500	215	1	med	med	PROPN
dpc-4500	215	2	.	.	PUNCT
dpc-4500	216	1	res	re	NOUN
dpc-4500	216	2	.	.	PROPN
dpc-4500	216	3	2014	2014	NUM
dpc-4500	216	4	;	;	PUNCT
dpc-4500	216	5	23(3	23(3	NUM
dpc-4500	216	6	):	):	PUNCT
dpc-4500	216	7	443	443	NUM
dpc-4500	216	8	-	-	SYM
dpc-4500	216	9	56	56	NUM
dpc-4500	216	10	.	.	PUNCT
dpc-4500	216	11	doi:10.17827	doi:10.17827	PROPN
dpc-4500	216	12	/aktd.72428	/aktd.72428	PUNCT
dpc-4500	216	13	.	.	PUNCT
dpc-4500	217	1	13	13	NUM
dpc-4500	217	2	.	.	NUM
dpc-4500	217	3	erel	erel	PROPN
dpc-4500	217	4	o	o	NOUN
dpc-4500	217	5	,	,	PUNCT
dpc-4500	217	6	neselioglu	neselioglu	PROPN
dpc-4500	217	7	s.	s.	PROPN
dpc-4500	217	8	a	a	DET
dpc-4500	217	9	novel	novel	NOUN
dpc-4500	217	10	and	and	CCONJ
dpc-4500	217	11	automated	automate	VERB
dpc-4500	217	12	assay	assay	NOUN
dpc-4500	217	13	for	for	ADP
dpc-4500	217	14	hiol	hiol	NOUN
dpc-4500	217	15	disulphide	disulphide	NOUN
dpc-4500	217	16	homeostasis	homeostasis	NOUN
dpc-4500	217	17	.	.	PUNCT
dpc-4500	218	1	clin	clin	PROPN
dpc-4500	218	2	biochem	biochem	PROPN
dpc-4500	218	3	.	.	PUNCT
dpc-4500	219	1	2014;47(18):326	2014;47(18):326	NUM
dpc-4500	219	2	-	-	PUNCT
dpc-4500	219	3	332	332	NUM
dpc-4500	219	4	.	.	PUNCT
dpc-4500	220	1	doi	doi	NOUN
dpc-4500	220	2	:	:	PUNCT
dpc-4500	220	3	 	 	SPACE
dpc-4500	220	4	10.1016	10.1016	NUM
dpc-4500	220	5	/	/	SYM
dpc-4500	220	6	j.clinbiochem.2014.09.026	j.clinbiochem.2014.09.026	PROPN
dpc-4500	220	7	pmid	pmid	PROPN
dpc-4500	220	8	:	:	PUNCT
dpc-4500	220	9	 	 	SPACE
dpc-4500	220	10	25304913	25304913	NUM
dpc-4500	220	11	.	.	PUNCT
dpc-4500	221	1	14	14	NUM
dpc-4500	221	2	.	.	PUNCT
dpc-4500	222	1	sbarouni	sbarouni	PROPN
dpc-4500	222	2	e	e	PROPN
dpc-4500	222	3	,	,	PUNCT
dpc-4500	222	4	georgiadou	georgiadou	NOUN
dpc-4500	222	5	p	p	SYM
dpc-4500	222	6	,	,	PUNCT
dpc-4500	222	7	voudris	voudris	NOUN
dpc-4500	222	8	v.	v.	ADP
dpc-4500	222	9	ischemia	ischemia	NOUN
dpc-4500	222	10	modified	modify	VERB
dpc-4500	222	11	albumin	albumin	ADJ
dpc-4500	222	12	changes	change	NOUN
dpc-4500	222	13	review	review	VERB
dpc-4500	222	14	and	and	CCONJ
dpc-4500	222	15	clinical	clinical	ADJ
dpc-4500	222	16	implications	implication	NOUN
dpc-4500	222	17	.	.	PUNCT
dpc-4500	223	1	clin	clin	PROPN
dpc-4500	223	2	chem	chem	NOUN
dpc-4500	223	3	lab	lab	PROPN
dpc-4500	223	4	med	me	VERB
dpc-4500	223	5	2011;49:177	2011;49:177	PROPN
dpc-4500	223	6	-	-	NUM
dpc-4500	223	7	84	84	NUM
dpc-4500	223	8	.	.	PUNCT
dpc-4500	224	1	doi	doi	NOUN
dpc-4500	224	2	:	:	PUNCT
dpc-4500	224	3	10.1515	10.1515	NUM
dpc-4500	224	4	/	/	SYM
dpc-4500	224	5	cclm.2011.037	cclm.2011.037	PROPN
dpc-4500	224	6	.	.	PUNCT
dpc-4500	225	1	epub	epub	NOUN
dpc-4500	225	2	2010	2010	NUM
dpc-4500	225	3	nov	nov	NOUN
dpc-4500	225	4	18	18	NUM
dpc-4500	225	5	.	.	PUNCT
dpc-4500	226	1	pmid	pmid	NOUN
dpc-4500	226	2	:	:	PUNCT
dpc-4500	226	3	21083441	21083441	NUM
dpc-4500	226	4	.	.	PUNCT
dpc-4500	227	1	15	15	NUM
dpc-4500	227	2	.	.	X
dpc-4500	228	1	guntas	guntas	NOUN
dpc-4500	228	2	g	g	PROPN
dpc-4500	228	3	,	,	PUNCT
dpc-4500	228	4	sahin	sahin	PROPN
dpc-4500	228	5	a	a	PROPN
dpc-4500	228	6	,	,	PUNCT
dpc-4500	228	7	duran	duran	NOUN
dpc-4500	228	8	s	s	PROPN
dpc-4500	228	9	,	,	PUNCT
dpc-4500	228	10	et	et	PROPN
dpc-4500	228	11	al	al	PROPN
dpc-4500	228	12	.	.	PUNCT
dpc-4500	228	13	evaluation	evaluation	NOUN
dpc-4500	228	14	of	of	ADP
dpc-4500	228	15	ischemia	ischemia	NOUN
dpc-4500	228	16	modified	modify	VERB
dpc-4500	228	17	albumin	albumin	NOUN
dpc-4500	228	18	in	in	ADP
dpc-4500	228	19	patients	patient	NOUN
dpc-4500	228	20	with	with	ADP
dpc-4500	228	21	inflammatory	inflammatory	ADJ
dpc-4500	228	22	bowel	bowel	NOUN
dpc-4500	228	23	disease	disease	NOUN
dpc-4500	228	24	.	.	PUNCT
dpc-4500	229	1	clin	clin	PROPN
dpc-4500	229	2	lab	lab	PROPN
dpc-4500	229	3	.	.	PROPN
dpc-4500	229	4	2017	2017	NUM
dpc-4500	229	5	;	;	PUNCT
dpc-4500	229	6	63(2):341	63(2):341	PROPN
dpc-4500	229	7	-	-	SYM
dpc-4500	229	8	7	7	NUM
dpc-4500	229	9	.	.	PUNCT
dpc-4500	229	10	doi	doi	NOUN
dpc-4500	229	11	:	:	PUNCT
dpc-4500	229	12	10.7754	10.7754	NUM
dpc-4500	229	13	/	/	SYM
dpc-4500	229	14	clin.lab.2016	clin.lab.2016	PROPN
dpc-4500	229	15	.160623	.160623	NOUN
dpc-4500	229	16	.	.	PUNCT
dpc-4500	230	1	pmid	pmid	NOUN
dpc-4500	230	2	:	:	PUNCT
dpc-4500	230	3	28182340	28182340	NUM
dpc-4500	230	4	.	.	PUNCT
dpc-4500	231	1	16	16	NUM
dpc-4500	231	2	.	.	PUNCT
dpc-4500	232	1	aşkın	aşkın	PROPN
dpc-4500	232	2	l	l	NOUN
dpc-4500	232	3	,	,	PUNCT
dpc-4500	232	4	serçelik	serçelik	VERB
dpc-4500	232	5	a	a	PRON
dpc-4500	232	6	,	,	PUNCT
dpc-4500	232	7	tanrıverdi	tanrıverdi	PROPN
dpc-4500	232	8	o	o	NOUN
dpc-4500	232	9	,	,	PUNCT
dpc-4500	232	10	süsenbük	süsenbük	PROPN
dpc-4500	232	11	a	a	X
dpc-4500	232	12	,	,	PUNCT
dpc-4500	232	13	türkmen	türkmen	PROPN
dpc-4500	232	14	s	s	PROPN
dpc-4500	232	15	,	,	PUNCT
dpc-4500	232	16	aktürk	aktürk	PROPN
dpc-4500	232	17	e.	e.	PROPN
dpc-4500	232	18	kardiyovasküler	kardiyovasküler	PROPN
dpc-4500	232	19	i̇skemik	i̇skemik	ADJ
dpc-4500	232	20	olayların	olayların	NOUN
dpc-4500	232	21	yeni	yeni	PROPN
dpc-4500	232	22	bir	bir	NOUN
dpc-4500	232	23	sistemik	sistemik	ADJ
dpc-4500	232	24	göstergesi	göstergesi	NOUN
dpc-4500	232	25	:	:	PUNCT
dpc-4500	232	26	i̇skemi	i̇skemi	VERB
dpc-4500	232	27	modifiye	modifiye	PROPN
dpc-4500	232	28	albumin	albumin	ADJ
dpc-4500	232	29	levels	level	NOUN
dpc-4500	232	30	.	.	PUNCT
dpc-4500	233	1	mn	mn	PROPN
dpc-4500	233	2	kardiyoloji	kardiyoloji	PROPN
dpc-4500	233	3	2019;26(3):198	2019;26(3):198	PROPN
dpc-4500	233	4	-	-	PUNCT
dpc-4500	233	5	202	202	NUM
dpc-4500	233	6	.	.	PUNCT
dpc-4500	233	7	17	17	NUM
dpc-4500	233	8	.	.	PUNCT
dpc-4500	234	1	ozdemir	ozdemir	PROPN
dpc-4500	234	2	m	m	PROPN
dpc-4500	234	3	,	,	PUNCT
dpc-4500	234	4	kiyici	kiyici	PROPN
dpc-4500	234	5	a	a	PROPN
dpc-4500	234	6	,	,	PUNCT
dpc-4500	234	7	balevi	balevi	ADJ
dpc-4500	234	8	a.	a.	NOUN
dpc-4500	234	9	assessment	assessment	NOUN
dpc-4500	234	10	of	of	ADP
dpc-4500	234	11	ischaemiamodified	ischaemiamodifie	VERB
dpc-4500	234	12	albumin	albumin	ADJ
dpc-4500	234	13	level	level	NOUN
dpc-4500	234	14	in	in	ADP
dpc-4500	234	15	patients	patient	NOUN
dpc-4500	234	16	with	with	ADP
dpc-4500	234	17	psoriasis	psoriasis	NOUN
dpc-4500	234	18	.	.	PUNCT
dpc-4500	235	1	clin	clin	PROPN
dpc-4500	235	2	exp	exp	NOUN
dpc-4500	235	3	dermatol	dermatol	NOUN
dpc-4500	235	4	.	.	PUNCT
dpc-4500	236	1	2012	2012	NUM
dpc-4500	236	2	;	;	PUNCT
dpc-4500	236	3	37:610–4	37:610–4	NUM
dpc-4500	236	4	.	.	PUNCT
dpc-4500	237	1	doi	doi	NOUN
dpc-4500	237	2	:	:	PUNCT
dpc-4500	237	3	10.1111	10.1111	NUM
dpc-4500	237	4	/	/	SYM
dpc-4500	237	5	j.1365	j.1365	PROPN
dpc-4500	237	6	-	-	PUNCT
dpc-4500	237	7	2230.2012.04384.x	2230.2012.04384.x	NUM
dpc-4500	237	8	.	.	PUNCT
dpc-4500	238	1	epub	epub	NOUN
dpc-4500	238	2	2012	2012	NUM
dpc-4500	238	3	may	may	AUX
dpc-4500	238	4	21	21	NUM
dpc-4500	238	5	.	.	PUNCT
dpc-4500	239	1	pmid	pmid	NOUN
dpc-4500	239	2	:	:	PUNCT
dpc-4500	239	3	22607558	22607558	NUM
dpc-4500	239	4	.	.	PUNCT
dpc-4500	240	1	18	18	NUM
dpc-4500	240	2	.	.	PUNCT
dpc-4500	241	1	bozkurt	bozkurt	PROPN
dpc-4500	241	2	m	m	PROPN
dpc-4500	241	3	,	,	PUNCT
dpc-4500	241	4	yüksel	yüksel	PROPN
dpc-4500	241	5	h	h	NOUN
dpc-4500	241	6	,	,	PUNCT
dpc-4500	241	7	em	em	PRON
dpc-4500	241	8	s	s	PROPN
dpc-4500	241	9	,	,	PUNCT
dpc-4500	241	10	et	et	PROPN
dpc-4500	241	11	al	al	PROPN
dpc-4500	241	12	.	.	PROPN
dpc-4500	241	13	serum	serum	PROPN
dpc-4500	241	14	prolidase	prolidase	NOUN
dpc-4500	241	15	enzyme	enzyme	NOUN
dpc-4500	241	16	activity	activity	NOUN
dpc-4500	241	17	and	and	CCONJ
dpc-4500	241	18	oxidative	oxidative	ADJ
dpc-4500	241	19	status	status	NOUN
dpc-4500	241	20	in	in	ADP
dpc-4500	241	21	patients	patient	NOUN
dpc-4500	241	22	with	with	ADP
dpc-4500	241	23	behçet	behçet	PROPN
dpc-4500	241	24	’s	’s	PART
dpc-4500	241	25	disease	disease	NOUN
dpc-4500	241	26	.	.	PUNCT
dpc-4500	242	1	redox	redox	PROPN
dpc-4500	242	2	rep	rep	PROPN
dpc-4500	242	3	.	.	PROPN
dpc-4500	242	4	prolidase	prolidase	PROPN
dpc-4500	242	5	is	be	AUX
dpc-4500	242	6	an	an	DET
dpc-4500	242	7	enzyme	enzyme	NOUN
dpc-4500	242	8	involved	involve	VERB
dpc-4500	242	9	in	in	ADP
dpc-4500	242	10	collagen	collagen	NOUN
dpc-4500	242	11	metabolism	metabolism	NOUN
dpc-4500	242	12	.	.	PUNCT
dpc-4500	243	1	it	it	PRON
dpc-4500	243	2	is	be	AUX
dpc-4500	243	3	widely	widely	ADV
dpc-4500	243	4	distributed	distribute	VERB
dpc-4500	243	5	in	in	ADP
dpc-4500	243	6	many	many	ADJ
dpc-4500	243	7	tissues	tissue	NOUN
dpc-4500	243	8	such	such	ADJ
dpc-4500	243	9	as	as	ADP
dpc-4500	243	10	bone	bone	NOUN
dpc-4500	243	11	,	,	PUNCT
dpc-4500	243	12	connective	connective	ADJ
dpc-4500	243	13	tissue	tissue	NOUN
dpc-4500	243	14	,	,	PUNCT
dpc-4500	243	15	and	and	CCONJ
dpc-4500	243	16	blood	blood	NOUN
dpc-4500	243	17	cells	cell	NOUN
dpc-4500	243	18	.	.	PUNCT
dpc-4500	244	1	various	various	ADJ
dpc-4500	244	2	studies	study	NOUN
dpc-4500	244	3	suggest	suggest	VERB
dpc-4500	244	4	that	that	SCONJ
dpc-4500	244	5	prolidase	prolidase	NOUN
dpc-4500	244	6	could	could	AUX
dpc-4500	244	7	play	play	VERB
dpc-4500	244	8	a	a	DET
dpc-4500	244	9	significant	significant	ADJ
dpc-4500	244	10	role	role	NOUN
dpc-4500	244	11	in	in	ADP
dpc-4500	244	12	many	many	ADJ
dpc-4500	244	13	physiological	physiological	ADJ
dpc-4500	244	14	and	and	CCONJ
dpc-4500	244	15	pathophysiological	pathophysiological	ADJ
dpc-4500	244	16	processes	process	NOUN
dpc-4500	244	17	,	,	PUNCT
dpc-4500	244	18	including	include	VERB
dpc-4500	244	19	wound	wound	NOUN
dpc-4500	244	20	healing	healing	NOUN
dpc-4500	244	21	,	,	PUNCT
dpc-4500	244	22	inflammation	inflammation	NOUN
dpc-4500	244	23	,	,	PUNCT
dpc-4500	244	24	and	and	CCONJ
dpc-4500	244	25	angiogenesis	angiogenesis	NOUN
dpc-4500	244	26	through	through	ADP
dpc-4500	244	27	the	the	DET
dpc-4500	244	28	regulation	regulation	NOUN
dpc-4500	244	29	of	of	ADP
dpc-4500	244	30	growth	growth	NOUN
dpc-4500	244	31	factors	factor	NOUN
dpc-4500	244	32	and	and	CCONJ
dpc-4500	244	33	transcription	transcription	NOUN
dpc-4500	244	34	factors	factor	NOUN
dpc-4500	244	35	[	[	X
dpc-4500	244	36	10,38	10,38	NOUN
dpc-4500	244	37	]	]	X
dpc-4500	244	38	.	.	PUNCT
dpc-4500	245	1	therefore	therefore	ADV
dpc-4500	245	2	,	,	PUNCT
dpc-4500	245	3	it	it	PRON
dpc-4500	245	4	has	have	AUX
dpc-4500	245	5	been	be	AUX
dpc-4500	245	6	proposed	propose	VERB
dpc-4500	245	7	that	that	SCONJ
dpc-4500	245	8	abnormalities	abnormality	NOUN
dpc-4500	245	9	in	in	ADP
dpc-4500	245	10	prolidase	prolidase	NOUN
dpc-4500	245	11	enzyme	enzyme	NOUN
dpc-4500	245	12	activity	activity	NOUN
dpc-4500	245	13	could	could	AUX
dpc-4500	245	14	play	play	VERB
dpc-4500	245	15	a	a	DET
dpc-4500	245	16	role	role	NOUN
dpc-4500	245	17	in	in	ADP
dpc-4500	245	18	the	the	DET
dpc-4500	245	19	progression	progression	NOUN
dpc-4500	245	20	of	of	ADP
dpc-4500	245	21	many	many	ADJ
dpc-4500	245	22	diseases	disease	NOUN
dpc-4500	245	23	[	[	X
dpc-4500	245	24	10	10	NUM
dpc-4500	245	25	]	]	PUNCT
dpc-4500	245	26	.	.	PUNCT
dpc-4500	246	1	yıldız	yıldız	PROPN
dpc-4500	246	2	et	et	PROPN
dpc-4500	246	3	al	al	PROPN
dpc-4500	246	4	.	.	PROPN
dpc-4500	246	5	have	have	AUX
dpc-4500	246	6	indicated	indicate	VERB
dpc-4500	246	7	that	that	SCONJ
dpc-4500	246	8	serum	serum	NOUN
dpc-4500	246	9	prolidase	prolidase	NOUN
dpc-4500	246	10	activity	activity	NOUN
dpc-4500	246	11	is	be	AUX
dpc-4500	246	12	directly	directly	ADV
dpc-4500	246	13	related	relate	VERB
dpc-4500	246	14	to	to	PART
dpc-4500	246	15	oxidative	oxidative	ADJ
dpc-4500	246	16	stress	stress	NOUN
dpc-4500	246	17	(	(	PUNCT
dpc-4500	246	18	os	os	NOUN
dpc-4500	246	19	)	)	PUNCT
dpc-4500	246	20	and	and	CCONJ
dpc-4500	246	21	can	can	AUX
dpc-4500	246	22	be	be	AUX
dpc-4500	246	23	used	use	VERB
dpc-4500	246	24	as	as	ADP
dpc-4500	246	25	an	an	DET
dpc-4500	246	26	indicator	indicator	NOUN
dpc-4500	246	27	of	of	ADP
dpc-4500	246	28	oxidative	oxidative	ADJ
dpc-4500	246	29	stress	stress	NOUN
dpc-4500	246	30	[	[	X
dpc-4500	246	31	20	20	NUM
dpc-4500	246	32	]	]	PUNCT
dpc-4500	246	33	.	.	PUNCT
dpc-4500	247	1	oxidative	oxidative	ADJ
dpc-4500	247	2	stress	stress	NOUN
dpc-4500	247	3	leads	lead	VERB
dpc-4500	247	4	to	to	ADP
dpc-4500	247	5	the	the	DET
dpc-4500	247	6	degradation	degradation	NOUN
dpc-4500	247	7	of	of	ADP
dpc-4500	247	8	collagen	collagen	NOUN
dpc-4500	247	9	,	,	PUNCT
dpc-4500	247	10	a	a	DET
dpc-4500	247	11	process	process	NOUN
dpc-4500	247	12	regulated	regulate	VERB
dpc-4500	247	13	by	by	ADP
dpc-4500	247	14	prolidase	prolidase	NOUN
dpc-4500	247	15	[	[	X
dpc-4500	247	16	19	19	NUM
dpc-4500	247	17	]	]	PUNCT
dpc-4500	247	18	.	.	PUNCT
dpc-4500	248	1	additionally	additionally	ADV
dpc-4500	248	2	,	,	PUNCT
dpc-4500	248	3	the	the	DET
dpc-4500	248	4	severity	severity	NOUN
dpc-4500	248	5	of	of	ADP
dpc-4500	248	6	os	os	NOUN
dpc-4500	248	7	is	be	AUX
dpc-4500	248	8	directly	directly	ADV
dpc-4500	248	9	linked	link	VERB
dpc-4500	248	10	to	to	ADP
dpc-4500	248	11	the	the	DET
dpc-4500	248	12	inhibition	inhibition	NOUN
dpc-4500	248	13	of	of	ADP
dpc-4500	248	14	collagen	collagen	NOUN
dpc-4500	248	15	structure	structure	NOUN
dpc-4500	248	16	,	,	PUNCT
dpc-4500	248	17	and	and	CCONJ
dpc-4500	248	18	prolidase	prolidase	NOUN
dpc-4500	248	19	is	be	AUX
dpc-4500	248	20	considered	consider	VERB
dpc-4500	248	21	the	the	DET
dpc-4500	248	22	main	main	ADJ
dpc-4500	248	23	enzyme	enzyme	NOUN
dpc-4500	248	24	in	in	ADP
dpc-4500	248	25	this	this	DET
dpc-4500	248	26	process	process	NOUN
dpc-4500	249	1	[	[	X
dpc-4500	249	2	10	10	NUM
dpc-4500	249	3	]	]	PUNCT
dpc-4500	249	4	.	.	PUNCT
dpc-4500	250	1	various	various	ADJ
dpc-4500	250	2	studies	study	NOUN
dpc-4500	250	3	to	to	ADP
dpc-4500	250	4	date	date	NOUN
dpc-4500	250	5	have	have	AUX
dpc-4500	250	6	shown	show	VERB
dpc-4500	250	7	that	that	SCONJ
dpc-4500	250	8	collagen	collagen	NOUN
dpc-4500	250	9	,	,	PUNCT
dpc-4500	250	10	being	be	AUX
dpc-4500	250	11	widely	widely	ADV
dpc-4500	250	12	found	find	VERB
dpc-4500	250	13	in	in	ADP
dpc-4500	250	14	many	many	ADJ
dpc-4500	250	15	tissues	tissue	NOUN
dpc-4500	250	16	,	,	PUNCT
dpc-4500	250	17	undergoes	undergo	VERB
dpc-4500	250	18	changes	change	NOUN
dpc-4500	250	19	during	during	ADP
dpc-4500	250	20	the	the	DET
dpc-4500	250	21	course	course	NOUN
dpc-4500	250	22	of	of	ADP
dpc-4500	250	23	various	various	ADJ
dpc-4500	250	24	diseases	disease	NOUN
dpc-4500	250	25	[	[	X
dpc-4500	250	26	18	18	NUM
dpc-4500	250	27	]	]	PUNCT
dpc-4500	250	28	.	.	PUNCT
dpc-4500	251	1	particularly	particularly	ADV
dpc-4500	251	2	in	in	ADP
dpc-4500	251	3	scleroderma	scleroderma	NOUN
dpc-4500	251	4	with	with	ADP
dpc-4500	251	5	organ	organ	NOUN
dpc-4500	251	6	involvement	involvement	NOUN
dpc-4500	251	7	and	and	CCONJ
dpc-4500	251	8	fibrosis	fibrosis	NOUN
dpc-4500	251	9	,	,	PUNCT
dpc-4500	251	10	prolidase	prolidase	NOUN
dpc-4500	251	11	levels	level	NOUN
dpc-4500	251	12	have	have	AUX
dpc-4500	251	13	been	be	AUX
dpc-4500	251	14	found	find	VERB
dpc-4500	251	15	to	to	PART
dpc-4500	251	16	be	be	AUX
dpc-4500	251	17	high	high	ADJ
dpc-4500	252	1	[	[	X
dpc-4500	252	2	38	38	NUM
dpc-4500	252	3	]	]	PUNCT
dpc-4500	252	4	.	.	PUNCT
dpc-4500	253	1	however	however	ADV
dpc-4500	253	2	,	,	PUNCT
dpc-4500	253	3	çelik	çelik	PROPN
dpc-4500	253	4	et	et	PROPN
dpc-4500	253	5	al	al	PROPN
dpc-4500	253	6	.	.	PROPN
dpc-4500	253	7	reported	report	VERB
dpc-4500	253	8	no	no	DET
dpc-4500	253	9	difference	difference	NOUN
dpc-4500	253	10	in	in	ADP
dpc-4500	253	11	serum	serum	NOUN
dpc-4500	253	12	prolidase	prolidase	NOUN
dpc-4500	253	13	activity	activity	NOUN
dpc-4500	253	14	between	between	ADP
dpc-4500	253	15	patients	patient	NOUN
dpc-4500	253	16	with	with	ADP
dpc-4500	253	17	scleroderma	scleroderma	NOUN
dpc-4500	253	18	and	and	CCONJ
dpc-4500	253	19	controls	control	VERB
dpc-4500	253	20	[	[	X
dpc-4500	253	21	40	40	NUM
dpc-4500	253	22	]	]	PUNCT
dpc-4500	253	23	.	.	PUNCT
dpc-4500	254	1	savaş	savaş	PROPN
dpc-4500	254	2	et	et	PROPN
dpc-4500	254	3	al	al	PROPN
dpc-4500	254	4	.	.	PROPN
dpc-4500	254	5	,	,	PUNCT
dpc-4500	254	6	in	in	ADP
dpc-4500	254	7	their	their	PRON
dpc-4500	254	8	study	study	NOUN
dpc-4500	254	9	,	,	PUNCT
dpc-4500	254	10	found	find	VERB
dpc-4500	254	11	low	low	ADJ
dpc-4500	254	12	serum	serum	NOUN
dpc-4500	254	13	prolidase	prolidase	NOUN
dpc-4500	254	14	levels	level	NOUN
dpc-4500	254	15	,	,	PUNCT
dpc-4500	254	16	suggesting	suggest	VERB
dpc-4500	254	17	this	this	PRON
dpc-4500	254	18	could	could	AUX
dpc-4500	254	19	be	be	AUX
dpc-4500	254	20	due	due	ADJ
dpc-4500	254	21	to	to	ADP
dpc-4500	254	22	a	a	DET
dpc-4500	254	23	decrease	decrease	NOUN
dpc-4500	254	24	in	in	ADP
dpc-4500	254	25	collagen	collagen	NOUN
dpc-4500	254	26	turnover	turnover	NOUN
dpc-4500	254	27	,	,	PUNCT
dpc-4500	254	28	and	and	CCONJ
dpc-4500	254	29	possibly	possibly	ADV
dpc-4500	254	30	a	a	DET
dpc-4500	254	31	result	result	NOUN
dpc-4500	254	32	of	of	ADP
dpc-4500	254	33	increased	increase	VERB
dpc-4500	254	34	synthesis	synthesis	NOUN
dpc-4500	254	35	and	and	CCONJ
dpc-4500	254	36	decreased	decrease	VERB
dpc-4500	254	37	degradation	degradation	NOUN
dpc-4500	254	38	.	.	PUNCT
dpc-4500	255	1	they	they	PRON
dpc-4500	255	2	also	also	ADV
dpc-4500	255	3	proposed	propose	VERB
dpc-4500	255	4	that	that	SCONJ
dpc-4500	255	5	this	this	PRON
dpc-4500	255	6	could	could	AUX
dpc-4500	255	7	affect	affect	VERB
dpc-4500	255	8	the	the	DET
dpc-4500	255	9	reduced	reduced	ADJ
dpc-4500	255	10	physical	physical	ADJ
dpc-4500	255	11	functions	function	NOUN
dpc-4500	255	12	in	in	ADP
dpc-4500	255	13	patients	patient	NOUN
dpc-4500	255	14	[	[	X
dpc-4500	255	15	48	48	NUM
dpc-4500	255	16	]	]	PUNCT
dpc-4500	255	17	.	.	PUNCT
dpc-4500	256	1	we	we	PRON
dpc-4500	256	2	also	also	ADV
dpc-4500	256	3	investigated	investigate	VERB
dpc-4500	256	4	prolidase	prolidase	NOUN
dpc-4500	256	5	levels	level	NOUN
dpc-4500	256	6	in	in	ADP
dpc-4500	256	7	ls	ls	PROPN
dpc-4500	256	8	,	,	PUNCT
dpc-4500	256	9	a	a	DET
dpc-4500	256	10	localized	localized	ADJ
dpc-4500	256	11	form	form	NOUN
dpc-4500	256	12	of	of	ADP
dpc-4500	256	13	systemic	systemic	ADJ
dpc-4500	256	14	scleroderma	scleroderma	NOUN
dpc-4500	256	15	,	,	PUNCT
dpc-4500	256	16	and	and	CCONJ
dpc-4500	256	17	found	find	VERB
dpc-4500	256	18	no	no	DET
dpc-4500	256	19	change	change	NOUN
dpc-4500	256	20	.	.	PUNCT
dpc-4500	257	1	this	this	PRON
dpc-4500	257	2	could	could	AUX
dpc-4500	257	3	be	be	AUX
dpc-4500	257	4	due	due	ADJ
dpc-4500	257	5	to	to	ADP
dpc-4500	257	6	the	the	DET
dpc-4500	257	7	localized	localized	ADJ
dpc-4500	257	8	nature	nature	NOUN
dpc-4500	257	9	of	of	ADP
dpc-4500	257	10	the	the	DET
dpc-4500	257	11	disease	disease	NOUN
dpc-4500	257	12	,	,	PUNCT
dpc-4500	257	13	not	not	PART
dpc-4500	257	14	involving	involve	VERB
dpc-4500	257	15	systemic	systemic	ADJ
dpc-4500	257	16	spread	spread	NOUN
dpc-4500	257	17	,	,	PUNCT
dpc-4500	257	18	or	or	CCONJ
dpc-4500	257	19	possibly	possibly	ADV
dpc-4500	257	20	due	due	ADP
dpc-4500	257	21	to	to	ADP
dpc-4500	257	22	the	the	DET
dpc-4500	257	23	small	small	ADJ
dpc-4500	257	24	number	number	NOUN
dpc-4500	257	25	of	of	ADP
dpc-4500	257	26	patients	patient	NOUN
dpc-4500	257	27	.	.	PUNCT
dpc-4500	258	1	conclusion	conclusion	NOUN
dpc-4500	258	2	localized	localized	ADJ
dpc-4500	258	3	scleroderma	scleroderma	NOUN
dpc-4500	258	4	is	be	AUX
dpc-4500	258	5	a	a	DET
dpc-4500	258	6	multifactorial	multifactorial	ADJ
dpc-4500	258	7	disease	disease	NOUN
dpc-4500	258	8	with	with	ADP
dpc-4500	258	9	an	an	DET
dpc-4500	258	10	unknown	unknown	ADJ
dpc-4500	258	11	cause	cause	NOUN
dpc-4500	258	12	.	.	PUNCT
dpc-4500	259	1	based	base	VERB
dpc-4500	259	2	on	on	ADP
dpc-4500	259	3	the	the	DET
dpc-4500	259	4	data	datum	NOUN
dpc-4500	259	5	obtained	obtain	VERB
dpc-4500	259	6	from	from	ADP
dpc-4500	259	7	our	our	PRON
dpc-4500	259	8	study	study	NOUN
dpc-4500	259	9	related	relate	VERB
dpc-4500	259	10	to	to	ADP
dpc-4500	259	11	os	os	VERB
dpc-4500	259	12	,	,	PUNCT
dpc-4500	259	13	we	we	PRON
dpc-4500	259	14	can	can	AUX
dpc-4500	259	15	say	say	VERB
dpc-4500	259	16	that	that	SCONJ
dpc-4500	259	17	the	the	DET
dpc-4500	259	18	thiol	thiol	ADJ
dpc-4500	259	19	-	-	PUNCT
dpc-4500	259	20	disulfide	disulfide	NOUN
dpc-4500	259	21	balance	balance	NOUN
dpc-4500	259	22	is	be	AUX
dpc-4500	259	23	not	not	PART
dpc-4500	259	24	disrupted	disrupt	VERB
dpc-4500	259	25	and	and	CCONJ
dpc-4500	259	26	prolidase	prolidase	NOUN
dpc-4500	259	27	levels	level	NOUN
dpc-4500	259	28	are	be	AUX
dpc-4500	259	29	not	not	PART
dpc-4500	259	30	affected	affect	VERB
dpc-4500	259	31	in	in	ADP
dpc-4500	259	32	ls	ls	PROPN
dpc-4500	259	33	.	.	PUNCT
dpc-4500	260	1	however	however	ADV
dpc-4500	260	2	,	,	PUNCT
dpc-4500	260	3	i	i	PRON
dpc-4500	260	4	m	m	VERB
dpc-4500	260	5	a	a	PRON
dpc-4500	260	6	is	be	AUX
dpc-4500	260	7	negatively	negatively	ADV
dpc-4500	260	8	affected	affect	VERB
dpc-4500	260	9	.	.	PUNCT
dpc-4500	261	1	despite	despite	SCONJ
dpc-4500	261	2	factors	factor	NOUN
dpc-4500	261	3	such	such	ADJ
dpc-4500	261	4	as	as	ADP
dpc-4500	261	5	age	age	NOUN
dpc-4500	261	6	and	and	CCONJ
dpc-4500	261	7	duration	duration	NOUN
dpc-4500	261	8	,	,	PUNCT
dpc-4500	261	9	the	the	DET
dpc-4500	261	10	oxidative	oxidative	ADJ
dpc-4500	261	11	balance	balance	NOUN
dpc-4500	261	12	is	be	AUX
dpc-4500	261	13	not	not	PART
dpc-4500	261	14	disturbed	disturbed	ADJ
dpc-4500	261	15	,	,	PUNCT
dpc-4500	261	16	suggesting	suggest	VERB
dpc-4500	261	17	that	that	SCONJ
dpc-4500	261	18	the	the	DET
dpc-4500	261	19	organism	organism	NOUN
dpc-4500	261	20	can	can	AUX
dpc-4500	261	21	correct	correct	VERB
dpc-4500	261	22	itself	itself	PRON
dpc-4500	261	23	with	with	ADP
dpc-4500	261	24	other	other	ADJ
dpc-4500	261	25	antioxidant	antioxidant	ADJ
dpc-4500	261	26	systems	system	NOUN
dpc-4500	261	27	.	.	PUNCT
dpc-4500	262	1	further	further	ADJ
dpc-4500	262	2	studies	study	NOUN
dpc-4500	262	3	are	be	AUX
dpc-4500	262	4	needed	need	VERB
dpc-4500	262	5	to	to	PART
dpc-4500	262	6	support	support	VERB
dpc-4500	262	7	these	these	DET
dpc-4500	262	8	findings	finding	NOUN
dpc-4500	262	9	.	.	PUNCT
dpc-4500	263	1	we	we	PRON
dpc-4500	263	2	believe	believe	VERB
dpc-4500	263	3	that	that	SCONJ
dpc-4500	263	4	new	new	ADJ
dpc-4500	263	5	and	and	CCONJ
dpc-4500	263	6	comprehensive	comprehensive	ADJ
dpc-4500	263	7	studies	study	NOUN
dpc-4500	263	8	in	in	ADP
dpc-4500	263	9	the	the	DET
dpc-4500	263	10	future	future	NOUN
dpc-4500	263	11	may	may	AUX
dpc-4500	263	12	elucidate	elucidate	VERB
dpc-4500	263	13	the	the	DET
dpc-4500	263	14	pathogenesis	pathogenesis	NOUN
dpc-4500	263	15	of	of	ADP
dpc-4500	263	16	ls	ls	PROPN
dpc-4500	263	17	.	.	PUNCT
dpc-4500	263	18	references	reference	NOUN
dpc-4500	263	19	1	1	NUM
dpc-4500	263	20	.	.	PUNCT
dpc-4500	264	1	papara	papara	PROPN
dpc-4500	264	2	c	c	X
dpc-4500	264	3	,	,	PUNCT
dpc-4500	264	4	de	de	X
dpc-4500	264	5	luca	luca	PROPN
dpc-4500	264	6	da	da	X
dpc-4500	264	7	,	,	PUNCT
dpc-4500	264	8	bieber	bieber	PROPN
dpc-4500	264	9	k	k	PROPN
dpc-4500	264	10	,	,	PUNCT
dpc-4500	264	11	vorobyev	vorobyev	NOUN
dpc-4500	264	12	a	a	NOUN
dpc-4500	264	13	,	,	PUNCT
dpc-4500	264	14	ludwig	ludwig	PROPN
dpc-4500	264	15	rj	rj	PROPN
dpc-4500	264	16	.	.	PROPN
dpc-4500	264	17	morphea	morphea	PROPN
dpc-4500	264	18	:	:	PUNCT
dpc-4500	265	1	the	the	DET
dpc-4500	265	2	2023	2023	NUM
dpc-4500	265	3	update	update	NOUN
dpc-4500	265	4	.	.	PUNCT
dpc-4500	266	1	front	front	ADJ
dpc-4500	266	2	med	med	PROPN
dpc-4500	266	3	(	(	PUNCT
dpc-4500	266	4	lausanne	lausanne	PROPN
dpc-4500	266	5	)	)	PUNCT
dpc-4500	266	6	.	.	PUNCT
dpc-4500	267	1	2023	2023	NUM
dpc-4500	267	2	;	;	PUNCT
dpc-4500	267	3	original	original	ADJ
dpc-4500	267	4	article	article	NOUN
dpc-4500	267	5	|	|	ADV
dpc-4500	267	6	dermatol	dermatol	ADJ
dpc-4500	267	7	pract	pract	NOUN
dpc-4500	267	8	concept	concept	NOUN
dpc-4500	267	9	.	.	PUNCT
dpc-4500	268	1	2024;14(4):e2024249	2024;14(4):e2024249	NUM
dpc-4500	268	2	7	7	NUM
dpc-4500	268	3	sclerosis	sclerosis	NOUN
dpc-4500	268	4	.	.	PUNCT
dpc-4500	268	5	  	  	SPACE
dpc-4500	269	1	clin	clin	PROPN
dpc-4500	269	2	rheumatol	rheumatol	PROPN
dpc-4500	269	3	  	  	SPACE
dpc-4500	269	4	30	30	NUM
dpc-4500	269	5	,	,	PUNCT
dpc-4500	269	6	921–925	921–925	NUM
dpc-4500	269	7	(	(	PUNCT
dpc-4500	269	8	2011	2011	NUM
dpc-4500	269	9	)	)	PUNCT
dpc-4500	269	10	.	.	PUNCT
dpc-4500	270	1	doi	doi	INTJ
dpc-4500	270	2	10.1007/	10.1007/	NUM
dpc-4500	270	3	s10067	s10067	NOUN
dpc-4500	270	4	-	-	PUNCT
dpc-4500	270	5	011	011	NUM
dpc-4500	270	6	-	-	PUNCT
dpc-4500	270	7	1695	1695	NUM
dpc-4500	270	8	-	-	SYM
dpc-4500	270	9	4	4	NUM
dpc-4500	270	10	.	.	X
dpc-4500	270	11	32	32	NUM
dpc-4500	270	12	.	.	PUNCT
dpc-4500	271	1	kilinc	kilinc	PROPN
dpc-4500	271	2	f	f	PROPN
dpc-4500	271	3	,	,	PUNCT
dpc-4500	271	4	sener	sener	NOUN
dpc-4500	271	5	s	s	PROPN
dpc-4500	271	6	,	,	PUNCT
dpc-4500	271	7	akbas	akbas	ADP
dpc-4500	271	8	a	a	DET
dpc-4500	271	9	,	,	PUNCT
dpc-4500	271	10	et	et	PROPN
dpc-4500	271	11	al	al	PROPN
dpc-4500	271	12	.	.	PROPN
dpc-4500	271	13	oxidative	oxidative	ADJ
dpc-4500	271	14	stress	stress	NOUN
dpc-4500	271	15	parameters	parameter	NOUN
dpc-4500	271	16	in	in	ADP
dpc-4500	271	17	localized	localized	ADJ
dpc-4500	271	18	scleroderma	scleroderma	NOUN
dpc-4500	271	19	patients	patient	NOUN
dpc-4500	271	20	.	.	PUNCT
dpc-4500	272	1	arch	arch	ADJ
dpc-4500	272	2	dermatol	dermatol	NOUN
dpc-4500	272	3	res	re	NOUN
dpc-4500	272	4	.	.	PUNCT
dpc-4500	273	1	2016;308	2016;308	NUM
dpc-4500	273	2	:	:	PUNCT
dpc-4500	273	3	625	625	NUM
dpc-4500	273	4	-	-	SYM
dpc-4500	273	5	629	629	NUM
dpc-4500	273	6	.	.	PUNCT
dpc-4500	273	7	doi	doi	NOUN
dpc-4500	273	8	:	:	PUNCT
dpc-4500	273	9	10.1007	10.1007	NUM
dpc-4500	273	10	/	/	SYM
dpc-4500	273	11	s00403	s00403	NOUN
dpc-4500	273	12	-	-	PUNCT
dpc-4500	273	13	016	016	NUM
dpc-4500	273	14	-	-	PUNCT
dpc-4500	273	15	1682	1682	NUM
dpc-4500	273	16	-	-	SYM
dpc-4500	273	17	3	3	NUM
dpc-4500	273	18	.	.	PUNCT
dpc-4500	274	1	epub	epub	PROPN
dpc-4500	274	2	2016	2016	NUM
dpc-4500	274	3	sep	sep	NOUN
dpc-4500	274	4	3	3	NUM
dpc-4500	274	5	.	.	PUNCT
dpc-4500	275	1	pmid	pmid	NOUN
dpc-4500	275	2	:	:	PUNCT
dpc-4500	275	3	27591994	27591994	NUM
dpc-4500	275	4	.	.	PUNCT
dpc-4500	276	1	33	33	NUM
dpc-4500	276	2	.	.	PUNCT
dpc-4500	277	1	uzuncakmak	uzuncakmak	PROPN
dpc-4500	277	2	tk	tk	PROPN
dpc-4500	277	3	,	,	PUNCT
dpc-4500	277	4	koska	koska	PROPN
dpc-4500	277	5	mc	mc	PROPN
dpc-4500	277	6	,	,	PUNCT
dpc-4500	277	7	ozkanli	ozkanli	PROPN
dpc-4500	277	8	s	s	PROPN
dpc-4500	277	9	,	,	PUNCT
dpc-4500	277	10	et	et	PROPN
dpc-4500	277	11	al	al	PROPN
dpc-4500	277	12	.	.	PROPN
dpc-4500	277	13	comparison	comparison	NOUN
dpc-4500	277	14	of	of	ADP
dpc-4500	277	15	the	the	DET
dpc-4500	277	16	tissue	tissue	NOUN
dpc-4500	277	17	expressions	expression	NOUN
dpc-4500	277	18	of	of	ADP
dpc-4500	277	19	glutathione	glutathione	NOUN
dpc-4500	277	20	s	s	PART
dpc-4500	277	21	transferase	transferase	NOUN
dpc-4500	277	22	isoenzymes	isoenzyme	VERB
dpc-4500	277	23	among	among	ADP
dpc-4500	277	24	patients	patient	NOUN
dpc-4500	277	25	with	with	ADP
dpc-4500	277	26	morphea	morphea	ADJ
dpc-4500	277	27	and	and	CCONJ
dpc-4500	277	28	healthy	healthy	ADJ
dpc-4500	277	29	controls	control	NOUN
dpc-4500	277	30	:	:	PUNCT
dpc-4500	277	31	a	a	DET
dpc-4500	277	32	preliminary	preliminary	ADJ
dpc-4500	277	33	study	study	NOUN
dpc-4500	277	34	.	.	PUNCT
dpc-4500	278	1	dermatol	dermatol	NOUN
dpc-4500	278	2	ther	ther	ADV
dpc-4500	278	3	.	.	PUNCT
dpc-4500	279	1	2020	2020	NUM
dpc-4500	279	2	nov;33(6):e14363	nov;33(6):e14363	NOUN
dpc-4500	279	3	.	.	PUNCT
dpc-4500	280	1	doi	doi	NOUN
dpc-4500	280	2	:	:	PUNCT
dpc-4500	280	3	10.1111	10.1111	NUM
dpc-4500	280	4	/	/	SYM
dpc-4500	280	5	dth.14363	dth.14363	NOUN
dpc-4500	280	6	.	.	PUNCT
dpc-4500	281	1	epub	epub	PROPN
dpc-4500	281	2	2020	2020	NUM
dpc-4500	281	3	oct	oct	PROPN
dpc-4500	281	4	8	8	NUM
dpc-4500	281	5	.	.	PUNCT
dpc-4500	282	1	pmid	pmid	NOUN
dpc-4500	282	2	:	:	PUNCT
dpc-4500	282	3	33002252	33002252	NUM
dpc-4500	282	4	.	.	PUNCT
dpc-4500	283	1	34	34	NUM
dpc-4500	283	2	.	.	PUNCT
dpc-4500	284	1	khanna	khanna	PROPN
dpc-4500	284	2	d	d	PROPN
dpc-4500	284	3	,	,	PUNCT
dpc-4500	284	4	furst	furst	PROPN
dpc-4500	284	5	de	de	PROPN
dpc-4500	284	6	,	,	PUNCT
dpc-4500	284	7	clements	clements	PROPN
dpc-4500	284	8	pj	pj	PROPN
dpc-4500	284	9	,	,	PUNCT
dpc-4500	284	10	et	et	PROPN
dpc-4500	284	11	al	al	PROPN
dpc-4500	284	12	.	.	PUNCT
dpc-4500	284	13	standardization	standardization	NOUN
dpc-4500	284	14	of	of	ADP
dpc-4500	284	15	the	the	DET
dpc-4500	284	16	modified	modify	VERB
dpc-4500	284	17	rodnan	rodnan	NOUN
dpc-4500	284	18	skin	skin	NOUN
dpc-4500	284	19	score	score	NOUN
dpc-4500	284	20	for	for	ADP
dpc-4500	284	21	use	use	NOUN
dpc-4500	284	22	in	in	ADP
dpc-4500	284	23	clinical	clinical	ADJ
dpc-4500	284	24	trials	trial	NOUN
dpc-4500	284	25	of	of	ADP
dpc-4500	284	26	systemic	systemic	ADJ
dpc-4500	284	27	sclerosis	sclerosis	NOUN
dpc-4500	284	28	.	.	PUNCT
dpc-4500	285	1	j	j	PROPN
dpc-4500	285	2	scleroderma	scleroderma	PROPN
dpc-4500	285	3	relat	relat	PROPN
dpc-4500	285	4	disord	disord	PROPN
dpc-4500	285	5	.	.	PUNCT
dpc-4500	286	1	2017	2017	NUM
dpc-4500	286	2	.	.	PUNCT
dpc-4500	287	1	doi:10.5301	doi:10.5301	X
dpc-4500	287	2	/jsrd.5000231	/jsrd.5000231	PUNCT
dpc-4500	288	1	35	35	NUM
dpc-4500	288	2	.	.	PUNCT
dpc-4500	289	1	arkachaisri	arkachaisri	PROPN
dpc-4500	289	2	t	t	PROPN
dpc-4500	289	3	,	,	PUNCT
dpc-4500	289	4	vilaiyuk	vilaiyuk	PROPN
dpc-4500	289	5	s	s	NOUN
dpc-4500	289	6	,	,	PUNCT
dpc-4500	289	7	torok	torok	PROPN
dpc-4500	289	8	ks	ks	PROPN
dpc-4500	289	9	,	,	PUNCT
dpc-4500	289	10	medsger	medsger	NOUN
dpc-4500	290	1	ta	ta	PROPN
dpc-4500	290	2	jr	jr	PROPN
dpc-4500	290	3	.	.	PUNCT
dpc-4500	290	4	development	development	NOUN
dpc-4500	290	5	and	and	CCONJ
dpc-4500	290	6	initial	initial	ADJ
dpc-4500	290	7	validation	validation	NOUN
dpc-4500	290	8	of	of	ADP
dpc-4500	290	9	the	the	DET
dpc-4500	290	10	localized	localize	VERB
dpc-4500	290	11	scleroderma	scleroderma	NOUN
dpc-4500	290	12	skin	skin	NOUN
dpc-4500	290	13	damage	damage	NOUN
dpc-4500	290	14	index	index	NOUN
dpc-4500	290	15	and	and	CCONJ
dpc-4500	290	16	physician	physician	NOUN
dpc-4500	290	17	global	global	ADJ
dpc-4500	290	18	assessment	assessment	NOUN
dpc-4500	290	19	of	of	ADP
dpc-4500	290	20	disease	disease	NOUN
dpc-4500	290	21	damage	damage	NOUN
dpc-4500	290	22	:	:	PUNCT
dpc-4500	290	23	a	a	DET
dpc-4500	290	24	proof	proof	NOUN
dpc-4500	290	25	-	-	PUNCT
dpc-4500	290	26	of	of	ADP
dpc-4500	290	27	-	-	PUNCT
dpc-4500	290	28	concept	concept	NOUN
dpc-4500	290	29	study	study	NOUN
dpc-4500	290	30	.	.	PUNCT
dpc-4500	291	1	rheumatology	rheumatology	NOUN
dpc-4500	291	2	(	(	PUNCT
dpc-4500	291	3	oxford	oxford	PROPN
dpc-4500	291	4	)	)	PUNCT
dpc-4500	291	5	2010;49	2010;49	NUM
dpc-4500	291	6	:	:	PUNCT
dpc-4500	291	7	373	373	NUM
dpc-4500	291	8	-	-	SYM
dpc-4500	291	9	81	81	NUM
dpc-4500	291	10	.	.	PUNCT
dpc-4500	292	1	doi	doi	NOUN
dpc-4500	292	2	:	:	PUNCT
dpc-4500	292	3	10.1093	10.1093	NUM
dpc-4500	292	4	/	/	SYM
dpc-4500	292	5	rheumatology	rheumatology	NOUN
dpc-4500	292	6	/	/	SYM
dpc-4500	292	7	kep361	kep361	PROPN
dpc-4500	292	8	.	.	PUNCT
dpc-4500	293	1	epub	epub	PROPN
dpc-4500	293	2	2009	2009	NUM
dpc-4500	293	3	dec	dec	PROPN
dpc-4500	293	4	14	14	NUM
dpc-4500	293	5	.	.	PUNCT
dpc-4500	294	1	pmid	pmid	NOUN
dpc-4500	294	2	:	:	PUNCT
dpc-4500	294	3	20008472	20008472	NUM
dpc-4500	294	4	;	;	PUNCT
dpc-4500	294	5	pmcid	pmcid	ADJ
dpc-4500	294	6	:	:	PUNCT
dpc-4500	294	7	pmc3498950	pmc3498950	NOUN
dpc-4500	294	8	.	.	PUNCT
dpc-4500	295	1	36	36	NUM
dpc-4500	295	2	.	.	X
dpc-4500	295	3	bar	bar	NOUN
dpc-4500	295	4	-	-	PUNCT
dpc-4500	295	5	or	or	CCONJ
dpc-4500	295	6	d	d	NOUN
dpc-4500	295	7	,	,	PUNCT
dpc-4500	295	8	lau	lau	PROPN
dpc-4500	295	9	e	e	PROPN
dpc-4500	295	10	,	,	PUNCT
dpc-4500	295	11	winkler	winkler	PROPN
dpc-4500	295	12	jv	jv	PROPN
dpc-4500	295	13	.	.	PUNCT
dpc-4500	296	1	a	a	DET
dpc-4500	296	2	novel	novel	NOUN
dpc-4500	296	3	assay	assay	VERB
dpc-4500	296	4	for	for	ADP
dpc-4500	296	5	cobaltalbumin	cobaltalbumin	NOUN
dpc-4500	296	6	binding	bind	VERB
dpc-4500	296	7	and	and	CCONJ
dpc-4500	296	8	its	its	PRON
dpc-4500	296	9	potential	potential	NOUN
dpc-4500	296	10	as	as	ADP
dpc-4500	296	11	a	a	DET
dpc-4500	296	12	marker	marker	NOUN
dpc-4500	296	13	for	for	ADP
dpc-4500	296	14	myocardial	myocardial	ADJ
dpc-4500	296	15	ischemia	ischemia	NOUN
dpc-4500	296	16	-	-	PUNCT
dpc-4500	296	17	a	a	DET
dpc-4500	296	18	preliminary	preliminary	ADJ
dpc-4500	296	19	report	report	NOUN
dpc-4500	296	20	.	.	PUNCT
dpc-4500	297	1	j	j	PROPN
dpc-4500	297	2	emerg	emerg	PROPN
dpc-4500	297	3	med	med	PROPN
dpc-4500	297	4	.	.	PROPN
dpc-4500	297	5	2000	2000	NUM
dpc-4500	297	6	;	;	PUNCT
dpc-4500	298	1	19(4):311	19(4):311	NUM
dpc-4500	298	2	-	-	SYM
dpc-4500	298	3	5	5	NUM
dpc-4500	298	4	.	.	PUNCT
dpc-4500	298	5	doi	doi	NOUN
dpc-4500	298	6	:	:	PUNCT
dpc-4500	298	7	10.1016	10.1016	NUM
dpc-4500	298	8	/	/	SYM
dpc-4500	298	9	s0736	s0736	PROPN
dpc-4500	298	10	-	-	PUNCT
dpc-4500	298	11	4679(00)00255	4679(00)00255	NUM
dpc-4500	298	12	-	-	PUNCT
dpc-4500	298	13	9	9	NUM
dpc-4500	298	14	.	.	PUNCT
dpc-4500	299	1	pmid	pmid	NOUN
dpc-4500	299	2	:	:	PUNCT
dpc-4500	299	3	11074321	11074321	NUM
dpc-4500	299	4	.	.	PUNCT
dpc-4500	300	1	37	37	NUM
dpc-4500	300	2	.	.	PUNCT
dpc-4500	301	1	myara	myara	PROPN
dpc-4500	301	2	i	i	PRON
dpc-4500	301	3	,	,	PUNCT
dpc-4500	301	4	myara	myara	VERB
dpc-4500	301	5	i	i	PRON
dpc-4500	301	6	,	,	PUNCT
dpc-4500	301	7	marcon	marcon	PROPN
dpc-4500	301	8	p	p	NOUN
dpc-4500	301	9	,	,	PUNCT
dpc-4500	301	10	lemonnier	lemonnier	ADV
dpc-4500	301	11	a	a	NOUN
dpc-4500	301	12	,	,	PUNCT
dpc-4500	301	13	chateliér	chateliér	PROPN
dpc-4500	301	14	b	b	PROPN
dpc-4500	301	15	,	,	PUNCT
dpc-4500	301	16	mangeot	mangeot	ADJ
dpc-4500	301	17	m.	m.	NOUN
dpc-4500	301	18	determination	determination	NOUN
dpc-4500	301	19	of	of	ADP
dpc-4500	301	20	prolinase	prolinase	NOUN
dpc-4500	301	21	activity	activity	NOUN
dpc-4500	301	22	in	in	ADP
dpc-4500	301	23	plasma	plasma	NOUN
dpc-4500	301	24	.	.	PUNCT
dpc-4500	302	1	application	application	NOUN
dpc-4500	302	2	to	to	ADP
dpc-4500	302	3	liver	liver	NOUN
dpc-4500	302	4	disease	disease	NOUN
dpc-4500	302	5	and	and	CCONJ
dpc-4500	302	6	its	its	PRON
dpc-4500	302	7	relation	relation	NOUN
dpc-4500	302	8	with	with	ADP
dpc-4500	302	9	prolidase	prolidase	NOUN
dpc-4500	302	10	activity	activity	NOUN
dpc-4500	302	11	.	.	PUNCT
dpc-4500	303	1	clin	clin	PROPN
dpc-4500	303	2	biochem	biochem	PROPN
dpc-4500	303	3	.	.	PUNCT
dpc-4500	304	1	1985	1985	NUM
dpc-4500	304	2	aug;18(4):220	aug;18(4):220	NOUN
dpc-4500	304	3	-	-	PUNCT
dpc-4500	304	4	3	3	NUM
dpc-4500	304	5	.	.	PUNCT
dpc-4500	304	6	doi	doi	NOUN
dpc-4500	304	7	:	:	PUNCT
dpc-4500	304	8	10.1016	10.1016	NUM
dpc-4500	304	9	/	/	SYM
dpc-4500	304	10	s0009	s0009	PROPN
dpc-4500	304	11	-	-	PUNCT
dpc-4500	304	12	9120(85)80043	9120(85)80043	NUM
dpc-4500	304	13	-	-	PUNCT
dpc-4500	304	14	6	6	NUM
dpc-4500	304	15	.	.	PUNCT
dpc-4500	305	1	pmid	pmid	NOUN
dpc-4500	305	2	:	:	PUNCT
dpc-4500	305	3	4042319	4042319	NUM
dpc-4500	305	4	.	.	PUNCT
dpc-4500	306	1	38	38	NUM
dpc-4500	306	2	.	.	PUNCT
dpc-4500	307	1	surazynski	surazynski	VERB
dpc-4500	307	2	a	a	PRON
dpc-4500	307	3	,	,	PUNCT
dpc-4500	307	4	surazynski	surazynski	ADJ
dpc-4500	307	5	a	a	PRON
dpc-4500	307	6	,	,	PUNCT
dpc-4500	307	7	miltyk	miltyk	PROPN
dpc-4500	307	8	w	w	PROPN
dpc-4500	307	9	,	,	PUNCT
dpc-4500	307	10	prokop	prokop	PROPN
dpc-4500	307	11	i	i	PRON
dpc-4500	307	12	,	,	PUNCT
dpc-4500	307	13	palka	palka	PROPN
dpc-4500	307	14	j.	j.	PROPN
dpc-4500	307	15	prolidase	prolidase	PROPN
dpc-4500	307	16	-	-	PUNCT
dpc-4500	307	17	dependent	dependent	ADJ
dpc-4500	307	18	regulation	regulation	NOUN
dpc-4500	307	19	of	of	ADP
dpc-4500	307	20	tgf	tgf	PROPN
dpc-4500	307	21	β	β	X
dpc-4500	307	22	(	(	PUNCT
dpc-4500	307	23	corrected	correct	VERB
dpc-4500	307	24	)	)	PUNCT
dpc-4500	307	25	and	and	CCONJ
dpc-4500	307	26	tgf	tgf	PROPN
dpc-4500	307	27	β	β	NOUN
dpc-4500	307	28	receptor	receptor	NOUN
dpc-4500	307	29	expressions	expression	NOUN
dpc-4500	307	30	in	in	ADP
dpc-4500	307	31	human	human	ADJ
dpc-4500	307	32	skin	skin	NOUN
dpc-4500	307	33	fibroblasts	fibroblast	NOUN
dpc-4500	307	34	.	.	PUNCT
dpc-4500	308	1	eur	eur	PROPN
dpc-4500	308	2	j	j	PROPN
dpc-4500	308	3	pharmacol	pharmacol	PROPN
dpc-4500	308	4	.	.	PUNCT
dpc-4500	309	1	2010	2010	NUM
dpc-4500	309	2	dec	dec	PROPN
dpc-4500	309	3	15;649(1	15;649(1	NUM
dpc-4500	309	4	-	-	PUNCT
dpc-4500	309	5	3):115	3):115	NUM
dpc-4500	309	6	-	-	PUNCT
dpc-4500	309	7	9	9	NUM
dpc-4500	309	8	.	.	PUNCT
dpc-4500	310	1	doi	doi	NOUN
dpc-4500	310	2	:	:	PUNCT
dpc-4500	310	3	10.1016	10.1016	NUM
dpc-4500	310	4	/j.ejphar.2010.09.034	/j.ejphar.2010.09.034	PUNCT
dpc-4500	310	5	.	.	PUNCT
dpc-4500	311	1	epub	epub	PROPN
dpc-4500	311	2	2010	2010	NUM
dpc-4500	311	3	sep	sep	PROPN
dpc-4500	311	4	21	21	NUM
dpc-4500	311	5	.	.	PUNCT
dpc-4500	312	1	pmid	pmid	NOUN
dpc-4500	312	2	:	:	PUNCT
dpc-4500	312	3	20868675	20868675	NUM
dpc-4500	312	4	.	.	PUNCT
dpc-4500	313	1	39	39	NUM
dpc-4500	313	2	.	.	PUNCT
dpc-4500	314	1	murrell	murrell	PROPN
dpc-4500	314	2	df	df	PROPN
dpc-4500	314	3	.	.	PUNCT
dpc-4500	315	1	a	a	DET
dpc-4500	315	2	radical	radical	ADJ
dpc-4500	315	3	proposal	proposal	NOUN
dpc-4500	315	4	for	for	ADP
dpc-4500	315	5	the	the	DET
dpc-4500	315	6	pathogenesis	pathogenesis	NOUN
dpc-4500	315	7	of	of	ADP
dpc-4500	315	8	scleroderma	scleroderma	NOUN
dpc-4500	315	9	.	.	PUNCT
dpc-4500	316	1	j	j	PROPN
dpc-4500	316	2	am	be	AUX
dpc-4500	316	3	acad	acad	ADJ
dpc-4500	316	4	dermatol	dermatol	NOUN
dpc-4500	316	5	.	.	PUNCT
dpc-4500	317	1	1993;28:78	1993;28:78	NUM
dpc-4500	317	2	-	-	SYM
dpc-4500	317	3	85	85	NUM
dpc-4500	317	4	.	.	PUNCT
dpc-4500	318	1	doi	doi	NOUN
dpc-4500	318	2	:	:	PUNCT
dpc-4500	318	3	10.1016	10.1016	NUM
dpc-4500	318	4	/0190	/0190	NUM
dpc-4500	318	5	-	-	PUNCT
dpc-4500	318	6	9622(93)70014	9622(93)70014	NUM
dpc-4500	318	7	-	-	PUNCT
dpc-4500	318	8	k.	k.	NOUN
dpc-4500	318	9	pmid	pmid	PROPN
dpc-4500	318	10	:	:	PUNCT
dpc-4500	318	11	8425975	8425975	NUM
dpc-4500	318	12	.	.	PUNCT
dpc-4500	319	1	40	40	NUM
dpc-4500	319	2	.	.	PUNCT
dpc-4500	320	1	celik	celik	VERB
dpc-4500	320	2	a	a	PRON
dpc-4500	320	3	,	,	PUNCT
dpc-4500	320	4	birer	birer	PROPN
dpc-4500	320	5	mn	mn	PROPN
dpc-4500	320	6	,	,	PUNCT
dpc-4500	320	7	kilinc	kilinc	PROPN
dpc-4500	320	8	m.	m.	NOUN
dpc-4500	320	9	serum	serum	PROPN
dpc-4500	320	10	prolidase	prolidase	NOUN
dpc-4500	320	11	activity	activity	NOUN
dpc-4500	320	12	in	in	ADP
dpc-4500	320	13	systemic	systemic	ADJ
dpc-4500	320	14	sclerosis	sclerosis	NOUN
dpc-4500	320	15	.	.	PUNCT
dpc-4500	321	1	clin	clin	PROPN
dpc-4500	321	2	rheumatol	rheumatol	PROPN
dpc-4500	321	3	.	.	PUNCT
dpc-4500	322	1	2017	2017	NUM
dpc-4500	322	2	aug;36(8):1827	aug;36(8):1827	PROPN
dpc-4500	322	3	-	-	PUNCT
dpc-4500	322	4	1832	1832	NUM
dpc-4500	322	5	.	.	PUNCT
dpc-4500	323	1	doi	doi	NOUN
dpc-4500	323	2	:	:	PUNCT
dpc-4500	323	3	10.1007	10.1007	NUM
dpc-4500	323	4	/	/	SYM
dpc-4500	323	5	s10067	s10067	NOUN
dpc-4500	323	6	-	-	PUNCT
dpc-4500	323	7	017	017	NUM
dpc-4500	323	8	-	-	PUNCT
dpc-4500	323	9	3677	3677	NUM
dpc-4500	323	10	-	-	PUNCT
dpc-4500	323	11	7	7	NUM
dpc-4500	323	12	.	.	PUNCT
dpc-4500	324	1	epub	epub	NOUN
dpc-4500	324	2	2017	2017	NUM
dpc-4500	324	3	may	may	PROPN
dpc-4500	324	4	22	22	NUM
dpc-4500	324	5	.	.	PUNCT
dpc-4500	325	1	pmid	pmid	NOUN
dpc-4500	325	2	:	:	PUNCT
dpc-4500	325	3	28534076	28534076	NUM
dpc-4500	325	4	.	.	PUNCT
dpc-4500	326	1	41	41	NUM
dpc-4500	326	2	.	.	PUNCT
dpc-4500	327	1	sambo	sambo	PROPN
dpc-4500	327	2	p	p	PROPN
dpc-4500	327	3	,	,	PUNCT
dpc-4500	327	4	baroni	baroni	PROPN
dpc-4500	327	5	ss	ss	PROPN
dpc-4500	327	6	,	,	PUNCT
dpc-4500	327	7	luchetti	luchetti	PROPN
dpc-4500	327	8	m	m	PROPN
dpc-4500	327	9	,	,	PUNCT
dpc-4500	327	10	et	et	PROPN
dpc-4500	327	11	al	al	PROPN
dpc-4500	327	12	.	.	PROPN
dpc-4500	327	13	oxidative	oxidative	ADJ
dpc-4500	327	14	stress	stress	NOUN
dpc-4500	327	15	in	in	ADP
dpc-4500	327	16	scleroderma	scleroderma	NOUN
dpc-4500	327	17	:	:	PUNCT
dpc-4500	327	18	maintenance	maintenance	NOUN
dpc-4500	327	19	of	of	ADP
dpc-4500	327	20	scleroderma	scleroderma	NOUN
dpc-4500	327	21	fibroblast	fibroblast	ADJ
dpc-4500	327	22	phenotype	phenotype	NOUN
dpc-4500	327	23	by	by	ADP
dpc-4500	327	24	the	the	DET
dpc-4500	327	25	constitutive	constitutive	ADJ
dpc-4500	327	26	up	up	ADJ
dpc-4500	327	27	-	-	PUNCT
dpc-4500	327	28	regulation	regulation	NOUN
dpc-4500	327	29	of	of	ADP
dpc-4500	327	30	reactive	reactive	ADJ
dpc-4500	327	31	oxygen	oxygen	NOUN
dpc-4500	327	32	species	specie	NOUN
dpc-4500	327	33	generation	generation	NOUN
dpc-4500	327	34	through	through	ADP
dpc-4500	327	35	the	the	DET
dpc-4500	327	36	nadph	nadph	ADJ
dpc-4500	327	37	oxidase	oxidase	NOUN
dpc-4500	327	38	complex	complex	ADJ
dpc-4500	327	39	pathway	pathway	NOUN
dpc-4500	327	40	.	.	PUNCT
dpc-4500	328	1	arthritis	arthritis	NOUN
dpc-4500	328	2	rheum	rheum	NOUN
dpc-4500	328	3	.	.	PUNCT
dpc-4500	329	1	2001;44(11):2653–64	2001;44(11):2653–64	NUM
dpc-4500	329	2	.	.	PUNCT
dpc-4500	330	1	doi	doi	NOUN
dpc-4500	330	2	:	:	PUNCT
dpc-4500	330	3	10.1002/1529	10.1002/1529	NUM
dpc-4500	330	4	-	-	SYM
dpc-4500	330	5	0131(200111	0131(200111	NOUN
dpc-4500	330	6	)	)	PUNCT
dpc-4500	330	7	44:11<2653::aid	44:11<2653::aid	NUM
dpc-4500	330	8	-	-	PUNCT
dpc-4500	330	9	art445>3.0.co;2	art445>3.0.co;2	NOUN
dpc-4500	330	10	-	-	PUNCT
dpc-4500	330	11	1	1	NUM
dpc-4500	330	12	.	.	PUNCT
dpc-4500	331	1	pmid	pmid	NOUN
dpc-4500	331	2	:	:	PUNCT
dpc-4500	331	3	11710721	11710721	NUM
dpc-4500	331	4	.	.	PUNCT
dpc-4500	332	1	42	42	NUM
dpc-4500	332	2	.	.	PUNCT
dpc-4500	333	1	devrim	devrim	PROPN
dpc-4500	333	2	e	e	NOUN
dpc-4500	333	3	,	,	PUNCT
dpc-4500	333	4	erten	erten	PROPN
dpc-4500	333	5	s	s	PROPN
dpc-4500	333	6	,	,	PUNCT
dpc-4500	333	7	erguder	erguder	ADJ
dpc-4500	333	8	ib	ib	NOUN
dpc-4500	333	9	,	,	PUNCT
dpc-4500	333	10	namuslu	namuslu	PROPN
dpc-4500	333	11	m	m	PROPN
dpc-4500	333	12	,	,	PUNCT
dpc-4500	333	13	turgay	turgay	PROPN
dpc-4500	333	14	m	m	PROPN
dpc-4500	333	15	,	,	PUNCT
dpc-4500	333	16	durak	durak	PROPN
dpc-4500	333	17	i.	i.	PROPN
dpc-4500	333	18	malondialdehyde	malondialdehyde	PROPN
dpc-4500	333	19	and	and	CCONJ
dpc-4500	333	20	nitric	nitric	ADJ
dpc-4500	333	21	oxide	oxide	NOUN
dpc-4500	333	22	levels	level	NOUN
dpc-4500	333	23	in	in	ADP
dpc-4500	333	24	erythrocytes	erythrocyte	NOUN
dpc-4500	333	25	from	from	ADP
dpc-4500	333	26	patients	patient	NOUN
dpc-4500	333	27	with	with	ADP
dpc-4500	333	28	systemic	systemic	ADJ
dpc-4500	333	29	sclerosis	sclerosis	NOUN
dpc-4500	333	30	.	.	PUNCT
dpc-4500	334	1	med	med	PROPN
dpc-4500	334	2	princ	princ	PROPN
dpc-4500	334	3	pract	pract	PROPN
dpc-4500	334	4	.	.	PUNCT
dpc-4500	335	1	2008;17(4	2008;17(4	NUM
dpc-4500	335	2	):	):	PUNCT
dpc-4500	335	3	349	349	NUM
dpc-4500	335	4	-	-	SYM
dpc-4500	335	5	350	350	NUM
dpc-4500	335	6	.	.	PUNCT
dpc-4500	336	1	doi:10.1159/000129620	doi:10.1159/000129620	NOUN
dpc-4500	336	2	.	.	PUNCT
dpc-4500	337	1	43	43	NUM
dpc-4500	337	2	.	.	PUNCT
dpc-4500	338	1	riccieri	riccieri	PROPN
dpc-4500	338	2	v	v	PROPN
dpc-4500	338	3	,	,	PUNCT
dpc-4500	338	4	spadaro	spadaro	NOUN
dpc-4500	338	5	a	a	PRON
dpc-4500	338	6	,	,	PUNCT
dpc-4500	338	7	fuksa	fuksa	NOUN
dpc-4500	338	8	l	l	NOUN
dpc-4500	338	9	,	,	PUNCT
dpc-4500	338	10	firuzi	firuzi	PROPN
dpc-4500	338	11	o	o	NOUN
dpc-4500	338	12	,	,	PUNCT
dpc-4500	338	13	saso	saso	PROPN
dpc-4500	338	14	l	l	PROPN
dpc-4500	338	15	,	,	PUNCT
dpc-4500	338	16	valesini	valesini	PROPN
dpc-4500	338	17	g.	g.	PROPN
dpc-4500	338	18	specific	specific	ADJ
dpc-4500	338	19	oxidative	oxidative	ADJ
dpc-4500	338	20	stress	stress	NOUN
dpc-4500	338	21	parameters	parameter	NOUN
dpc-4500	338	22	differently	differently	ADV
dpc-4500	338	23	correlate	correlate	VERB
dpc-4500	338	24	with	with	ADP
dpc-4500	338	25	nailfold	nailfold	ADJ
dpc-4500	338	26	capillaroscopy	capillaroscopy	NOUN
dpc-4500	338	27	changes	change	NOUN
dpc-4500	338	28	and	and	CCONJ
dpc-4500	338	29	organ	organ	NOUN
dpc-4500	338	30	involvement	involvement	NOUN
dpc-4500	338	31	in	in	ADP
dpc-4500	338	32	systemic	systemic	ADJ
dpc-4500	338	33	sclerosis	sclerosis	NOUN
dpc-4500	338	34	.	.	PUNCT
dpc-4500	339	1	clin	clin	PROPN
dpc-4500	339	2	rheumatol	rheumatol	NOUN
dpc-4500	339	3	.	.	PUNCT
dpc-4500	340	1	2008;27:225	2008;27:225	NUM
dpc-4500	340	2	-	-	SYM
dpc-4500	340	3	230	230	NUM
dpc-4500	340	4	.	.	PUNCT
dpc-4500	341	1	doi	doi	NOUN
dpc-4500	341	2	:	:	PUNCT
dpc-4500	341	3	10.1007	10.1007	NUM
dpc-4500	341	4	/	/	SYM
dpc-4500	341	5	s10067	s10067	NOUN
dpc-4500	341	6	-	-	PUNCT
dpc-4500	341	7	007	007	NUM
dpc-4500	341	8	-	-	PUNCT
dpc-4500	341	9	0769	0769	NUM
dpc-4500	341	10	-	-	SYM
dpc-4500	341	11	9	9	NUM
dpc-4500	341	12	.	.	PUNCT
dpc-4500	342	1	epub	epub	NOUN
dpc-4500	342	2	2007	2007	NUM
dpc-4500	342	3	oct	oct	NOUN
dpc-4500	342	4	27	27	NUM
dpc-4500	342	5	.	.	PUNCT
dpc-4500	343	1	pmid	pmid	NOUN
dpc-4500	343	2	:	:	PUNCT
dpc-4500	343	3	17965907	17965907	NUM
dpc-4500	343	4	.	.	PUNCT
dpc-4500	344	1	44	44	NUM
dpc-4500	344	2	.	.	PUNCT
dpc-4500	345	1	rinnerthaler	rinnerthaler	PROPN
dpc-4500	345	2	m	m	PROPN
dpc-4500	345	3	,	,	PUNCT
dpc-4500	345	4	bischof	bischof	PROPN
dpc-4500	345	5	j	j	PROPN
dpc-4500	345	6	,	,	PUNCT
dpc-4500	345	7	streubel	streubel	PROPN
dpc-4500	345	8	mk	mk	PROPN
dpc-4500	345	9	,	,	PUNCT
dpc-4500	345	10	trost	trost	PROPN
dpc-4500	345	11	a	a	PRON
dpc-4500	345	12	,	,	PUNCT
dpc-4500	345	13	richter	richter	PROPN
dpc-4500	345	14	k.	k.	PROPN
dpc-4500	345	15	oxidative	oxidative	ADJ
dpc-4500	345	16	stresi	stresi	NOUN
dpc-4500	345	17	in	in	ADP
dpc-4500	345	18	aging	age	VERB
dpc-4500	345	19	human	human	ADJ
dpc-4500	345	20	skin	skin	NOUN
dpc-4500	345	21	.	.	PUNCT
dpc-4500	346	1	biomolecules	biomolecule	NOUN
dpc-4500	346	2	.	.	PUNCT
dpc-4500	347	1	2015	2015	NUM
dpc-4500	347	2	apr	apr	NOUN
dpc-4500	347	3	2014	2014	NUM
dpc-4500	347	4	;	;	PUNCT
dpc-4500	347	5	19(2):59	19(2):59	NUM
dpc-4500	347	6	-	-	SYM
dpc-4500	347	7	64	64	NUM
dpc-4500	347	8	.	.	PUNCT
dpc-4500	348	1	doi	doi	NOUN
dpc-4500	348	2	:	:	PUNCT
dpc-4500	348	3	10.1179/1351000213y.0000000072	10.1179/1351000213y.0000000072	NUM
dpc-4500	348	4	.	.	PUNCT
dpc-4500	349	1	epub	epub	PROPN
dpc-4500	349	2	2013	2013	NUM
dpc-4500	349	3	nov	nov	PROPN
dpc-4500	349	4	12	12	NUM
dpc-4500	349	5	.	.	PUNCT
dpc-4500	350	1	pmid	pmid	NOUN
dpc-4500	350	2	:	:	PUNCT
dpc-4500	350	3	24225260	24225260	NUM
dpc-4500	350	4	;	;	PUNCT
dpc-4500	350	5	pmcid	pmcid	NOUN
dpc-4500	350	6	:	:	PUNCT
dpc-4500	350	7	pmc6837555	pmc6837555	NOUN
dpc-4500	350	8	.	.	PUNCT
dpc-4500	351	1	19	19	NUM
dpc-4500	351	2	.	.	PUNCT
dpc-4500	351	3	altindag	altindag	PROPN
dpc-4500	351	4	o	o	PROPN
dpc-4500	351	5	,	,	PUNCT
dpc-4500	351	6	erel	erel	NOUN
dpc-4500	351	7	o	o	NOUN
dpc-4500	351	8	,	,	PUNCT
dpc-4500	351	9	aksoy	aksoy	PROPN
dpc-4500	351	10	n	n	CCONJ
dpc-4500	351	11	,	,	PUNCT
dpc-4500	351	12	selek	selek	NOUN
dpc-4500	351	13	s	s	PART
dpc-4500	351	14	,	,	PUNCT
dpc-4500	351	15	celik	celik	VERB
dpc-4500	351	16	h	h	PROPN
dpc-4500	351	17	,	,	PUNCT
dpc-4500	351	18	karaoglanoglu	karaoglanoglu	PROPN
dpc-4500	351	19	m.	m.	NOUN
dpc-4500	351	20	increased	increase	VERB
dpc-4500	351	21	oxidative	oxidative	ADJ
dpc-4500	351	22	stress	stress	NOUN
dpc-4500	351	23	and	and	CCONJ
dpc-4500	351	24	its	its	PRON
dpc-4500	351	25	relation	relation	NOUN
dpc-4500	351	26	with	with	ADP
dpc-4500	351	27	collagen	collagen	NOUN
dpc-4500	351	28	metabolism	metabolism	NOUN
dpc-4500	351	29	in	in	ADP
dpc-4500	351	30	knee	knee	NOUN
dpc-4500	351	31	osteoarthritis	osteoarthritis	NOUN
dpc-4500	351	32	.	.	PUNCT
dpc-4500	352	1	rheumatol	rheumatol	PROPN
dpc-4500	352	2	int	int	NOUN
dpc-4500	352	3	.	.	PUNCT
dpc-4500	353	1	2007;27:339–44	2007;27:339–44	X
dpc-4500	353	2	.	.	X
dpc-4500	353	3	doi	doi	NOUN
dpc-4500	353	4	:	:	PUNCT
dpc-4500	353	5	10.1007	10.1007	NUM
dpc-4500	353	6	/	/	SYM
dpc-4500	353	7	s00296	s00296	PROPN
dpc-4500	353	8	-	-	PUNCT
dpc-4500	353	9	006	006	NUM
dpc-4500	353	10	-	-	PUNCT
dpc-4500	353	11	0247	0247	NUM
dpc-4500	353	12	-	-	PUNCT
dpc-4500	353	13	8	8	NUM
dpc-4500	353	14	.	.	PUNCT
dpc-4500	354	1	epub	epub	PROPN
dpc-4500	354	2	2006	2006	NUM
dpc-4500	354	3	nov	nov	PROPN
dpc-4500	354	4	10	10	NUM
dpc-4500	354	5	.	.	PUNCT
dpc-4500	355	1	pmid	pmid	NOUN
dpc-4500	355	2	:	:	PUNCT
dpc-4500	355	3	17096092	17096092	NUM
dpc-4500	355	4	.	.	PUNCT
dpc-4500	356	1	20	20	NUM
dpc-4500	356	2	.	.	X
dpc-4500	357	1	20.yildiz	20.yildiz	PUNCT
dpc-4500	357	2	a	a	X
dpc-4500	357	3	,	,	PUNCT
dpc-4500	357	4	demirbag	demirbag	PROPN
dpc-4500	357	5	r	r	PROPN
dpc-4500	357	6	,	,	PUNCT
dpc-4500	357	7	yilmaz	yilmaz	PROPN
dpc-4500	357	8	r	r	PROPN
dpc-4500	357	9	,	,	PUNCT
dpc-4500	357	10	et	et	PROPN
dpc-4500	357	11	al	al	PROPN
dpc-4500	357	12	.	.	PUNCT
dpc-4500	358	1	the	the	DET
dpc-4500	358	2	association	association	NOUN
dpc-4500	358	3	of	of	ADP
dpc-4500	358	4	serum	serum	NOUN
dpc-4500	358	5	prolidase	prolidase	NOUN
dpc-4500	358	6	activity	activity	NOUN
dpc-4500	358	7	with	with	ADP
dpc-4500	358	8	the	the	DET
dpc-4500	358	9	presence	presence	NOUN
dpc-4500	358	10	and	and	CCONJ
dpc-4500	358	11	severity	severity	NOUN
dpc-4500	358	12	of	of	ADP
dpc-4500	358	13	coronary	coronary	ADJ
dpc-4500	358	14	artery	artery	NOUN
dpc-4500	358	15	disease	disease	NOUN
dpc-4500	358	16	.	.	PUNCT
dpc-4500	359	1	coron	coron	PROPN
dpc-4500	359	2	artery	artery	NOUN
dpc-4500	359	3	dis	dis	PROPN
dpc-4500	359	4	.	.	PUNCT
dpc-4500	360	1	2008;19(5):319–25	2008;19(5):319–25	X
dpc-4500	360	2	.	.	PUNCT
dpc-4500	361	1	doi	doi	NOUN
dpc-4500	361	2	:	:	PUNCT
dpc-4500	361	3	10.1097	10.1097	NUM
dpc-4500	361	4	/	/	SYM
dpc-4500	361	5	mca.0b013e32830042ba	mca.0b013e32830042ba	NOUN
dpc-4500	361	6	.	.	PUNCT
dpc-4500	362	1	pmid	pmid	NOUN
dpc-4500	362	2	:	:	PUNCT
dpc-4500	362	3	18607169	18607169	NUM
dpc-4500	362	4	.	.	PUNCT
dpc-4500	363	1	21	21	NUM
dpc-4500	363	2	.	.	PUNCT
dpc-4500	364	1	21.aciksari	21.aciksari	NUM
dpc-4500	364	2	g	g	NOUN
dpc-4500	364	3	,	,	PUNCT
dpc-4500	364	4	demir	demir	PROPN
dpc-4500	364	5	b	b	PROPN
dpc-4500	364	6	,	,	PUNCT
dpc-4500	364	7	uygun	uygun	PROPN
dpc-4500	364	8	t	t	PROPN
dpc-4500	364	9	,	,	PUNCT
dpc-4500	364	10	et	et	PROPN
dpc-4500	364	11	al	al	PROPN
dpc-4500	364	12	.	.	PROPN
dpc-4500	364	13	serum	serum	PROPN
dpc-4500	364	14	prolidase	prolidase	NOUN
dpc-4500	364	15	activity	activity	NOUN
dpc-4500	364	16	in	in	ADP
dpc-4500	364	17	patients	patient	NOUN
dpc-4500	364	18	with	with	ADP
dpc-4500	364	19	cardiac	cardiac	ADJ
dpc-4500	364	20	syndrome	syndrome	NOUN
dpc-4500	364	21	x.	x.	PROPN
dpc-4500	364	22	north	north	PROPN
dpc-4500	364	23	clin	clin	PROPN
dpc-4500	365	1	istanb	istanb	PROPN
dpc-4500	365	2	2020;7(5):471–477	2020;7(5):471–477	NUM
dpc-4500	365	3	.	.	PUNCT
dpc-4500	365	4	doi	doi	NOUN
dpc-4500	365	5	:	:	PUNCT
dpc-4500	365	6	10.14744	10.14744	NUM
dpc-4500	365	7	/	/	SYM
dpc-4500	365	8	nci.2020.09086	nci.2020.09086	NOUN
dpc-4500	365	9	.	.	PUNCT
dpc-4500	366	1	pmid	pmid	NOUN
dpc-4500	366	2	:	:	PUNCT
dpc-4500	366	3	3316	3316	NUM
dpc-4500	366	4	3883	3883	NUM
dpc-4500	366	5	;	;	PUNCT
dpc-4500	366	6	pmcid	pmcid	ADJ
dpc-4500	366	7	:	:	PUNCT
dpc-4500	366	8	pmc7603856	pmc7603856	NOUN
dpc-4500	366	9	.	.	PUNCT
dpc-4500	367	1	22	22	NUM
dpc-4500	367	2	.	.	PUNCT
dpc-4500	368	1	22.luo	22.luo	PROPN
dpc-4500	368	2	jy	jy	PROPN
dpc-4500	368	3	,	,	PUNCT
dpc-4500	368	4	liu	liu	PROPN
dpc-4500	368	5	x	x	PROPN
dpc-4500	368	6	,	,	PUNCT
dpc-4500	368	7	jiang	jiang	PROPN
dpc-4500	368	8	m	m	PROPN
dpc-4500	368	9	,	,	PUNCT
dpc-4500	368	10	zhao	zhao	PROPN
dpc-4500	368	11	hp	hp	PROPN
dpc-4500	368	12	,	,	PUNCT
dpc-4500	368	13	zhao	zhao	PROPN
dpc-4500	368	14	jj	jj	PROPN
dpc-4500	368	15	.	.	PROPN
dpc-4500	368	16	oxidative	oxidative	ADJ
dpc-4500	368	17	stress	stress	NOUN
dpc-4500	368	18	markers	marker	NOUN
dpc-4500	368	19	in	in	ADP
dpc-4500	368	20	blood	blood	NOUN
dpc-4500	368	21	in	in	ADP
dpc-4500	368	22	system	system	NOUN
dpc-4500	368	23	in	in	ADP
dpc-4500	368	24	blood	blood	NOUN
dpc-4500	368	25	in	in	ADP
dpc-4500	368	26	systemic	systemic	ADJ
dpc-4500	368	27	sclerosis	sclerosis	NOUN
dpc-4500	368	28	:	:	PUNCT
dpc-4500	368	29	a	a	DET
dpc-4500	368	30	meta	meta	ADJ
dpc-4500	368	31	-	-	PUNCT
dpc-4500	368	32	analysis	analysis	NOUN
dpc-4500	368	33	.	.	PUNCT
dpc-4500	369	1	mod	mod	ADJ
dpc-4500	369	2	rheumatol	rheumatol	NOUN
dpc-4500	369	3	.	.	PUNCT
dpc-4500	370	1	2017;27:306	2017;27:306	NUM
dpc-4500	370	2	-	-	PUNCT
dpc-4500	370	3	314	314	NUM
dpc-4500	370	4	.	.	PUNCT
dpc-4500	371	1	doi	doi	NOUN
dpc-4500	371	2	:	:	PUNCT
dpc-4500	371	3	10.1080/14397595.2016.1206510	10.1080/14397595.2016.1206510	NUM
dpc-4500	371	4	.	.	X
dpc-4500	372	1	epub	epub	PROPN
dpc-4500	372	2	2016	2016	NUM
dpc-4500	372	3	jul	jul	PROPN
dpc-4500	372	4	18	18	NUM
dpc-4500	372	5	.	.	PUNCT
dpc-4500	373	1	pmid	pmid	NOUN
dpc-4500	373	2	:	:	PUNCT
dpc-4500	373	3	27425641	27425641	NUM
dpc-4500	373	4	.	.	PUNCT
dpc-4500	374	1	23	23	NUM
dpc-4500	374	2	.	.	PUNCT
dpc-4500	375	1	vona	vona	PROPN
dpc-4500	375	2	r	r	PROPN
dpc-4500	375	3	,	,	PUNCT
dpc-4500	375	4	giovannetti	giovannetti	NOUN
dpc-4500	375	5	a	a	PRON
dpc-4500	375	6	,	,	PUNCT
dpc-4500	375	7	gambardella	gambardella	PROPN
dpc-4500	375	8	l	l	NOUN
dpc-4500	375	9	,	,	PUNCT
dpc-4500	375	10	malorni	malorni	NOUN
dpc-4500	375	11	w	w	PROPN
dpc-4500	375	12	,	,	PUNCT
dpc-4500	375	13	pietraforte	pietraforte	ADJ
dpc-4500	375	14	d	d	NOUN
dpc-4500	375	15	,	,	PUNCT
dpc-4500	375	16	straface	straface	NOUN
dpc-4500	375	17	e.	e.	PROPN
dpc-4500	375	18	oxidative	oxidative	ADJ
dpc-4500	375	19	stress	stress	NOUN
dpc-4500	375	20	in	in	ADP
dpc-4500	375	21	the	the	DET
dpc-4500	375	22	pathogenesis	pathogenesis	NOUN
dpc-4500	375	23	of	of	ADP
dpc-4500	375	24	systemic	systemic	ADJ
dpc-4500	375	25	scleroderma	scleroderma	NOUN
dpc-4500	375	26	:	:	PUNCT
dpc-4500	375	27	an	an	DET
dpc-4500	375	28	overview	overview	NOUN
dpc-4500	375	29	.	.	PUNCT
dpc-4500	376	1	j	j	PROPN
dpc-4500	376	2	cell	cell	NOUN
dpc-4500	376	3	mol	mol	ADP
dpc-4500	376	4	med	med	PROPN
dpc-4500	376	5	.	.	PUNCT
dpc-4500	377	1	2018;22:33083314	2018;22:33083314	X
dpc-4500	377	2	.	.	PUNCT
dpc-4500	377	3	doi	doi	NOUN
dpc-4500	377	4	:	:	PUNCT
dpc-4500	378	1	10.1111	10.1111	NUM
dpc-4500	378	2	/	/	SYM
dpc-4500	378	3	jcmm.13630	jcmm.13630	PROPN
dpc-4500	378	4	.	.	PUNCT
dpc-4500	378	5	epub	epub	PROPN
dpc-4500	378	6	2018	2018	NUM
dpc-4500	378	7	apr	apr	NOUN
dpc-4500	378	8	17	17	NUM
dpc-4500	378	9	.	.	PUNCT
dpc-4500	379	1	pmid	pmid	NOUN
dpc-4500	379	2	:	:	PUNCT
dpc-4500	379	3	29664231	29664231	NUM
dpc-4500	379	4	;	;	PUNCT
dpc-4500	379	5	pmcid	pmcid	NOUN
dpc-4500	379	6	:	:	PUNCT
dpc-4500	379	7	pmc6010858	pmc6010858	NOUN
dpc-4500	379	8	.	.	PUNCT
dpc-4500	380	1	24	24	NUM
dpc-4500	380	2	.	.	PUNCT
dpc-4500	381	1	piera	piera	PROPN
dpc-4500	381	2	-	-	PUNCT
dpc-4500	381	3	velazquez	velazquez	PROPN
dpc-4500	381	4	s	s	PROPN
dpc-4500	381	5	,	,	PUNCT
dpc-4500	381	6	jimenez	jimenez	PROPN
dpc-4500	381	7	sa	sa	PROPN
dpc-4500	381	8	.	.	PUNCT
dpc-4500	381	9	oxidative	oxidative	ADJ
dpc-4500	381	10	stress	stress	NOUN
dpc-4500	381	11	induced	induce	VERB
dpc-4500	381	12	by	by	ADP
dpc-4500	381	13	reactive	reactive	ADJ
dpc-4500	381	14	oxygen	oxygen	NOUN
dpc-4500	381	15	species	specie	NOUN
dpc-4500	381	16	(	(	PUNCT
dpc-4500	381	17	ros	ros	PROPN
dpc-4500	381	18	)	)	PUNCT
dpc-4500	381	19	and	and	CCONJ
dpc-4500	381	20	nadph	nadph	ADJ
dpc-4500	381	21	oxidase	oxidase	NOUN
dpc-4500	381	22	4	4	NUM
dpc-4500	381	23	(	(	PUNCT
dpc-4500	381	24	nox4	nox4	PROPN
dpc-4500	381	25	)	)	PUNCT
dpc-4500	381	26	in	in	ADP
dpc-4500	381	27	the	the	DET
dpc-4500	381	28	pathogenesis	pathogenesis	NOUN
dpc-4500	381	29	of	of	ADP
dpc-4500	381	30	the	the	DET
dpc-4500	381	31	fibrotic	fibrotic	ADJ
dpc-4500	381	32	process	process	NOUN
dpc-4500	381	33	in	in	ADP
dpc-4500	381	34	systemic	systemic	ADJ
dpc-4500	381	35	sclerosis	sclerosis	NOUN
dpc-4500	381	36	:	:	PUNCT
dpc-4500	381	37	a	a	DET
dpc-4500	381	38	promising	promising	ADJ
dpc-4500	381	39	therapeutic	therapeutic	ADJ
dpc-4500	381	40	target	target	NOUN
dpc-4500	381	41	.	.	PUNCT
dpc-4500	381	42	 	 	SPACE
dpc-4500	382	1	j	j	PROPN
dpc-4500	382	2	clin	clin	PROPN
dpc-4500	382	3	med	me	VERB
dpc-4500	382	4	.	.	PUNCT
dpc-4500	383	1	2021;10(20):4791	2021;10(20):4791	X
dpc-4500	383	2	.	.	PUNCT
dpc-4500	383	3	published	publish	VERB
dpc-4500	383	4	2021	2021	NUM
dpc-4500	383	5	oct	oct	NOUN
dpc-4500	383	6	19	19	NUM
dpc-4500	383	7	.	.	PUNCT
dpc-4500	384	1	doi:10.3390	doi:10.3390	PROPN
dpc-4500	384	2	/	/	SYM
dpc-4500	384	3	jcm10204791	jcm10204791	PROPN
dpc-4500	384	4	.	.	PUNCT
dpc-4500	385	1	25	25	NUM
dpc-4500	385	2	.	.	PUNCT
dpc-4500	385	3	gabrielli	gabrielli	PROPN
dpc-4500	385	4	a	a	PRON
dpc-4500	385	5	,	,	PUNCT
dpc-4500	385	6	svegliati	svegliati	PROPN
dpc-4500	385	7	s	s	PART
dpc-4500	385	8	,	,	PUNCT
dpc-4500	385	9	moroncini	moroncini	PROPN
dpc-4500	385	10	g	g	PROPN
dpc-4500	385	11	,	,	PUNCT
dpc-4500	385	12	amico	amico	PROPN
dpc-4500	385	13	d.	d.	PROPN
dpc-4500	385	14	new	new	PROPN
dpc-4500	385	15	insights	insight	NOUN
dpc-4500	385	16	into	into	ADP
dpc-4500	385	17	the	the	DET
dpc-4500	385	18	role	role	NOUN
dpc-4500	385	19	of	of	ADP
dpc-4500	385	20	oxidative	oxidative	ADJ
dpc-4500	385	21	stress	stress	NOUN
dpc-4500	385	22	in	in	ADP
dpc-4500	385	23	scleroderma	scleroderma	NOUN
dpc-4500	385	24	fibrosis	fibrosis	NOUN
dpc-4500	385	25	.	.	PUNCT
dpc-4500	386	1	open	open	ADJ
dpc-4500	386	2	rheumatol	rheumatol	PROPN
dpc-4500	386	3	j.	j.	PROPN
dpc-4500	386	4	2012;6:87	2012;6:87	PROPN
dpc-4500	386	5	-	-	PUNCT
dpc-4500	386	6	95	95	NUM
dpc-4500	386	7	.	.	PUNCT
dpc-4500	387	1	doi	doi	NOUN
dpc-4500	387	2	:	:	PUNCT
dpc-4500	388	1	10.2174/1874312901206010087	10.2174/1874312901206010087	NUM
dpc-4500	388	2	.	.	PUNCT
dpc-4500	389	1	epub	epub	PROPN
dpc-4500	389	2	2012	2012	NUM
dpc-4500	389	3	jun	jun	PROPN
dpc-4500	389	4	15	15	NUM
dpc-4500	389	5	.	.	PUNCT
dpc-4500	390	1	pmid	pmid	NOUN
dpc-4500	390	2	:	:	PUNCT
dpc-4500	390	3	22802906	22802906	NUM
dpc-4500	390	4	;	;	PUNCT
dpc-4500	390	5	pmcid	pmcid	NOUN
dpc-4500	390	6	:	:	PUNCT
dpc-4500	390	7	pmc3395898	pmc3395898	ADJ
dpc-4500	390	8	.	.	PUNCT
dpc-4500	391	1	26	26	NUM
dpc-4500	391	2	.	.	PUNCT
dpc-4500	392	1	abdulle	abdulle	PROPN
dpc-4500	392	2	ae	ae	PROPN
dpc-4500	392	3	,	,	PUNCT
dpc-4500	392	4	van	van	PROPN
dpc-4500	392	5	roon	roon	PROPN
dpc-4500	392	6	am	am	PROPN
dpc-4500	392	7	,	,	PUNCT
dpc-4500	392	8	smit	smit	PROPN
dpc-4500	392	9	aj	aj	PROPN
dpc-4500	392	10	,	,	PUNCT
dpc-4500	392	11	et	et	PROPN
dpc-4500	392	12	al	al	PROPN
dpc-4500	392	13	.	.	PROPN
dpc-4500	393	1	rapid	rapid	ADJ
dpc-4500	393	2	free	free	PROPN
dpc-4500	393	3	thiol	thiol	PROPN
dpc-4500	393	4	rebound	rebound	NOUN
dpc-4500	393	5	is	be	AUX
dpc-4500	393	6	a	a	DET
dpc-4500	393	7	physiological	physiological	ADJ
dpc-4500	393	8	response	response	NOUN
dpc-4500	393	9	following	follow	VERB
dpc-4500	393	10	cold	cold	ADJ
dpc-4500	393	11	-	-	PUNCT
dpc-4500	393	12	induced	induce	VERB
dpc-4500	393	13	vasoconstriction	vasoconstriction	NOUN
dpc-4500	393	14	in	in	ADP
dpc-4500	393	15	healthy	healthy	ADJ
dpc-4500	393	16	humans	human	NOUN
dpc-4500	393	17	,	,	PUNCT
dpc-4500	393	18	primary	primary	ADJ
dpc-4500	393	19	raynaud	raynaud	NOUN
dpc-4500	393	20	and	and	CCONJ
dpc-4500	393	21	systemic	systemic	ADJ
dpc-4500	393	22	sclerosis	sclerosis	NOUN
dpc-4500	393	23	.	.	PUNCT
dpc-4500	394	1	physiol	physiol	PROPN
dpc-4500	394	2	rep	rep	PROPN
dpc-4500	394	3	.	.	PROPN
dpc-4500	394	4	2019	2019	NUM
dpc-4500	394	5	mar;7(6):e14017	mar;7(6):e14017	PROPN
dpc-4500	394	6	.	.	PUNCT
dpc-4500	394	7	doi	doi	NOUN
dpc-4500	394	8	:	:	PUNCT
dpc-4500	394	9	10.14814	10.14814	NUM
dpc-4500	394	10	/phy2.14017	/phy2.14017	PUNCT
dpc-4500	394	11	.	.	PUNCT
dpc-4500	395	1	pmid	pmid	NOUN
dpc-4500	395	2	:	:	PUNCT
dpc-4500	395	3	3091	3091	NUM
dpc-4500	395	4	.	.	PUNCT
dpc-4500	396	1	27	27	NUM
dpc-4500	396	2	.	.	PUNCT
dpc-4500	396	3	kundu	kundu	PROPN
dpc-4500	396	4	d	d	PROPN
dpc-4500	396	5	,	,	PUNCT
dpc-4500	396	6	abraham	abraham	PROPN
dpc-4500	396	7	d	d	PROPN
dpc-4500	396	8	,	,	PUNCT
dpc-4500	396	9	black	black	ADJ
dpc-4500	396	10	cm	cm	NOUN
dpc-4500	396	11	,	,	PUNCT
dpc-4500	396	12	denton	denton	PROPN
dpc-4500	396	13	cp	cp	PROPN
dpc-4500	396	14	,	,	PUNCT
dpc-4500	396	15	bruckdorfer	bruckdorfer	PROPN
dpc-4500	396	16	kr	kr	PROPN
dpc-4500	396	17	.	.	PROPN
dpc-4500	396	18	reduced	reduce	VERB
dpc-4500	396	19	levels	level	NOUN
dpc-4500	396	20	of	of	ADP
dpc-4500	396	21	s	s	NOUN
dpc-4500	396	22	-	-	NOUN
dpc-4500	396	23	nitrosothiols	nitrosothiol	NOUN
dpc-4500	396	24	in	in	ADP
dpc-4500	396	25	plasma	plasma	NOUN
dpc-4500	396	26	of	of	ADP
dpc-4500	396	27	patients	patient	NOUN
dpc-4500	396	28	with	with	ADP
dpc-4500	396	29	systemic	systemic	ADJ
dpc-4500	396	30	sclerosis	sclerosis	NOUN
dpc-4500	396	31	and	and	CCONJ
dpc-4500	396	32	raynaud	raynaud	PROPN
dpc-4500	396	33	’s	’s	PART
dpc-4500	396	34	phenomenon	phenomenon	NOUN
dpc-4500	396	35	.	.	PUNCT
dpc-4500	397	1	vascul	vascul	PROPN
dpc-4500	397	2	pharmacol	pharmacol	PROPN
dpc-4500	397	3	.	.	PUNCT
dpc-4500	398	1	2014;63	2014;63	NUM
dpc-4500	398	2	:	:	PUNCT
dpc-4500	398	3	178	178	NUM
dpc-4500	398	4	-	-	SYM
dpc-4500	398	5	181	181	NUM
dpc-4500	398	6	.	.	PUNCT
dpc-4500	399	1	doi	doi	NOUN
dpc-4500	399	2	:	:	PUNCT
dpc-4500	399	3	10.1016	10.1016	NUM
dpc-4500	399	4	/	/	SYM
dpc-4500	399	5	j.vph.2014.09.003	j.vph.2014.09.003	PROPN
dpc-4500	399	6	.	.	PUNCT
dpc-4500	400	1	epub	epub	PROPN
dpc-4500	400	2	2014	2014	NUM
dpc-4500	400	3	oct	oct	NOUN
dpc-4500	400	4	15	15	NUM
dpc-4500	400	5	.	.	PUNCT
dpc-4500	401	1	pmid	pmid	NOUN
dpc-4500	401	2	:	:	PUNCT
dpc-4500	401	3	25446164	25446164	NUM
dpc-4500	401	4	;	;	PUNCT
dpc-4500	401	5	pmcid	pmcid	ADJ
dpc-4500	401	6	:	:	PUNCT
dpc-4500	401	7	pmc4265732	pmc4265732	ADJ
dpc-4500	401	8	.	.	PUNCT
dpc-4500	402	1	28	28	NUM
dpc-4500	402	2	.	.	PUNCT
dpc-4500	402	3	grygiel	grygiel	NOUN
dpc-4500	402	4	-	-	PUNCT
dpc-4500	402	5	gorniak	gorniak	PROPN
dpc-4500	402	6	b	b	PROPN
dpc-4500	402	7	,	,	PUNCT
dpc-4500	402	8	puszczewicz	puszczewicz	ADJ
dpc-4500	402	9	m.	m.	NOUN
dpc-4500	402	10	oxidative	oxidative	ADJ
dpc-4500	402	11	damage	damage	NOUN
dpc-4500	402	12	and	and	CCONJ
dpc-4500	402	13	antioxidative	antioxidative	ADJ
dpc-4500	402	14	therapy	therapy	NOUN
dpc-4500	402	15	in	in	ADP
dpc-4500	402	16	systemic	systemic	ADJ
dpc-4500	402	17	sclerosis	sclerosis	NOUN
dpc-4500	402	18	.	.	PUNCT
dpc-4500	403	1	mediators	mediator	NOUN
dpc-4500	403	2	inflamm	inflamm	NOUN
dpc-4500	403	3	.	.	PUNCT
dpc-4500	404	1	2014;2014:389582	2014;2014:389582	NUM
dpc-4500	404	2	.	.	PUNCT
dpc-4500	405	1	doi	doi	NOUN
dpc-4500	405	2	:	:	PUNCT
dpc-4500	405	3	10.1155/2014/389582	10.1155/2014/389582	NUM
dpc-4500	405	4	.	.	PUNCT
dpc-4500	406	1	epub	epub	PROPN
dpc-4500	406	2	2014	2014	NUM
dpc-4500	406	3	sep	sep	PROPN
dpc-4500	406	4	8	8	NUM
dpc-4500	406	5	.	.	PUNCT
dpc-4500	407	1	pmid	pmid	NOUN
dpc-4500	407	2	:	:	PUNCT
dpc-4500	407	3	25313270	25313270	NUM
dpc-4500	407	4	;	;	PUNCT
dpc-4500	407	5	pmcid	pmcid	NOUN
dpc-4500	407	6	:	:	PUNCT
dpc-4500	407	7	pmc4172878	pmc4172878	ADJ
dpc-4500	407	8	.	.	PUNCT
dpc-4500	408	1	29	29	NUM
dpc-4500	408	2	.	.	PUNCT
dpc-4500	409	1	svegliati	svegliati	PROPN
dpc-4500	409	2	s	s	PROPN
dpc-4500	409	3	,	,	PUNCT
dpc-4500	409	4	spadoni	spadoni	PROPN
dpc-4500	409	5	t	t	PROPN
dpc-4500	409	6	,	,	PUNCT
dpc-4500	409	7	moroncini	moroncini	PROPN
dpc-4500	409	8	g	g	PROPN
dpc-4500	409	9	,	,	PUNCT
dpc-4500	409	10	gabrielli	gabrielli	PROPN
dpc-4500	409	11	a.	a.	PROPN
dpc-4500	409	12	nadph	nadph	PROPN
dpc-4500	409	13	oxidase	oxidase	NOUN
dpc-4500	409	14	,	,	PUNCT
dpc-4500	409	15	oxidative	oxidative	ADJ
dpc-4500	409	16	stress	stress	NOUN
dpc-4500	409	17	and	and	CCONJ
dpc-4500	409	18	fibrosis	fibrosis	NOUN
dpc-4500	409	19	in	in	ADP
dpc-4500	409	20	systemic	systemic	ADJ
dpc-4500	409	21	sclerosis	sclerosis	NOUN
dpc-4500	409	22	.	.	PUNCT
dpc-4500	410	1	free	free	ADJ
dpc-4500	410	2	radic	radic	ADJ
dpc-4500	410	3	biol	biol	PROPN
dpc-4500	410	4	med	me	VERB
dpc-4500	410	5	.	.	PUNCT
dpc-4500	411	1	2018	2018	NUM
dpc-4500	411	2	sep;125:90	sep;125:90	ADV
dpc-4500	411	3	-	-	PUNCT
dpc-4500	411	4	97	97	NUM
dpc-4500	411	5	.	.	PUNCT
dpc-4500	412	1	doi	doi	NOUN
dpc-4500	412	2	:	:	PUNCT
dpc-4500	412	3	10.1016	10.1016	NUM
dpc-4500	412	4	/	/	SYM
dpc-4500	412	5	j.freeradbiomed	j.freeradbiome	VERB
dpc-4500	412	6	.2018.04.554	.2018.04.554	PROPN
dpc-4500	412	7	.	.	PUNCT
dpc-4500	413	1	epub	epub	PROPN
dpc-4500	413	2	2018	2018	NUM
dpc-4500	413	3	apr	apr	VERB
dpc-4500	413	4	22	22	NUM
dpc-4500	413	5	.	.	PUNCT
dpc-4500	414	1	pmid	pmid	NOUN
dpc-4500	414	2	:	:	PUNCT
dpc-4500	414	3	29694853	29694853	NUM
dpc-4500	414	4	.	.	PUNCT
dpc-4500	415	1	30	30	NUM
dpc-4500	415	2	.	.	PUNCT
dpc-4500	416	1	dziedzic	dziedzic	NOUN
dpc-4500	416	2	r	r	PROPN
dpc-4500	416	3	,	,	PUNCT
dpc-4500	416	4	wójcik	wójcik	PROPN
dpc-4500	416	5	k	k	PROPN
dpc-4500	416	6	,	,	PUNCT
dpc-4500	416	7	olchawa	olchawa	PROPN
dpc-4500	416	8	m	m	PROPN
dpc-4500	416	9	,	,	PUNCT
dpc-4500	416	10	et	et	PROPN
dpc-4500	416	11	al	al	PROPN
dpc-4500	416	12	.	.	PROPN
dpc-4500	416	13	increased	increase	VERB
dpc-4500	416	14	oxidative	oxidative	ADJ
dpc-4500	416	15	stress	stress	NOUN
dpc-4500	416	16	response	response	NOUN
dpc-4500	416	17	in	in	ADP
dpc-4500	416	18	circulating	circulate	VERB
dpc-4500	416	19	blood	blood	NOUN
dpc-4500	416	20	of	of	ADP
dpc-4500	416	21	systemic	systemic	ADJ
dpc-4500	416	22	sclerosis	sclerosis	NOUN
dpc-4500	416	23	patients	patient	NOUN
dpc-4500	416	24	relation	relation	NOUN
dpc-4500	416	25	to	to	ADP
dpc-4500	416	26	disease	disease	NOUN
dpc-4500	416	27	characteristics	characteristic	NOUN
dpc-4500	416	28	and	and	CCONJ
dpc-4500	416	29	inflammatory	inflammatory	ADJ
dpc-4500	416	30	blood	blood	NOUN
dpc-4500	416	31	biomarkers	biomarker	NOUN
dpc-4500	416	32	.	.	PUNCT
dpc-4500	417	1	semin	semin	PROPN
dpc-4500	417	2	arthritis	arthritis	PROPN
dpc-4500	417	3	rheum	rheum	PROPN
dpc-4500	417	4	.	.	PUNCT
dpc-4500	418	1	2023	2023	NUM
dpc-4500	418	2	oct;62:152228	oct;62:152228	NOUN
dpc-4500	418	3	.	.	PUNCT
dpc-4500	419	1	doi	doi	NOUN
dpc-4500	419	2	:	:	PUNCT
dpc-4500	419	3	10.1016	10.1016	NUM
dpc-4500	419	4	/	/	SYM
dpc-4500	419	5	j.semarthrit.2023.152228	j.semarthrit.2023.152228	PROPN
dpc-4500	419	6	.	.	PUNCT
dpc-4500	420	1	epub	epub	PROPN
dpc-4500	420	2	2023	2023	NUM
dpc-4500	420	3	jun	jun	PROPN
dpc-4500	420	4	9	9	NUM
dpc-4500	420	5	.	.	PUNCT
dpc-4500	421	1	pmid	pmid	NOUN
dpc-4500	421	2	:	:	PUNCT
dpc-4500	421	3	37429138	37429138	NUM
dpc-4500	421	4	.	.	PUNCT
dpc-4500	422	1	31	31	NUM
dpc-4500	422	2	.	.	PUNCT
dpc-4500	423	1	ogawa	ogawa	PROPN
dpc-4500	423	2	f	f	PROPN
dpc-4500	423	3	,	,	PUNCT
dpc-4500	423	4	shimizu	shimizu	PROPN
dpc-4500	423	5	k	k	PROPN
dpc-4500	423	6	,	,	PUNCT
dpc-4500	423	7	muroi	muroi	NOUN
dpc-4500	423	8	e	e	NOUN
dpc-4500	423	9	,	,	PUNCT
dpc-4500	423	10	et	et	PROPN
dpc-4500	423	11	al	al	PROPN
dpc-4500	423	12	.	.	PROPN
dpc-4500	423	13	  	  	SPACE
dpc-4500	423	14	increasing	increase	VERB
dpc-4500	423	15	levels	level	NOUN
dpc-4500	423	16	of	of	ADP
dpc-4500	423	17	serum	serum	NOUN
dpc-4500	423	18	antioxidant	antioxidant	ADJ
dpc-4500	423	19	status	status	NOUN
dpc-4500	423	20	,	,	PUNCT
dpc-4500	423	21	total	total	ADJ
dpc-4500	423	22	antioxidant	antioxidant	ADJ
dpc-4500	423	23	power	power	NOUN
dpc-4500	423	24	,	,	PUNCT
dpc-4500	423	25	in	in	ADP
dpc-4500	423	26	systemic	systemic	ADJ
dpc-4500	423	27	8	8	NUM
dpc-4500	423	28	original	original	ADJ
dpc-4500	423	29	article	article	NOUN
dpc-4500	423	30	|	|	ADV
dpc-4500	423	31	dermatol	dermatol	ADJ
dpc-4500	423	32	pract	pract	NOUN
dpc-4500	423	33	concept	concept	NOUN
dpc-4500	423	34	.	.	PUNCT
dpc-4500	424	1	2024;14(4):e2024249	2024;14(4):e2024249	NUM
dpc-4500	424	2	47	47	NUM
dpc-4500	424	3	.	.	PUNCT
dpc-4500	425	1	kirmit	kirmit	PROPN
dpc-4500	425	2	a	a	PRON
dpc-4500	425	3	,	,	PUNCT
dpc-4500	425	4	kader	kader	PROPN
dpc-4500	425	5	s	s	PROPN
dpc-4500	425	6	,	,	PUNCT
dpc-4500	425	7	aksoy	aksoy	PROPN
dpc-4500	425	8	m	m	PROPN
dpc-4500	425	9	,	,	PUNCT
dpc-4500	425	10	bal	bal	PROPN
dpc-4500	425	11	c	c	PROPN
dpc-4500	425	12	,	,	PUNCT
dpc-4500	425	13	nural	nural	PROPN
dpc-4500	425	14	c	c	PROPN
dpc-4500	425	15	,	,	PUNCT
dpc-4500	425	16	aslan	aslan	PROPN
dpc-4500	425	17	o.	o.	PROPN
dpc-4500	425	18	trace	trace	NOUN
dpc-4500	425	19	elements	element	NOUN
dpc-4500	425	20	and	and	CCONJ
dpc-4500	425	21	oxidative	oxidative	ADJ
dpc-4500	425	22	stress	stress	NOUN
dpc-4500	425	23	status	status	NOUN
dpc-4500	425	24	in	in	ADP
dpc-4500	425	25	patients	patient	NOUN
dpc-4500	425	26	with	with	ADP
dpc-4500	425	27	psoriasis	psoriasis	NOUN
dpc-4500	425	28	.	.	PUNCT
dpc-4500	425	29	 	 	SPACE
dpc-4500	426	1	adv	adv	PROPN
dpc-4500	426	2	.	.	PROPN
dpc-4500	426	3	dermatol	dermatol	NOUN
dpc-4500	426	4	.	.	PUNCT
dpc-4500	427	1	allergol	allergol	PROPN
dpc-4500	427	2	.	.	PUNCT
dpc-4500	427	3	 	 	SPACE
dpc-4500	428	1	2020	2020	NUM
dpc-4500	428	2	,	,	PUNCT
dpc-4500	428	3	 	 	SPACE
dpc-4500	428	4	37	37	NUM
dpc-4500	428	5	,	,	PUNCT
dpc-4500	428	6	333–39	333–39	NUM
dpc-4500	428	7	.	.	PUNCT
dpc-4500	429	1	doi	doi	NOUN
dpc-4500	429	2	:	:	PUNCT
dpc-4500	429	3	10.5114	10.5114	NUM
dpc-4500	429	4	/ada.2020.94265	/ada.2020.94265	X
dpc-4500	429	5	.	.	PUNCT
dpc-4500	430	1	epub	epub	PROPN
dpc-4500	430	2	2020	2020	NUM
dpc-4500	430	3	apr	apr	VERB
dpc-4500	430	4	7	7	NUM
dpc-4500	430	5	.	.	PUNCT
dpc-4500	431	1	pmid	pmid	NOUN
dpc-4500	431	2	:	:	PUNCT
dpc-4500	431	3	32792872	32792872	NUM
dpc-4500	431	4	;	;	PUNCT
dpc-4500	431	5	pmcid	pmcid	NOUN
dpc-4500	431	6	:	:	PUNCT
dpc-4500	431	7	pmc7394161	pmc7394161	ADJ
dpc-4500	431	8	.	.	PUNCT
dpc-4500	432	1	48	48	NUM
dpc-4500	432	2	.	.	PUNCT
dpc-4500	433	1	savas	savas	PROPN
dpc-4500	433	2	e	e	PROPN
dpc-4500	433	3	,	,	PUNCT
dpc-4500	433	4	aksoy	aksoy	PROPN
dpc-4500	433	5	n	n	CCONJ
dpc-4500	433	6	,	,	PUNCT
dpc-4500	433	7	pehlivan	pehlivan	PROPN
dpc-4500	433	8	y	y	PROPN
dpc-4500	433	9	,	,	PUNCT
dpc-4500	433	10	et	et	PROPN
dpc-4500	433	11	al	al	PROPN
dpc-4500	433	12	.	.	PUNCT
dpc-4500	433	13	evaluation	evaluation	NOUN
dpc-4500	433	14	of	of	ADP
dpc-4500	433	15	oxidant	oxidant	NOUN
dpc-4500	433	16	and	and	CCONJ
dpc-4500	433	17	antioxidant	antioxidant	ADJ
dpc-4500	433	18	status	status	NOUN
dpc-4500	433	19	and	and	CCONJ
dpc-4500	433	20	relation	relation	NOUN
dpc-4500	433	21	with	with	ADP
dpc-4500	433	22	prolidase	prolidase	NOUN
dpc-4500	433	23	in	in	ADP
dpc-4500	433	24	systemic	systemic	ADJ
dpc-4500	433	25	sclerosis	sclerosis	NOUN
dpc-4500	433	26	.	.	PUNCT
dpc-4500	434	1	wien	wien	PROPN
dpc-4500	434	2	klin	klin	PROPN
dpc-4500	434	3	wochenschr	wochenschr	PROPN
dpc-4500	434	4	.	.	PROPN
dpc-4500	435	1	2014	2014	NUM
dpc-4500	435	2	jun;126(11	jun;126(11	VERB
dpc-4500	435	3	-	-	ADJ
dpc-4500	435	4	12):341	12):341	NUM
dpc-4500	435	5	-	-	PUNCT
dpc-4500	435	6	6	6	NUM
dpc-4500	435	7	.	.	PUNCT
dpc-4500	435	8	doi	doi	NOUN
dpc-4500	435	9	:	:	PUNCT
dpc-4500	435	10	10.1007	10.1007	NUM
dpc-4500	435	11	/	/	SYM
dpc-4500	435	12	s00508	s00508	NOUN
dpc-4500	435	13	-	-	PUNCT
dpc-4500	435	14	014	014	NUM
dpc-4500	435	15	-	-	PUNCT
dpc-4500	435	16	0534	0534	NUM
dpc-4500	435	17	-	-	PUNCT
dpc-4500	435	18	4	4	NUM
dpc-4500	435	19	.	.	PUNCT
dpc-4500	436	1	epub	epub	NOUN
dpc-4500	436	2	2014	2014	NUM
dpc-4500	436	3	may	may	PROPN
dpc-4500	436	4	14	14	NUM
dpc-4500	436	5	.	.	PUNCT
dpc-4500	437	1	pmid	pmid	NOUN
dpc-4500	437	2	:	:	PUNCT
dpc-4500	437	3	24825595	24825595	NUM
dpc-4500	437	4	21;5(2):545	21;5(2):545	NUM
dpc-4500	437	5	-	-	SYM
dpc-4500	437	6	89	89	NUM
dpc-4500	437	7	.	.	PUNCT
dpc-4500	438	1	doi	doi	NOUN
dpc-4500	438	2	:	:	PUNCT
dpc-4500	438	3	10.3390	10.3390	NUM
dpc-4500	438	4	/	/	SYM
dpc-4500	438	5	biom5020545	biom5020545	PROPN
dpc-4500	438	6	.	.	PUNCT
dpc-4500	439	1	pmid	pmid	NOUN
dpc-4500	439	2	:	:	PUNCT
dpc-4500	439	3	25906193	25906193	NUM
dpc-4500	439	4	;	;	PUNCT
dpc-4500	439	5	pmcid	pmcid	NOUN
dpc-4500	439	6	:	:	PUNCT
dpc-4500	439	7	pmc4496685	pmc4496685	VERB
dpc-4500	439	8	.	.	PUNCT
dpc-4500	440	1	45	45	NUM
dpc-4500	440	2	.	.	PUNCT
dpc-4500	440	3	apple	apple	PROPN
dpc-4500	440	4	fs	fs	PROPN
dpc-4500	440	5	.	.	PROPN
dpc-4500	441	1	clinical	clinical	ADJ
dpc-4500	441	2	and	and	CCONJ
dpc-4500	441	3	analytical	analytical	ADJ
dpc-4500	441	4	review	review	NOUN
dpc-4500	441	5	of	of	ADP
dpc-4500	441	6	ischemia	ischemia	NOUN
dpc-4500	441	7	-	-	PUNCT
dpc-4500	441	8	modified	modify	VERB
dpc-4500	441	9	albumin	albumin	NOUN
dpc-4500	441	10	measured	measure	VERB
dpc-4500	441	11	by	by	ADP
dpc-4500	441	12	the	the	DET
dpc-4500	441	13	albumin	albumin	ADJ
dpc-4500	441	14	cobalt	cobalt	NOUN
dpc-4500	441	15	binding	bind	VERB
dpc-4500	441	16	test	test	NOUN
dpc-4500	441	17	.	.	PUNCT
dpc-4500	442	1	adv	adv	PROPN
dpc-4500	442	2	clin	clin	PROPN
dpc-4500	442	3	chem	chem	PROPN
dpc-4500	442	4	.	.	PUNCT
dpc-4500	443	1	2005;39:1	2005;39:1	NUM
dpc-4500	443	2	-	-	SYM
dpc-4500	443	3	10	10	NUM
dpc-4500	443	4	.	.	PUNCT
dpc-4500	444	1	doi	doi	NOUN
dpc-4500	444	2	:	:	PUNCT
dpc-4500	444	3	10.1016	10.1016	NUM
dpc-4500	444	4	/	/	SYM
dpc-4500	444	5	s0065	s0065	ADP
dpc-4500	444	6	-	-	PUNCT
dpc-4500	444	7	2423(04)39001	2423(04)39001	NUM
dpc-4500	444	8	-	-	PUNCT
dpc-4500	444	9	3	3	NUM
dpc-4500	444	10	.	.	PUNCT
dpc-4500	445	1	pmid	pmid	NOUN
dpc-4500	445	2	:	:	PUNCT
dpc-4500	445	3	16013666	16013666	NUM
dpc-4500	445	4	.	.	PUNCT
dpc-4500	446	1	46	46	NUM
dpc-4500	446	2	.	.	PUNCT
dpc-4500	447	1	kor	kor	PROPN
dpc-4500	448	1	a	a	PRON
dpc-4500	448	2	,	,	PUNCT
dpc-4500	448	3	maraş	maraş	ADJ
dpc-4500	448	4	y	y	NOUN
dpc-4500	448	5	,	,	PUNCT
dpc-4500	448	6	atalar	atalar	ADJ
dpc-4500	448	7	e	e	NOUN
dpc-4500	448	8	,	,	PUNCT
dpc-4500	448	9	fırat	fırat	NOUN
dpc-4500	448	10	oğuz	oğuz	PROPN
dpc-4500	448	11	e	e	NOUN
dpc-4500	448	12	,	,	PUNCT
dpc-4500	448	13	gök	gök	ADV
dpc-4500	448	14	k	k	NOUN
dpc-4500	448	15	,	,	PUNCT
dpc-4500	448	16	erel	erel	NOUN
dpc-4500	448	17	ö.	ö.	PROPN
dpc-4500	448	18	ischemia	ischemia	NOUN
dpc-4500	448	19	-	-	PUNCT
dpc-4500	448	20	modified	modify	VERB
dpc-4500	448	21	albumin	albumin	ADJ
dpc-4500	448	22	levels	level	NOUN
dpc-4500	448	23	are	be	AUX
dpc-4500	448	24	elevated	elevate	VERB
dpc-4500	448	25	,	,	PUNCT
dpc-4500	448	26	and	and	CCONJ
dpc-4500	448	27	thiol	thiol	ADJ
dpc-4500	448	28	/	/	SYM
dpc-4500	448	29	disulfite	disulfite	NOUN
dpc-4500	448	30	homeostasis	homeostasis	NOUN
dpc-4500	448	31	is	be	AUX
dpc-4500	448	32	impaired	impair	VERB
dpc-4500	448	33	in	in	ADP
dpc-4500	448	34	behçet	behçet	PROPN
dpc-4500	448	35	’s	’s	PART
dpc-4500	448	36	disease	disease	NOUN
dpc-4500	448	37	.	.	PUNCT
dpc-4500	449	1	ulus	ulus	ADJ
dpc-4500	449	2	romatol	romatol	PROPN
dpc-4500	449	3	derg	derg	PROPN
dpc-4500	449	4	2022;14(1):15	2022;14(1):15	PROPN
dpc-4500	449	5	-	-	SYM
dpc-4500	449	6	22	22	NUM
dpc-4500	449	7	.	.	PUNCT